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Quality of life (QoL) questionnaires are important measures of change in clinical trials and as 
clinical tools they can be used to identify individual problems that may be amenable to 
intervention. However, to date no disease-specific measures of QoL for neuromuscular 
disease (NMD) have been developed. Generic measures have been used but they do not look 
at issues that are specifically relevant in NMD. Therefore, they may miss issues of 
importance to patients and they may also lack sensitivity to change. 
In order to develop a disease specific measure of QoL for NMD, qualitative interviews and a 
postal survey were conducted to explore patients' experiences. A literature review exploring 
the QoL concept, the evolution of QoL assessment and difficulties incurred in measuring QoL 
resulted in the development of a theoretical model of QoL. This was used alongside 
interviews and survey findings to design a disease-specific QoL questionnaire, the 
Individualised Neuromuscular Quality of Life questionnaire (INQoL). 
The INQoL looks at the impact of key NMD symptoms and the effects of NMD upon specific 
areas of life. Resulting scores are based upon patients' satisfaction with and the importance 
they attach to these life areas. 
A pilot study demonstrated the face and content validity of the INQoL and its acceptability to 
patients. Clinimetric evaluation established construct validity and test-retest reliability. A 
preliminary measure of responsiveness over a 3-6 month period was also obtained. Finally, 
clinical utility was assessed in a pilot study. This demonstrated its acceptability to both 
patients and physicians in a clinical setting and potential usefulness as a clinical tool. 
Further research will confirm the responsiveness of the INQoL. There are also plans to 
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CHAPTER I 
CONCEPTUAL AND MEASUREMENT ISSUES IN 
QUALITY OF LIFE 
20 
Chapter 1: Conceptual and measurement issues in quality of life. 
1.1 Introduction. 
Quality of life (QoL) has played an important role in health care since the early 
foundations of medical treatment and ethics. Indeed, patients' point of view about 
QoL and its relation to health can be traced back over 300 years (Apolone and 
Mosconi, 1998). However, it is only over the last century that QoL issues have gained 
more prominence, initially in the fields of politics and sociology but more recently in 
health care. 
In medicine, QoL issues began to receive more attention' after the World Health 
Organisation (WHO, 1948) defined health as "not only the absence of disease-and 
infirmity but also the presence of physical, mental and social well-being". This new 
definition challenged limitations inherent in the previous, largely negative 
conceptualisation of health as simply "the absence of disease". The positive 
connotations of QoL assessment led to its increasing popularity (Gill and Feinstein, 
1994; McHorney et al, 1993) and from the mid-1970s QoL assessments started to 
appear in clinical trials, most notably in the fields of oncology, rheumatology and 
psychiatry (Farquar, 1995). Since this time, QoL assessment has become increasingly 
fashionable. However, there has been considerable uncertainty over the pertinence 
and usefulness of the data generated using existing QoL measures. 
In order to determine the relevance of QoL research and its role in health care it is 
important to explain the rationale behind QoL assessment, to define `quality-of-life' 
and to determine whether or not it is possible to measure QoL. 
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1.2 Why Measure QoL? 
Over the last century, dramatic improvements in health care have led to increases in 
life expectancy and a consequent rise in the number of people living with chronic 
conditions. As a result it has become inappropriate to use traditional measures of 
outcome. Mortality statistics are relevant in acute illness in which the main aim of 
treatment is to prolong or save life. However, for those living with a chronic illness or 
disability, treatment is directed more towards improving QoL (Bowling, 1997). 
Biological (e. g. muscle biopsy, CK level) and functional tests (e. g. muscle strength 
and performance in neuromuscular disease) may not reflect important factors that can 
be affected by medical or social interventions (e. g. QoL or disability). It has therefore 
become necessary to conduct assessments of subjective factors in order to understand 
the effects of disease within the context of patients' lives. Issues such as life 
satisfaction, relationships with family members and the ability to socialise 
(Drummond, 2000) have been incorporated into assessments. These are more relevant 
to patients and may be particularly useful in determining the efficacy of certain 
interventions. 
1.3 The Paradox of Quality of Life. 
The difficulty with using QoL measures to evaluate treatment and overall health is 
that QoL scores often contradict clinician's ratings of health status (Slevin et al, 1988; 
Rothwell et al, 1997) as well as objective measures of health or physical function 
(Addington-Hall and Kalra, 2001). For example, unexpectedly high levels of QoL 
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have been reported in studies of chronically ill and disabled patients (Burckhardt et 
al, 1989; Lundqvist, 1991; Strombeck et al, 2000). Similarly, cancer patients have 
reported levels of satisfaction comparable to healthy comparison groups (Watson and 
Pennebaker, 1989; Fromm et al, 1996; Taylor et al, 1984). 
In a study of patients with moderate to severe disabilities, 50% reported having either 
an excellent or good quality of life (Albrecht and Devlieger, 1999). These 
unexpectedly high levels of QoL were reported as a `disability paradox'. 
These findings of disparity between QoL findings and the clinical picture have meant 
that the usefulness of QoL assessment is uncertain, as it is difficult to determine the 
value of treatments if the outcome changes little despite changes in the clinical 
picture. 
These findings have led researchers to examine the concept of QoL in greater depth 
and have promoted the development of QoL theories with advances in QoL 
measurement. 
1.4 What is Quality of Life? 
The main problem in assessing QoL is the widely acknowledged lack of consensus on 
its definition (Bowling and Brazier, 1995). This has made it difficult to measure QoL 
in a comprehensive and efficient manner and to generalise between QoL studies (Gill 
and Feinstein, 1994). The tendency to class any non-clinical measurement under the 
QoL umbrella (Bowling, 1997) and include QoL measures as an afterthought in 
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clinical trials (Bergner, 1989) has further exacerbated this problem. 
The abstract and subjective nature of QoL lies behind the problems in its 
conceptualisation (Gill and Feinstein, 1994). However, a number of definitions of 
QoL and health-related quality of life (HRQL) converge on the idea that QoL depends 
upon the perceived distance between an individual's current state and the ideal state to 
which s/he aspires (table 1.1). The influence of the social and physical world on QoL 
has also been acknowledged (Elkinton, 1966; Orley and Kukyen, 1994; WHOQoL 
Group 1995). 
The introduction of the health related quality of life (HRQL) construct demonstrated a 
move to enhance the specificity and usefulness of QoL assessment in health care. 
However, like the QoL concept, HRQL is seldom defined in the literature (Bowling, 
1995) and it is arguably no less obscure than QoL considering that almost all areas of 
life are in some way `health-related'. For example, mobility restrictions not only 
influence functional capacities, but also social and family life, occupational life and 
financial status. The definitions of HRQL presented in table 1.2 also imply the 
importance of a state of harmony or equilibrium. 
The idea of QoL as the gap between an individual's current state and how they would 
like to be presents QoL as a conceivably measurable entity. These definitions 
acknowledge the dynamic nature of QoL and take into account the influence of the 
situation (e. g. ill health) and each individual person and his/her goals. 
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Table 1.1: Definitions of quality of life 
" "Harmony within a man, and between a man and his world" (Elkinton, 1966) 
" "The degree of satisfaction of human needs" (Hornquist, 1982) 
" "Individuals' perceptions of their position in life in the context of the culture and value 
systems where they live and in relation to their goals, expectations, standards and 
concerns" (Orley and Kukyen, 1994; WHOQoL Group, 1995) 
" "The extent to which our hopes and ambitions are matched by experience" (Calman, 
1984) 
" "Appraisal of one's current state against some ideal" (Cella and Tulsky 1990; Cella and 
Tulsky 1993) 
" "The discrepancy between ideal and real states" (Campbell et al, 1976) 
Table 1.2: Definitions of health-related quality of life 
""The best possible physical and emotional state compatible with [a patient's] medical 
condition" (Leplege and Hunt, 1997). 
" "A patient-centred focus relating to the impact of a perceived health state on the ability 
to lead a fulfilled life" (Price, 1996) 
1.5 Goal Fulfilment and Emotional Equilibrium: Discrepancy Theories 
The relationship of QoL to a perceived discrepancy between current state and an 
individual's internal standard of comparison is compatible with the multiple 
discrepancy theory (MDT) of satisfaction (Michalos, 1985) and the self-discrepancy 
theory of emotion (Higgins, 1987). 
The MDT states that people compare themselves to multiple standards of 
reference. These include the individual's own past conditions, their aspirations 
and ideal levels of satisfaction, the needs they wish to fulfil and goals they wish to 
achieve, as well as the situations of other people. Comparison with these standards 
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results in a degree of satisfaction based on the discrepancy between the 
individual's current condition and these standards. 
2. In self-discrepancy theory, emotional reaction is believed to depend upon the 
discrepancy between a person's current state and either their ideal state or their 
`ought' state (how others believe a person should or ought to be). Upwards 
comparison (with a standard higher than the individual's own state) is thought to 
result in a decrease in satisfaction and downwards comparison (with a standard 
lower than their current state), in increased satisfaction. 
The dependence of QoL upon this type of discrepancy has been documented in recent 
research on QoL in disability. Albrecht and Devlieger (Albrecht and Devlieger, 1999) 
propose that self-image is impaired when there are discrepancies between what we 
would like to do and what we can do, or between what we used to be able to do and 
what we now can do. By closing such gaps, through a reduction in the constraints of 
the environment or by enhancing an individual's physical capacity, it is believed that a 
`balance between mind, body and spirit' can be achieved, thereby improving QoL. 
1.6 Minimising discrepancy and achieving high QoL 
Perceived `control' is important to QoL (Taylor, 1983; Heyink, 1993) with patients 
who take control and introduce order into their lives reporting high levels of QoL. 
These patients can actively move towards and fulfil aspirations by learning what is 
possible and setting realistic goals. Conversely, patients who report difficulties in 
managing their impairments, have been found to report lower levels of QoL (Albrecht 
and Devlieger, 1999) 
Narrowing perceived discrepancies can occur through an actual (bottom-up) change or 
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a perceived (top-down) change in the situation (due to psychological processes) 
(Diener, 1984). `Bottom-up' changes that might result in an improvement in QoL 
include: 
" An improvement in the patient's physical capacity 
"A reduction in the constraints of the environment 
" An increase in the patient's social support 
`Top-down' changes that might result in an improvement in QoL include: 
9A lowering of expectations 
The setting of more realistic goals 
1.6.1 The Bottom-Up Approach 
The `bottom-up' approach to QoL is based on the idea that there are basic and 
universal human needs (e. g. need for food, warmth and social contact) which, if 
fulfilled, result in positive well being. This parallels the more traditional medical view 
that QoL depends upon an individual's physical state and that those with more severe 
illness or disability will have poorer QoL due to greater difficulties in fulfilling the 
roles and functions expected of `healthy' individuals. Advocates of this approach 
believe that- addressing these `universal' human needs through the use of particular 
medical interventions will improve QoL. 
Maslow's hierarchy of needs (Maslow, 1962; Maslow, 1970) can be equated with this 
approach. This states that the needs at the bottom of the hierarchy must be met, 
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namely the need for warmth, food and safety before an individual can pursue 
satisfaction in other areas of life. The higher needs delineated by Maslow, such as the 
need for acceptance, love, esteem and ultimately self-actualisation (being completely 
true to one's own nature) are likely also shared. However, the way in which these 
needs are fulfilled is likely to differ between individuals. Therefore, there is no agreed 
formula for the fulfilment of individual needs. This presents difficulties in accurately 
capturing QoL and formulating effective interventions to improve QoL. 
1.6.2 The Top-Down Approach 
The `top-down' approach to QoL, or the idea that psychological processes act to alter 
internal standards and accommodate changes (e. g. the onset of disease) can be used to 
explain many unexpected findings in QoL studies. 
These psychological processes are widely studied in relation to happiness and well- 
being (Headey et al, 1984; Wilson, 1967), which like QoL appear to be remarkably 
stable despite changing circumstances. Changes in QoL are widely believed to 
depend upon the influence of coping and adaptation (Lundqvist, 1991; Muldoon et al, 
1998). These influences are particularly important in the QoL evaluations of patients 
with chronic conditions (Cassileth et al, 1984; Breetvelt and van Dam, 1991). 
1.6.2.1 Coping 
Coping strategies are used in order to achieve a balance, or a match, between the 
patient's perceived state and an internal standard of reference (e. g. the individual's 
ideal or the norm of the surrounding social world) (Taylor and Lobel, 1989; 
VanderZee and Buunk, 1995; Gibbons, 1999). Patients adopt diverse coping strategies 
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that depend upon factors such as personality, the situation and the resources available 
(Lazarus and Folkman, 1984; Folkman, 1997). These strategies include seeking 
social support (Taylor et al, 1986; Sarason et al, 1985) and engaging in spiritual 
practice (Park et al, 1990). 
Problem-focused coping tends to involve action on the external world (e. g. fitting a 
stairlift to make moving between floors at home easier), whereas psychological coping 
strategies include refraining expectations (Heyink, 1993; Allison, 1997), and 
reordering goals (Rapkin, 1994). For example, goals might be reorganised in order to 
maintain the self-concept by downgrading the importance of domains that are a 
constant source of negative emotion (Taylor and Brown, 1988; McCrae and Costa, 
1988). 
1.6.2.2 Adaptation 
Adaptation, described as "psychological recuperation after a setback" (Heyink, 1993) 
is important in helping individuals to regain and maintain acceptable levels of well- 
being. It is believed to take place through the process of `habituation' (Helson, 1964), 
in which the reactions of the emotion system to new events gradually dampens over 
time. 
Many findings show that adaptation plays an important role in the well-being of 
people with disability or ill health. For example, time since injury positively predicts 
general satisfaction (Krause and Sternberg, 1997) and patients with congenital 
disabilities report better adjustment than those who acquire disability later on in life 
(Li and Moore, 1998). Adaptation complicates QoL measurement, as it means that 
QoL is likely to remain relatively stable over time despite apparent changes in 
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physical health. 
Of course, the individual situation or the stimulus may influence the rate of 
adaptation. For example, adaptation to the effects of a sweeping event, such as the 
onset of a very disabling condition is likely to take a long time because of the long- 
term effects that this is likely to have on daily life (Suh et al, 1996). Disabling 
conditions may impinge upon a wide variety of goals making adjustment to other 
goals more arduous (Deiner et al, 1999). Similarly, individual differences between 
people and differences in their circumstances influence adaptation and the coping 
strategies adopted. This makes it difficult to interpret QoL findings without 
considering the life context of the individual. 
1.6.2.3. The Influence of Personality 
Another explanation for the disparity between patients' reported experience of health 
and the clinical picture is the influence of personality upon the evaluation of events. 
Knowledge of problems is likely to change more over time than evaluations of health 
status. This is because emotional evaluations are influenced by personality which 
means they are therefore likely to remain relatively stable (Lazarus and Smith, 1988). 
In fact, personality has been found to be one of the strongest and most consistent 
predictors of subjective well-being (Gill and Feinstein, 1994; Bullinger, 1999; Costa 
and McCrae, 1984). Well-being may even depend more on personality than upon the 
individual's positive and negative experiences (Costa and McCrae, 1980; Brickman et 
al, 1978; Diener 1984). 
However, this does not explain findings of significantly lower levels of happiness in 
patients with spinal cord injury compared to those in a `healthy' control group 
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(Brickman et al, 1978). Nor does it explain findings of more negative psychological 
reactions in more severely disabled patients (Viney and Westbrook, 1981). This 
fluctuation of well-being over time and the influence of external events upon 
satisfaction suggests that recent life events interact with personality to influence 
overall well-being (Brief et al, 1993; Feist et al, 1995). 
1.6.2.4 Goal restructuring, response shift and its influence on well being 
An inability or expected inability to satisfy certain goals may lead goal restructuring. 
For example, the importance attached to goals and the content of these goals may 
change (Rapkin, 1994), new goals may emerge (Hyland, 1998), and some goals may 
be abandoned altogether. This process may lead to improved levels of well-being as 
more achievable goals are adopted. 
Goal restructuring has been described in the extensive literature on response shift as 
the process believed to underlie unexpected changes in QoL evaluations. Three types 
of response shift have been proposed (Sprangers and Schwartz, 1999). These 
influence QoL through : 
1. recalibration of the internal standards to which the patient compares his/her 
current state 
2. a change in the conceptualisation of goals (or content of goals) 
3. a change in the importance/value attached to goals 
This framework aims to elucidate the factors that underlie changes in QoL. It is 
proposed that demarcating aspects of response shift in QoL measures will indicate 
whether changes in reported QoL relate to changes in the patient's state of health, 
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their functional ability or to changes in the patient's conceptualisation of QoL. 
1.7 Does Goal Fulfilment Lead to Positive Well-being? 
Defining QoL as the distance between the individual's current and ideal state of being 
presents a neat and measurable entity. However, it is apparent that the closure of this 
`gap' may not result in well-being and that further psychological processes may be at 
work. 
1.7.1 Value of the goal 
As delineated in the response shift literature (Sprangers and Schwartz, 1999), 
individual patients attach differing amounts of importance to the relief of various 
complaints and to particular goals or life areas (Wright et al, 1994). This means that 
goals or areas of life that are more important to individual patients are likely to have a 
greater bearing on QoL. Consequently, a discrepancy between an individual's current 
and ideal state in one of these areas is more likely to have a negative effect than a 
similar discrepancy in an area that is of little consequence to the individual. For 
example, a 65 year old woman who has always been very family oriented may be 
more upset about not being able to pick up her grandchildren than by limitations to her 
leisure activities. 
1.7.2 Expectations 
Regardless of the gap between a patient's current state and the state to which s/he 
aspires, expectations about whether they will achieve their desired state depend upon 
factors such as life situation (Scheier and Carver, 1987) and past success in fulfilling 
goals (Csikszentmihalyi, 1990). Expectations brought about by medical prognosis also 
influence QoL. For example, a study of patients who had been severely injured in an 
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accident but who had a good prognosis reported high levels of reported QoL 
(Schnyder et al, 1999). It may be that as these patients were optimistic about future 
recovery there was no need for them to adapt or adopt any long-term coping strategy 
(Schnyder et al, 1999). 
The more negative expectations that are likely to be held by patients with chronic 
progressive disorders may also play a significant role in QoL, particularly if the 
patient is apprehensive about the prospects of future deterioration. Conversely, 
uncertainty is also believed to play an important role in coping (Allison, 1997), and in 
the maintenance of hope (Padilla et al, 1992). 
Realistic expectations may play an important part in maintaining well-being (e. g. the 
knowledge that a particular treatment will relieve pain in the long term). However, 
changes in expectations complicate the interpretation of QoL scores. For example, 
patient expectations may improve following a successful intervention meaning that 
subsequent measurements of QoL are unlikely to reflect similar beneficial effects due 
to parallel improvements in both current and expected condition (Macduff, 2000). 
1.7.3 Progress and rate of progress 
According to the theory of hedonic relativism it is human nature to strive towards ever 
higher aspirations (Brickman and Campbell, 1971). In fact, the process of moving 
towards or away from one's goals may be more important than the actual achievement 
of these goals (Hsee et al, 1991; Hsee and Abelson, 1991). Furthermore, it has been 
proposed that when efforts to achieve a particular goal are disrupted, individuals stop 
to assess the likelihood they will achieve their goal, taking into account physical or 
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social constraints as well as the resources available to them. This implies that the 
reference against which behaviour is compared may not be the final desired outcome 
but the actual process leading to the achievement of a goal. 
The rate of progression towards or away from aspirations may also be important to 
patients' subjective well-being (Hsee et al, 1991). Therefore, the acceptable or 
desired rate of discrepancy reduction may be another standard of reference with which 
the individual compares their current rate of progress (Carver et al, 1996). 
1.8 Frameworks of Disability and QoL 
1.8.1 QoL within the context of the ICIDH-2 
It has been suggested that the World Health Organisation's "International 
Classification of Impairments, Disabilities, and Handicaps' (ICIDH; WHO, 1980) 
provides a more complete description of disease consequences and health outcomes 
than do generic HRQL measures (Ebrahim, 1995). This may be because it demarcates 
the different levels of disease in a framework that can be used to explain the 
underlying determinants of QoL, and upon which goals for rehabilitation can be 
based. 
The multidimensional relationship between the three levels of disease impact (I, D, 
and H), previously represented in an interactive model (Carr and Thompson, 1994) is 
recognised in the revised ICIDH model (ICIDH-2) (Bickenbach et al, 1999) (Gray and 
Hendershot, 2000). This revised model renames the levels of `Impairment, Disability 
and Handicap' as `Impairment, Activities and Participation' respectively. These 
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represent the direct result of disease or disability upon structure or function at body 
level (Impairment), the restriction or lack of ability to perform activities at the level of 
the individual (Activities) and the disadvantage and role limitation to the individual in 
a social context (Participation). 
The model incorporates the facilitators and barriers that encourage or impede an 
individual's involvement in the activities typical of "healthy" individuals in their 
society. It thereby captures the impact of the condition in the context of patients' lives 
and the environment in which they live. This makes it a good starting point for 
practical intervention and therapeutic action beyond purely medical interventions. 
1.8.2 The Quality of Life "Process" 
Many QoL questionnaires contain items about symptoms and functioning within 
various life domains as well as items that relate to satisfaction and general well-being, 
all of which are important to the overall picture of QoL. The aggregation of scores 
into an overall QoL index or separate domain scores does not always allow 
investigators to differentiate between the determinants of QoL (e. g. symptoms, 
disease- and symptom-related impact) and QoL itself. 
QoL has more recently been approached as a process rather than as an outcome 
(Leventhal and Coleman, 1997; Hyland, 1992; Wilson and Cleary, 1995). These 
approaches seek to separate out and thereby better understand the determinants of 
QoL. The process model (Leventhal and Coleman, 1997) includes: 
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1. a. Symptoms, emotions and functioning as experienced by patients 
b. Patients attribution of these symptoms, emotions and functioning to disease or 
treatment 
2. Patients' interpretation of their physical and emotional sensations 
3. The integration of these assessments (e. g. experienced symptoms, emotions and the 
interpretations of these physical and emotional sensations) into overall QoL 
judgements. 
Hyland presents a similar model that represents QoL as a causal sequence of 
symptoms and anticipated symptoms, the problems caused by these and patients' 
evaluation of these symptoms and problems (Hyland, 1992). Psychological factors 
are also introduced into the model. These include the interpretation of symptoms, 
coping style and final evaluations of these problems and symptoms. 
By separating out these underlying factors these models aim to clarify how health 
professionals can use HRQL data to guide and improve therapeutic interventions 
(Wilson and Cleary 1995; Carr and Higginson, 2001). Questionnaires based on these 
models should highlight problems that may be amenable to treatment and indicate the 
most appropriate intervention (e. g. drug treatment, advice, occupational therapy, 
support from social services). They could also provide an idea of how the patient is 
coping with his/her condition and help in the assessment of interventions by 
separating out the effects of adaptation and coping from the direct effects of treatment. 
1.9 A Proposed Model of Health-Related Quality of Life 
From the findings about the influence of illness and disability upon QoL with 
reference to psychological, social and physical factors, a theoretical model of QoL 
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was developed (Figure 1.1). This is based upon 4 main frameworks. 
1. The discrepancy framework 
2. Response shift 
3. The ICIDH-2 (a disability rehabilitation framework) 
4. Process accounts of QoL 
The ICIDH-2 section of the model comprises the Impairment, Activities and 
Participation boxes, each of which may be influenced by an intervention. How 
individuals are affected in these three areas determines their overall current state, 
which also influences their expectations. 
Expectations are also influenced by the individual's internal standards (e. g. how they 
have been in the past or their perceptions of other people) which in turn influences the 
individual's goals. The perceived discrepancy between the individual's current state 
and their goal or ideal state and their progress towards this determines the individual's 
QoL. This evaluation brings about response shift. Through this the individual's 
internal standards or the content of their goals may change with reductions in the 
discrepancy between current and goal state leading to improvements in QoL. They 
may also attach a different value to these goals and thereby change the degree of 
influence of a perceived discrepancy upon QoL. 
This model provides a good theoretical basis on which to develop a QoL questionnaire 
as it encapsulates QoL-as-process models by incorporating disease impact at the levels 
of the ICIDH-2, as well as the psychological influences that act to regulate overall 
evaluations of QoL. Such a framework should facilitate the interpretation of scores 
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Figure 1.1a. Proposed model of health-related quality of life 
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Figure 1.1b. Simplified model of health-related quality of life 
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derived from the scale making it easier to determine the underlying determinants of an 
individual's QoL. 
1.10 Additional QoL Determinants not Employed in Proposed Theoretical Model 
Numerous other psychological processes are likely to influence the perception or 
experience of QoL. These processes were not incorporated into the framework in 
order to avoid unnecessary complication, but are described in sections 1.10.1 and 
1.10.2. 
1.10.1 Inappropriate Aspiration Level 
Inappropriately high or low level aspirations are believed to be detrimental to 
subjective well being. For example, unreasonably high aspirations are related to 
anxiety (Emmons 1992), whereas low-level aspirations have been found to lead to 
boredom (Csikszentmihalyi 1990). Low level aspirations may also reflect a series of 
past failures (Carver et al, 1996; Csikzentmihnly, 1990). This means that well-being 
may well be affected even if the distance between an individual's current state and 
their aspirations is small. 
Similarly, goal restructuring may not always result in increased QoL levels. In 
chronically ill patients, the abandonment of valued goals may eliminate the 
discrepancy between real and ideal states. However, if this also results in a reduction 
in the overall level of positive emotion and motivation there is unlikely to be an 
improvement in QoL (Rapkin, 1994). 
The theoretical model outlined by Hyland (Hyland, 1992) proposed two separate 
affective systems, positive well-being and negative well-being. He also proposes that 
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in order to maintain emotional equilibrium individuals avoid situations in which 
failure is likely or the possibility of fulfilment is low. Therefore, although they may 
minimise negative well-being by abandoning goals and avoiding failure, their chance 
of experiencing positive events and enhancing positive well-being would 
simultaneously be reduced. 
1.10.2 Type of Aspiration 
The nature of the individual's circumstances and their aspirations are also important to 
QoL. For example, the fulfilment of realistic goals that relate to intrinsic needs are 
likely to have a positive impact upon QoL. However, the fulfilment of extrinsically 
motivated desires may ultimately be less satisfying (Emmons 1992; Kasser and Ryan 
1996; Maslow 1970; Diener et al, 1999; Csikszentmihalyi, 1990). For example, an 
individual who has a job in which s/he feels valuable and is respected by his/her 
colleagues is likely to have a higher level of QoL than someone who earns more 
(extrinsic motivation for financial wealth) but does not feel valued or respected for 
what they do. 
These findings correspond to the idea that in order to improve QoL basic and 
universal needs must first be fulfilled before striving towards other goals. 
Nonetheless, the specific kinds of aspirations held within a `hierarchy of needs' 
(Maslow, 1970) are likely to differ depending upon the personality and situation of the 
individual. 
1.11 Conclusion 
QoL assessment represents an important move away from more objective measures of 
health such as morbidity and mortality. These measures provide insufficient 
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information about the impact of disease in the context of patients' lives, an issue that 
has become increasingly important as people are living longer and facing chronic 
illnesses that may impede their ability to lead fulfilled lives. The subjective 
experience of illness is assessed through the administration of QoL measures. 
The importance of assessing QoL is widely acknowledged. However, it has proved to 
be a difficult task given the difficulties involved in conceptualising the construct such 
that it provides useful information within the context of health care. 
The most useful and intuitive definitions of QoL are based around the idea that QoL 
depends upon patients' perception of the degree to which his/her aspirations are 
fulfilled and the perceived possibility of fulfilling them. In the context of disease 
impact, this translates into a conceptualisation of HRQL as the degree to which the 
patient perceives the fulfilment of her aspirations to be influenced by her health. 
However, QoL is not only influenced by the patients' ability to fulfil their aspirations 
or goals. Other factors that play an important role include the individual's progress 
and rate of progress towards their aspirations, their expectations (e. g. based on past 
success in achieving goals or medical prognosis) and their ability to recalibrate the 
scale used to judge their current state. The importance attached to goals also 
influences their contribution to perceived QoL. 
QoL study findings and theories were discussed and have been incorporated into a 
model of HRQL. This framework incorporates the major aspects of discrepancy 
theories of QoL, theories of response shift, the ICIDH-2 and process accounts of QoL. 
It aims to present a comprehensive model that delineates the way QoL is evaluated by 
the individual, incorporating both internal and external influences and how they 
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interact (e. g. expectations and changing internal standards). The interaction between 
personal characteristics and the individual's social and physical environment influence 
evaluations of QoL. By understanding this interaction we can improve QoL 
assessment. The possibility of using the ICIDH-2 or "biopsychosocial" model 
alongside QoL questionnaires may help to guide intervention and rehabilitation. 
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CHAPTER II 
QUALITY OF LIFE QUESTIONNAIRES 
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Chapter 2: Quality of life questionnaires 
2.1 Introduction 
Due to the lack of confidence in the accuracy and reliability of responses to the 
informal question of `how are you feeling? ' (Parkerson et al., 1992), standardised QoL 
questionnaires have increasingly been adopted (Ware, 1993; Jones, 1997). However, 
many QoL studies are impeded by poor design and insufficient assessment methods 
(Bowling, 1997). For example, in a review of the face validity of 75 articles 
purporting to report QoL investigations, it was found that more than half the articles 
examined did not mention the term `quality of life' (Gill and Feinstein, 1994). Further 
findings showed that 15% of the studies reviewed did not provide the investigators' 
conceptualisation of QoL, 47% did not identify the specific domains incorporated in 
the QoL assessment and 36% did not explain their choice of QoL instrument. 
This lack of consistency in QoL assessment and reporting and differences in the 
rationale, development and content of existing QoL measures make it difficult to 
compare and generalise across different studies. 
Despite this, there is increasing evidence about the reliability and validity of QoL 
measures (McDowell and Newell, 1996) as well as numerous clinical trials that 
demonstrate the ability of these measures to demonstrate clinically important change 
(Croog et al., 1986; Bombardier et al., 1986; Tugwell et al., 2000). 
In order to get an idea of the differences between measures and of their merits and 
drawbacks a number of the key QoL questionnaires currently in use will be discussed. 
This will lead on to a more specific discussion of QoL assessment in NMD to date. 
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2.2 Types of Quality of life questionnaire 
The two main types of QoL scale are generic and disease-specific measures. These 
have different properties which make them suitable for use in different kinds of 
investigation (Price, 1996). 
2.2.1 Generic measures 
Generic instruments are developed to assess a wide range of domains and can be 
applied to a diversity of health states, diseases, and conditions. They are usually 
developed over many years, and can therefore be used with more confidence in their 
validity than newly developed specific questionnaires. 
Generic questionnaires can be used to derive norms for age and sex when used in 
population surveys (Price, 1996). This makes them useful in making comparisons 
between different disease groups and conducting health surveys in population or 
patient groups (Fletcher et al., 1992). They also include domains that may not 
typically be included in disease-specific measures and can therefore detect unexpected 
effects. However, as they tend to be less concerned with clinical matters than disease- 
specific measures they may be less suitable for use in clinical practice (Troidl, 1991). 
As they do not pick up more specific areas of concern they often also lack sensitivity 
to clinically relevant change (Fletcher et al, 1992; Price, 1996). 
2.2.2 Disease-specific measures 
In order to address the shortcomings of generic QoL questionnaires, a large array of 
disease-specific instruments started to emerge during the 1980s. These ranged from 
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those developed for hypertension and heart disease (e. g. Croog et al, 1986), to those 
for arthritis (Bombardier et al., 1986). 
These measures include only relevant dimensions which increases their intuitive 
relevance making them more acceptable and less of a burden to patients (Fletcher et 
al., 1992). They also have greater responsiveness than generic questionnaires given 
their particular relevance to the patients under study (Bessette et al., 1998; Bradley et 
al., 1999) (Sprangers and Aronson, 1991). 
The acceptability of these measures and their sensitivity to change means that they are 
useful for monitoring patients progress over time in clinical trials and in clinical 
practice (Bech, 1993). However, they cannot be used to compare groups with 
different conditions, which decreases their usefulness in evaluating interventions that 
are not disease specific (e. g. different nursing methods). They may also overlook 
effects in dimensions that are not included but may be covered in more general 
questionnaires (Fletcher et al, 1992). 
2.2.3 The complementary roles of generic and disease-specific measures 
Generic and disease-specific scales play complementary roles in QoL assessment 
(Task Force of the MGFA, 2000). It is therefore widely recommended that both types 
of scale be used in QoL studies (Garratt et al., 1996; Fletcher et al, 1992; Bowling and 
Brazier, 1995). Disease-targeted scales can provide unique information to supplement 
areas overlooked by generic questionnaires (Vickrey et al., 1997). 
Modular instruments have also been promoted (Padilla et al., 1990; Vickrey et al., 
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1997). These provide a core base of norm-referenced questions relevant to many 
different diseases and populations. Condition-specific modules and questions can be 
added to this core set of questions as required. 
2.3 Standardised generic indices of QoL 
2.3.1 Utility Measures 
Utility measures of QoL are derived from economic and decision theory to reflect 
patients' treatment preferences. The preferences (trade-offs or gambles) may come 
directly from patients' valuation of their own health state, or via ratings of 
hypothetical states of health (Feeny et al., 1996). 
The utility measures used to calculate QoL include econometric tools such as the 
time-trade off, the standard gamble or rating scale methods. The standard gamble 
involves patients choosing between living for rest of their lives in a particular health 
state (e. g. current health) and gambling on an imaginary treatment that could result in 
either a favourable or an unfavourable outcome (e. g. perfect health or death). For the 
time-trade-off method patients are asked to make tradeoffs between a shorter life span 
in perfect health state versus a longer life span in a particular health' state (e. g. current 
health). Rating scales require respondents to rate their current health on a scale (e. g. 
visual analogue scale) that ranges from the worst (0) to the best imaginable health 
state (100). For each of these methods the respondents score is converted into a 
number between 0 and 1. These utility measures are then used to derive quality 
adjusted life years (QALYs) (years of life adjusted for the decrement in quality of 
life), summary measures that incorporate quantity of life as well as HRQL. These are 
calculated by weighting the amount of time spent in various health states by the utility 
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value that reflects the desirability of that state. These are used to justify the use of 
resources for treatment. 
Indirect methods of utility assessment include the Quality of Well-Being (QWB) 
Scale (Kaplan et al., 1976), the Health Utilities Index (HUI) (Feeny et al., 1996) and 
the EuroqoL (Euroqol Group, 1990). 
The HUI systems (of which there are three) provide a more comprehensive approach 
to measuring health status. These use questionnaires to gain information about the 
type and extent of the disabilities and to obtain utility scores providing information 
about the relative importance of the disabilities (Furlong et al., 2001). 
The QWB scale (Kaplan et al., 1976) combines mortality, morbidity and the 
benefits/side-effects of treatment into a single summary score that represents the 
outcome of treatment as QALYs. However, its length and necessary administration by 
a trained interviewer makes it impractical for use as a customary clinical tool (Carr et 
al., 1996). 
The EUROQoL (Euroqol Group, 1990) assesses perceived health in five dimensions; 
mobility, self-care, pain, usual activities and psychological status with items weighted 
according to valuations provided by the general population. Respondents are also 
required to give an overall evaluation of health status on a visual analogue scale 
assessment (represented by a `thermometer'). 
The brevity of the EUROQoL means that responder burden is minimised and it is 
therefore more likely to be completed in full be respondents. However, it does not 
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include important dimensions such as energy and social relationships (Jenkinson et 
al., 1997) and has limited response options, which means that the scale may be 
insensitive to change and unacceptable to many respondents. 
There are a number of limitations associated with the use of utility measures. Firstly, 
they have been found to show only a modest correlation with health status measures 
(Tsevat et al, 1994). This may be because they capture factors other than HRQL, 
such as risk aversion, value attached to life and attitudes towards particular types of 
medical treatment (Wilson and Cleary, 1995). There is also concern that the 
hypothetical questions about abstract health states used in utilities assessment may not 
be a sound basis on which to rest economic decisions about health care as individuals' 
values tend to change with their situation. For example, patients with severe or 
critical conditions have been found to rate death as the worst possible health state 
whereas healthy individuals rate `unconscious' and `worst health state' as worse than 
death (Badia et al., 1995). 
2.3.2 QoL Profiles 
Other than utility measures that result in a single score (index) of QoL there are a 
number of questionnaires that that include questions about different areas or domains 
of life that result in several individual scores representing each area of life. 
For example, the Nottingham Health Profile (NHP) (Hunt and McEwan, 1980; Hunt, 
McEwan et al., 1985; Hunt and McKenna, 1989) has gained widespread use in both 
medical and non-medical settings, in its original form and in translated versions. The 
NHP provides a profile of six scores, representing emotional reactions, energy, pain, 
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physical mobility, sleep and social isolation. 
The first half of the questionnaire represents only severe problems giving rise to floor 
effects, as individuals who are in good health or only mildly affected are inclined to 
affirm few statements. This results in a highly skewed distribution of scores with a 
disproportionate number of respondents scoring at the low end of the scale (Brazier et 
al., 1992), therefore limiting the accuracy and responsiveness of the measure (Hunt et 
al., 1985). 
The use of individual weightings on NHP items has also been cast into doubt as there 
have been high levels of correlation between unweighted and weighted scores 
(Jenkinson, 1991). 
The Sickness Impact Profile (SIP) (Bergner et al., 1981) and its UK version the 
Functional Limitations Profile (FLP) (Patrick and Peach, 1989) measure ill health in 
relation to its impact on behaviour and daily activities and has been used as a standard 
with which to appraise other QoL instruments. The SIP includes 136 items that 
measure 12 dimensions of health, putting it among the longest of the generic 
measures. However, as the questionnaire takes an average of 30 minutes to complete it 
is often impractical for use in QoL studies. It has also been argued that there are 
inconsistencies in its scoring system and a new system has been proposed (Pollard 
and Johnston, 2001). Restrictions have also been demonstrated in the responsiveness 
of the SIP. For example, it is not sensitive enough to monitor disease progression in 
individual patients with motor neurone disease (MND) (McGuire et al., 1996). This 
has led to the development of a modified disease-specific version for MND (McGuire 
et al., 1997). Other disease-specific measures have also been derived from the SIP for 
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stroke (van Straten et al., 1997) and rheumatoid arthritis (Sullivan et al., 1993). 
The MOS Short Form 36 (SF-36) (Ware and Sherbourne, 1992) is a 36-item subset of 
the measures originally developed for the RAND Medical Outcomes Study (Jenkinson 
et al., 1996). Currently the measure of choice, it has gained widespread use in both 
clinical and research settings. It measures subjective heath status on eight dimensions; 
physical function, role limitations, social function, mental health, energy/vitality, pain, 
health perceptions and change in health. Its brevity, acceptability to patients, coverage 
of a wide range of life areas affected by illness and its established properties of 
validity make it an attractive choice of measure (Brazier et al., 1992). However, its 
brevity but coverage of a wide range of areas means that detailed information may be 
lost making the instrument susceptible to floor and ceiling effects (Murrell et al., 
1999). This loss of precision may be acceptable in large-scale population surveys but 
not smaller scale clinical research where detailed information is necessary in order to 
detect clinically important change (Carr et al., 1996). 
2.4 Individualised/Patient Centred Questionnaires 
The domains of standardised scales often only partly tap the relevant information 
(Bowling, 1995) and incorporate items that are superfluous to many other 
respondents. This means they are often less sensitive to change than individualised 
measures that are designed to pinpoint the areas of most relevance and importance to 
patients (Feinstein et al., 1986; Bech, 1993). 
A number of individualised measures have emerged over recent years, most notably 
the Schedule for the Evaluation of Quality of Life (SEIQoL; O'Boyle et al., 1992) and 
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the Patient Generated Index (PGD (Ruts et al., 1994). These individualised 
instruments ask the patient to generate areas of life that have the most relevance and 
importance to their QoL. As these scales are customised to individual patients they 
tend to be more responsive to change (Jones, 1997). The avoidance of irrelevant 
questions also saves the additional burden imposed by longer questionnaires. 
2.4.1 The SEIQoL 
The Schedule for the Evaluation of Quality of Life (SEIQoL) asks respondents to list 
the five most important areas of their lives (cues) in relation to their overall QoL. 
They are then requested to rate their status on each cue on a visual analogue scale 
(VAS). Relative weights of importance are attached to each cue, using one of the two 
available methods of weighting. 
The original interview-based version of the SEIQoL has a complicated weighting 
system, derived from a decision analysis technique called judgement analysis 
(O'Boyle et al., 1992; Browne et al., 1994; Murrell et al., 1999). The relative weight 
of each nominated area is determined by presenting respondents with the profiles of 
30 hypothetical people and asking them to rate the QoL of each person profile on a 
visual analogue scale. Regression analysis is then used to derive the weights for the 
five cues. Scores obtained using this method have been found to be responsive to 
change (Murrell et al., 1999). 
However, as the judgement analysis method of item weighting is very time- 
consuming, the SEIQoL- DW, or direct weighting method was developed to provide a 
more practical tool. This involves weighting each of the nominated domains by 
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representing the relative importance of each area on a sectogram (a round disc with 
coloured segments like a pie chart) that can be adjusted manually so that the more 
important domains receive a larger proportion of the disc. Scores obtained using the 
direct weighting method have been found to relate closely to global ratings of QoL 
and are more sensitive to change than the SF-36 (Murrell et al., 1999). The SEIQOL- 
DW takes between 5 and 10 minutes to administer and has been recommended for use 
in large scale clinical trials as an adjunct to health status measures (Hickey et al., 
1996). 
2.4.2 The Patient Generated Index (PGI) 
The Patient Generated Index (PGI) is an individualised measure of QoL based on 
Calman's definition (Calman, 1984) and the idea that by narrowing the gap between a 
patient's current state and their hopes and expectations there will be a consequent 
improvement in QoL (Ruta et al., 1994). 
Completion of the PGI is similar to the SEIQoL in that it involves patients listing the 
five most important areas of their lives that are affected by their condition and rating 
how badly affected they are in each of the five areas. In a more recent version of the 
PGI two other categories are also rated. One of the categories refers to `all other 
aspects of their life not already mentioned' and the other to `areas affected by all other 
health problems' (other than the one already mentioned) 
(www. dundee. ac. uk/epidemiology/PGI). The final stage involves patients "imagining" 
they can spend 60 "points" (or 14 points in the updated version) in order to improve 
one or more of these areas. Point allocation is used to represent the relative 
importance that would be placed by the patient on an improvement in each of the 
areas. The final PGI score is designed to represent the extent to which reality falls 
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short of expectation in those areas of life in which the patient would most value an 
improvement. The individualised nature of QoL means that the PGI enables the 
generation of high-level activities (e. g. skiing, jogging, squash) compared to the 
physical functioning scale of the SF-36 which covers lower level physical activities 
mainly related to everyday activities (e. g. lifting heavy groceries, bathing and 
dressing). 
The PGI is different from the SEIQoL in that it elicits the five most important areas 
affected by the patient's medical condition, rather than the five most important areas 
of life in general. This means that the particular influence of the patients condition on 
QoL should be highlighted and thereby make the measure more sensitive than the 
SEIQoL to treatment effects (Garratt et al., 1996). Nonetheless, the PGI has been 
recommended for use only as an adjunct to widely used generic questionnaires, such 
as the SF-36 following difficulties experienced in using the direct weighting system 
(point spending) and low response rates to a postal survey version of the scale 
(Macduff and Russell, 1998). 
2.4.3 The Repertory Grid 
The repertory grid method has been adopted as an individualised QoL measure 
(Thunedborg et al., 1993). This involves individuals' comparing their current self- 
image, "you as you are now", to a series of states including, "you as you were before 
treatment" and "you as you wish you were". Respondents are asked to list personally 
relevant issues within a set of predefined life domains (e. g. physical, social) and any 
other `constructs' of importance and then rate these along with a set of predefined 
constructs. 
55 
Unfortunately the assessment is interviewer administered and time consuming, taking 
between 60 and 90 minutes to complete. It also requires the respondent to have a 
reasonably high level of verbal and cognitive ability thereby limiting its wider 
application. 
2.4.4 Disease-specific Individualised Questionnaires 
A number of individualised disease specific measures have also been adopted. This 
includes partially individualised measures for lung disease (Guyatt et al., 1987) the 
Idiographic Functional Status Assessment for AIDS patients (Rapkin, 1994) and the 
Audit for Diabetes Dependent Quality of Life (ADDQoL) (Bradley et al., 1999). 
These adopt a similar approach to the other individualised measures mentioned, 
requiring patients to generate activities or issues affected by their condition and/or 
rating their importance or subjective meaning. 
2.5 Standardised measures of QoL that capture the subjective impact of disease 
The two central properties of individualised QoL questionnaires are individually- 
generated domains and the importance ratings used to weight the domains. These are 
attractive properties considering the subjective and highly individual nature of QoL. 
However, it is not always practical to incorporate both of these attributes into 
questionnaires given the amount of time and resources required to administer the 
scales and problems associated with using the data they supply (e. g. assessing change 
over time when the issues nominated between assessments). 
It is uncertain which of these properties is of greatest advantage (Leventhal and 
Coleman, 1997). Individually generated domains are more relevant to the patient than 
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domains imposed by a standardised measure. However, these domains may change 
over time and make it difficult to assess changes in QoL. The application of 
importance ratings to a range of universal or comprehensive life domains may be a 
more practical way of eliciting an individualised assessment of QoL domains 
(Bullinger, 1999; Can and Higginson, 2001). This method has emerged over the last 
few years. These questionnaires do not ask patients to generate their own items, but 
obtain a better idea of individuals' QoL through patients' ratings of the importance of 
or satisfaction in the broad domains included in the measures (Wood-Dauphinee, 
1999). 
2.5.1 The Subjective Quality of Life Profile (SQLP) 
The SQLP (Dazord et al., 1993), like the PGI, looks at the perceived distance between 
the individual's current state and their goals. The questionnaire provides standardised 
goals but respondents are questioned about: 1. the importance attributed to each goal; 
2. tolerance of the distance between reality and goal state and; 3. their ability to cope 
with this distance. In delineating these issues the measure aims to provide an 
explanation behind individual evaluations of QoL. 
2.5.2 International quality of life assessment: The WHOQOLS 
The World Health Organisation Quality of Life Scale (WHOQOLS) was developed as 
the result of an international project set up to develop a questionnaire that would focus 
on positive aspects of people's lives and potential ways to strengthen them 
(WHOQOL Group, 1993; WHOQOL Group, 1995). The WHOQOL does not ask 
patients to generate life domains or goals, but attempts to evaluate life quality within 
the context of each individual's life by assessing satisfaction with particular life areas, 
or `facets' of QoL. These facets are the same across the different versions of the 
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instrument, each comprising culture/country-specific items. 
Satisfaction with life areas is believed to be more indicative of QoL than more 
objective measures of these areas (e. g. financial income) as it are easier to compare 
across culture or socio-economic status levels (Orley et al., 1998). For example with 
social activities, satisfaction can be compared regardless of the activity, setting, or 
frequency of participation. 
Add-on modules for the assessment of QoL in specific populations (e. g. children, 
cancer patients, AIDS patients) have also been proposed. A shortened version of 26 
items has been developed (WHOQOL-BREF; WHOQOL Group, 1998) and is 
recommended for use in clinical work, large-scale studies and clinical trials where 
only a brief assessment is possible. 
2.6 Measurement of the QoL process 
The aggregation of questionnaire scores into a profile or single index often masks the 
determinants of overall QoL. However, the process leading to QoL evaluations 
(Hyland, 1992; Leventhal and Coleman, 1997) may best be represented by a 
questionnaire or questionnaires designed to capture aspects of each level of the 
evaluative process (Fries and Singh, 1996; Spilker and Revicki, 1996). This would 
involve separating out these levels of disease impact into symptom experience, 
treatment effects, the impact of symptoms and treatment within the context of the 
individual's life and an overall evaluation of QoL. 
2.6.1 The 'Measure Yourself Medical Outcome Profile' (MYMOP) 
One questionnaire that might be useful in uncovering the determinants that underlie 
QoL is the Measure Yourself Medical Outcome Profile (MYMOP) (Paterson, 1996; 
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Paterson and Britten, 2000). Designed for use in general practice, this measure 
provides a problem-specific profile of scores. It requires patients to generate one or 
two symptoms of concern and to rate these for severity. It also elicits one activity of 
daily living affected by the symptom(s) and the degree of difficulty associated with 
this activity. The final question asks patients to rate their general well-being. 
It has been argued that the MYMOP is more a measure of symptom impact than of 
QoL (Jenkinson, 1996). However, the questionnaire is not presented exclusively as a 
QoL measure but rather as a patient generated measure of disease impact. As the 
MYMOP looks at both the potential determinants of QoL and QoL itself as suggested 
in QoL-as-process accounts (Hyland, 1992; Leventhal and Coleman, 1997), it presents 
a guiding framework for new instruments. 
2.7 Ethical Concerns in QoL Assessment 
2.7.1 Interference with QoL. 
The first ethical concern is that assessing QoL, particularly through utility methods 
such as the time trade off, or the standard gamble technique, could interfere with 
patients' QoL (Joyce, 1993). Asking patients to make trade-offs, for example between 
life expectancy and QoL could cause upset to severely ill patients, particularly 
undesirable if the research is to be of no direct benefit to these patients. 
QoL self-report measures may also threaten the adaptive suppression used by many 
patients to protect themselves from negative feelings associated with their illness and 
its consequences (Cella, 1995). 
In terms of the research process, unrelenting endeavours to recruit patients or ensure 
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the completion of forms may also be detrimental to QoL (Fraser, 1993). 
2.7.2 Raising Expectations. 
QoL questionnaires and the specific questions incorporated in these instruments may 
raise patients' expectations. Simply mentioning a QoL study or a QoL questionnaire 
may lead patients to believe that the assessment will lead to an intervention that will 
improve their life quality. Similarly, asking questions about medical treatment may 
introduce false hope in patients living with conditions for which there is no available 
treatment. 
2.7.3 Confidentiality/ Privacy. 
A number of the questions included in QoL questionnaires may be perceived as 
threatening, particularly questions about personal issues such as emotional state, body 
image and sexual activity (Smith, 1999). Patients may not wish to divulge this 
information to a stranger and may see it as immaterial to their medical care. 
2.7.4 Ensuring the ethical investigation of QoL 
Despite these concerns, avoiding asking questions about the effect of illness and 
treatment upon QoL could lead to the application of unnecessary or inappropriate 
treatment (Cella, 1995). However, it is important to consider the ethical implications 
and to ensure careful selection of questionnaires and strict confidentiality of responses 
before embarking on a QoL study. 
2.8 Developing QoL Instruments. 
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Good QoL questionnaires tend to result from a rigorous development process 
involving item selection, item reduction, design of questionnaire format, pre-testing, 
and validation (e. g. testing for reliability, validity and responsiveness). Numerous 
different methods have been adopted in the development of QoL questionnaires. For 
example the Sickness Impact Profile (SIP) (Bergner et al., 1981), was developed on 
the basis of a literature review and the reports of health professionals as well as 
healthy and ill laypersons. The WHOQOL utilised expert review, focus groups, expert 
and lay question writing panels, development piloting and field testing (WHOQOL 
group, 1995). 
Until recently, expert opinion has been used routinely in developing the content of 
QoL questionnaires. However, this has increasingly been abandoned and 
questionnaire items are now more commonly generated from patients' reports. This 
makes sense as QoL measures aim to identify patients' perceptions of QoL and 
doctors perceptions may not take important issues into account, particularly those of a 
less medical nature. QoL questionnaires are now more commonly developed using 
information about patients' experiences elicited using qualitative interviews and focus 
groups. 
2.9 Quality of life in Neuromuscular Disease 
Neuromuscular diseases (NMDs) are chronic progressive conditions that have 
numerous implications for QoL. There are few treatments available for NMD despite 
ongoing efforts to develop new treatments and use existing drugs in the hope that they 
will confer beneficial effects. 
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The treatment of Polymyositis (PM) and Dermatomyositis (DM) involves the use of 
steroids or other immunosuppressive drugs and recovery has been shown to be more 
common following the introduction of these treatments (Brain, 1985). However, there 
are no clear guidelines to the optimal dose or duration of treatment (Lane et al, 1989), 
and few therapies have been shown to be effective in randomized clinical trials (Miller 
et al., 1992; Dalakas et al., 1993). Other worthwhile interventions include 
physiotherapy and hydrotherapy as well as assistive devices such as wheelchairs, foot 
splints, respiratory support and aids in the home. The use of validated QoL 
instruments could better document the effectiveness of these interventions. The side 
effects associated with drugs currently used in certain muscle conditions such as 
corticosteroids in PM and DM further demonstrates the importance of investigating 
QoL in NMD. 
In the absence of disease specific measures for NMD, researchers have often used the 
`best measure' available. However, these generic measures may not always be suited 
to the investigator's purpose. 
Generic measures including the SF-36 (Ware and Sherbourne, 1992; Brazier et al., 
1992), the NHP (Hunt et al., 1985) and the SIP (Bergner et al., 1981) have been used 
in studies with NMD patients (Bach et al., 1991; Pehrsson et al., 1994; Ahlstrom and 
Gunnarsson, 1996; Ahlstrom and Sjoden, 1996; Ahlstrom et al., 1994; Drouet et al., 
1996; Alexanderson et al., 1999; Chung et al., 2001). A disease-specific measure 
developed for use in rheumatoid arthritis, the revised Arthritis Impact Measurement 
Scales (AIMS2) (Meenan et al., 1992) has also been used in myositis patients (Drouet 
et al., 1996). 
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A number of these studies have shown NMD to have an influence on certain domains 
of QoL as assessed by the questionnaires used (Ahlstrom et al., 1994; Ahlstrom and 
Gunnarsson, 1996; Drouet et al., 1996; Chung et al., 2001). However, as these 
measures are not derived from patients' experiences of NMD they may neglect issues 
that are of considerable importance and conversely incorporate superfluous items. 
This means that they are unlikely to provide an accurate picture of QoL in muscle 
disease and may therefore also lack sensitivity to change. 
Generic measures have also demonstrated unexpectedly high levels of life satisfaction 
in NMD patients with severe functional disability (Bach et al., 1991; Pehrsson et al., 
1994). 
There are two possible reasons behind the high levels of life satisfaction reported by 
NMD patients. The first is that questionnaires used in these studies might not be 
appropriate for use with patient populations or purposes divergent from those for 
which the questionnaire was intended. Therefore, the questionnaire items, their 
scaling and their wording may not be suitable for use with NMD patients. 
The second possible reason for the high levels of reported QoL is the ability of 
individuals to adapt to their situation through changing their goals and expectations 
(Taylor and Brown, 1988; Lundqvist, 1991; Allison, 1997; Muldoon et al., 1998; 
Cassileth et al., 1984; Breetvelt and van Dam, 1991). These findings of high QoL 
levels have been mirrored in studies of other chronically ill or disabled patients 
(Cassileth et al., 1984; Burckhardt et al., 1989; Lundqvist, 1991). It may be that this 
process of adaptation results in QoL levels comparable to those of `healthy' 
individuals making it difficult for QoL measures to detect any change in health 
(Allison, 1997; Breetvelt and van Dam, 1991; Sprangers and Schwartz, 1999; 
Gibbons, 1999; Albrecht and Devlinger, 1999). 
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These findings indicate the limitations in using generic questionnaires for patients 
with NMD. Muscle conditions are chronic and progressive and therefore it may be 
more appropriate to adopt disease-specific measures, widely heralded for their 
sensitivity to change (Patrick and Deyo, 1989; Sprangers and Aronson, 1991; Garratt 
et al., 1993). 
The aim behind this study was therefore to develop a measure of QoL specific to adult 
NMD that would represent the effects of NMD as experienced by different 
individuals. 
2.10 Hypothesis 
Currently used measures of outcome in NMD encompass clinical measures such as 
muscle strength and biological indicators such as Creatine Kinase (CK) level. 
Although such measures provide information that is of clinical importance, they 
overlook individual circumstances and life context and therefore do not bear direct 
relevance to patients. 
QoL questionnaires are used in clinical trials to represent patients' experience and the 
use of generic QoL questionnaires in a number of NMD trials has demonstrated 
increasing awareness about the importance of patients' point of view. However, these 
generic scales do not capture all the issues that are relevant to NMD patients and 
conversely incorporate superfluous issues. This means that such questionnaires are 
unlikely to detect clinically important change in patients with NMD. 
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The INQoL was therefore developed as a patient-centred measure that would capture 
the diversity of patients' experiences. The questionnaire asks each patient to rate their 
difficulties and the importance of the difficulties caused by specific symptoms. 
Patients are also asked to rate difficulties in specific life areas, their satisfaction with 
these areas of life and the importance of disease impact upon these areas. 
It is hypothesised that this new disease-specific QoL questionnaire will be a more 
accurate indicator of QoL in patients with NMD than the measures currently available. 
As such, it should also be more sensitive to clinically important change and will be 
appropriate for use as a clinical tool, highlighting issues that may be amenable to 
intervention and helping monitor patients' progress. 
2.10.1 Main hypothesis 
There is a need for a neuromuscular disease-specific QoL questionnaire that is based 
on theories of QoL which centre around the idea that QoL is determined an 
individual's perception of the distance between their current state and the state to 
which they aspire. The individual's life context and disposition influence this 
perception. Such a tool should enable patients to representatively convey the 
influence of NMD upon their lives. This measure should also be more acceptable to 
patients than generic measures that are less likely to adequately represent NMD 
patients' QoL. Such a measure will also be useful in clinical practice providing a 
summary of QoL that can be used to highlight individual concerns and monitor 
progress over time. 
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2.11 Aims and Objectives 
This thesis describes the development of a disease-specific QoL questionnaire for use 
in NMD. This patient-centred questionnaire will be used as a measure of outcome in 
clinical trials and as a clinical tool. 
The objectives of the project were: 
1. To explore what it is like to live with NMD with a view to designing a 
questionnaire based on patients' reported experiences. This was done through: 
a. In-depth semi-structured interviews with NMD patients 
b. A postal survey providing quantitative and qualitative data on the impact of NMD 
2. To develop an individualised QoL measure specific to NMD for use as : 
a. A measure of outcome in clinical trials 
b. A clinical tool in muscle clinic consultations 
3. To assess the clinimetric properties of the questionnaire, including its: 
a. Validity 
b. Reliability 
c. Responsiveness to change 
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4. To evaluate the questionnaire in a clinical setting for its: 
a. Acceptability to doctors and to patients 
b. Clinical utility/usefulness 
2.12 The Structure of the Thesis 
This project involved several phases including three separate studies, two of which 
determined the content of the new questionnaire (qualitative interviews and postal 
survey) and the third of which involved testing the questionnaire resulting from these 
exploratory studies. 
In order to ensure a clear account of the development and validation of the INQoL the 
thesis is structured to present the background, preparation, implementation and 
findings of the individual studies separately and chronologically (table 2.1, p. 68). 
Chapter 5 describes principles of questionnaire design and comprises a section of its 
own. It precedes the postal survey and INQoL design and validation chapters as the 
issues described were relevant in constructing the survey instrument and QoL 
questionnaire. 
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Table 2.1: Thesis structure 
Introduction 
Chapter 1: Review of QoL literature 
Chapter 2: Review of existing QoL questionnaires and the assessment of QoL in NMD 
Qualitative interview study 
Chapter 3: Description of qualitative research and interviewing 
Chapter 4: Qualitative interview study introduction, methods, results and discussion 
Questionnaire design issues 
Chapter 5: Constructing questionnaires 
Postal Survey 
Chapter 6: Description of general postal survey methodology 
Chapter 7: Postal survey introduction, methods, results and discussion 
Design and validation of the INQoL 
Chapter 8: Description of QoL scale design methodology & the construction of the INQoL 
Chapter 9: Description of the clinimetric properties of QoL instruments and their evaluation 
Chapter 10: Clinimetric evaluation of the INQoL (methods) 
Chapter 11: Clinimetric evaluation of the INQoL (results and discussion) 
Chapter 12: Clinical utility study 
General Discussion and Conclusions 
Chapter 13: Discussions 
Chapter 14: Conclusions 
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CHAPTER III 
QUALITATIVE INTERVIEWING AND QUALITATIVE DATA ANALYSIS: 
THE FIRST STAGE IN THE DEVELOPMENT OF A QUALITY OF LIFE 
QUESTIONNAIRE 
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Chapter 3: Qualitative Interviewing and Qualitative Data Analysis: The first 
stage in the development of a quality of life questionnaire 
The first stage in the development of the disease-specific quality-of-life questionnaire 
involved exploring neuromuscular (NMD) patients' experience of their condition. 
QoL in NMD has previously received little attention. The aim of the initial phase of 
the study was therefore to obtain a representative account of the experiences of NMD 
patients through qualitative interviewing and data analysis. This chapter will provide 
an outline of qualitative research and its methods. 
3.1 What is qualitative research? 
Qualitative research takes the form of exploratory investigation that focuses upon 
`naturally occurring, ordinary events in natural settings' (Miles and Huberman, 1994). 
In investigating the experiences of individuals, qualitative research asks the questions 
`what?, `why? ' and `how? ' enabling in-depth exploration of a particular phenomenon 
or experience. This contrasts with the question asked in quantitative research, `how 
much? ' which should be asked once the issue under study is better understood (Pope 
and Mays, 1995). 
3.2 Why use qualitative research? 
Qualitative research is useful in investigating issues about which little is known, or in 
which there has been little previous research. This makes it perfect for exploring the 
effects of NMD considering that there are no existing disease-specific measures of 
QoL for these conditions. 
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Most existing scales are based upon the opinions of experts rather than upon those of 
patients, or upon existing QoL scales such as the SF36 or the Sickness Impact Profile. 
However, these questionnaires do not always accurately represent the patient's point 
of view (Carr, 2001). The use of a qualitative methodology was thought likely to 
result in a more accurate representation of patients' experiences, for use as the basis 
for a patient-centred questionnaire. 
One of the main advantages of using qualitative research is that it requires only small 
numbers of participants, yet allows issues to be explored in great depth and results in 
rich and detailed data. 
Qualitative research can also be a useful precursor to quantitative research (Pope and 
Mays, 1995), giving an indication of the areas to probe further for quantitative 
information. This can be useful in the development of QoL scales as quantitative 
methods can be used to generate information about the relevance and importance of 
potential scale items. This type of methodology has already been used in the 
development of questionnaires (Bryman, 1988) including QoL scales (e. g. Hunt et al., 
1985). 
3.3 Theoretical frameworks used in qualitative research 
Among the remarkable array of approaches to qualitative analysis are the five main 
traditions of biography, ethnography, case study, grounded theory and 
phenomenology (Cresswell, 1998). These traditions are each geared towards a 
specific field of research or have a specific aim. 
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3.3.1 Biography 
A biography is the study of an individual and his/her experiences and has been defined 
in the Oxford English Dictionary as `a written record of the life of an individual'. 
Biographical studies tend to involve interviews and the analysis of documents (e. g. 
letters, diaries) about the individual (Smith, 1995). 
3.3.2 Ethnography 
An ethnography is the description and interpretation of a culture, social group or 
system. It involves the researcher in an extended observation of the group often 
through living alongside the people in their everyday lives or interviewing members of 
the group. This allows the examination of the group's observable behaviours, customs 
and ways of life in order to achieve a better understanding of their behaviour, 
language and communication (Cresswell, 1998). 
3.3.3 Case Study 
A case study involves investigating single or multiple cases over time though detailed 
data collection involving many different sources of information (e. g. observations, 
interviews, and documents). It is not a methodological choice but more of a choice of 
the object to be studied (Stake, 1995). 
The case may be an individual or an event or even an activity situated within its usual 
setting. It is most commonly heard of in relation to medical case histories in which a 
picture is built up of an individual patient with regard to a particular issue (e. g. 
condition or complaint). This may involve observation and interviews, examination 
of medical reports and investigations and consultation with health professionals who 
have worked with the patients. 
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3.3.4 Grounded theory 
Grounded theory has been described as a general methodology for developing a theory 
that is grounded in systematically gathered and analysed data (Strauss and Corbin, 
1995). It involves the researcher in interviews and visits to the field of interest in 
order to investigate actions and reactions to a phenomenon in a social context 
(Cresswell, 1998). Grounded theory analysis entails developing and interrelating 
categories of information in order to form theories and hypotheses about the topic of 
interest (Strauss and Corbin, 1995). 
3.3.5 Phenomenology 
Founded upon the philosophical writings of Husserl (Cresswell, 1998; Sokolowski, 
2000), phenomenology is the `study of lived experiences and the way we understand 
those experiences to develop a worldview' (Marshall and Rossman, 1999). It is used 
to investigate a specific experience or phenomenon in an attempt to see things from 
the others' point of view (Taylor and Bogdan, 1984). 
Phenomenologists' interpretation of qualitative data is built on the assumption of a 
stable relationship between `outward appearance' (what someone says) and `inner 
consciousness' (underlying feelings and psychological constructs) (Giorgi, 1995). 
This assumption is central to the development of an understanding of the experience 
of a particular phenomenon (Cresswell, 1998). Phenomenological analysis will be 
described in section 3.6.3. 
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3.4 Which approach to Adopt? 
Researchers holding more traditional approaches to qualitative research (Strauss, 
1987) advocate the application of specific and unadulterated methodology from one of 
the qualitative traditions. This is believed to maximise the validity and reliability of 
qualitative research. However, it may not be appropriate to impose exact 
interpretative structures onto social and psychological phenomena as life experiences 
are unlikely to fit into such a strict analytic framework. A more eclectic approach to 
qualitative analysis has therefore been advocated (Seale, 1999). 
Nonetheless, it is helpful to base qualitative analysis around one particular tradition in 
order to guide the study and keep the complicated process of data analysis as 
straightforward as possible. 
As the aim of this study was to describe and better understand individuals' experience 
of NMD, a phenomenological position was adopted with key elements of 
phenomenological analysis applied to the interview data (Chapter 4). 
3.5 Methods used in Qualitative Research 
Participant observation, in-depth or semi-structured interviewing, and focus groups 
are just some of the techniques used in qualitative research (see Miles and Huberman, 
1994, and Denzin and Lincoln, 1994; for a full list of the available techniques). 
The choice of method depends largely upon the issue under study and upon the 
resources and time available to the researcher. For example, focus groups (group 
interviews) are ideal for the researcher conducting an inexpensive study to explore a 
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socially relevant phenomenon occurring naturally in a particular group (e. g. attitudes 
or cultural practices). 
For the purposes of this study it was considered most appropriate to use semi- 
structured interviewing. Although this is more time consuming than focus groups, 
requiring a greater number of interviews, it allows a more thorough exploration of 
individuals' experience. It was felt that this would provide the best basis for the 
questionnaire. 
3.5.1 Qualitative interviewing 
Qualitative or `in-depth' interviewing is frequently adopted in health services 
research. These studies are logistically less onerous to organise and conduct than 
studies involving people in their natural environment, such as participant observation, 
that require the researcher to be immersed in the life of a group or community for a 
prolonged period of time (Punch, 1995). Qualitative interviews glean rich data and 
are highly flexible in exploring areas of interest. 
Good questions in qualitative interviews are open-ended, non-leading, sensitive, and 
clear to the interviewee (Britten, 1995). Unlike the structured interview, questions are 
adapted to suit the interviewee's style of speech. Questions are posed within the 
natural flow of the interview and interviewees are encouraged to clarify and elaborate 
upon what they disclose (Pope and Mays, 1995). 
Researchers conducting interview studies aim to establish rapport and create a relaxed 
atmosphere conducive to the disclosure of potentially sensitive and personal 
information. It is therefore important for the interviewer to pay attention, be non- 
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judgemental, to let the participant talk, and be sensitive to his or her feelings 
throughout the interview (Taylor and Bogdan, 1984). 
3.5.2 Semi-structured Interviewing 
In phenomenological interviewing the researcher commonly has an idea of the issues 
that might be important to look at. In this situation is makes sense for researchers to 
conduct semi-structured rather than unstructured interviews in order to maximise the 
relevance of the data. Semi-structured interviews are guided by the use of an 
interview schedule (Britten, 1995). 
3.5.2.1 Interview schedules 
Interview schedules are useful in studies that aim to delve into particular areas of 
interest and are helpful in the preparatory phase of interview studies, compelling the 
researcher to consider all the issues to be covered. This helps prepare the researcher 
for any sensitive issues that might arise and gives him/her the opportunity to devise 
appropriate question wording and any additional questions that may be necessary. 
Interview schedules tend to open with a broad, general question such as " tell me 
about .... " or "what is your experience of ..... 
". This allows the interviewee to set the 
ball rolling and share his/her own account of the experience. The interviewer can then 
guide the interview depending upon what the interviewee is interested in talking about 
and what s/he wishes to cover. 
3.5.3 Audio-taping interviews 
Tape-recording allows the researcher to obtain a full, representative account of the 
interview. It frees the researcher from writing notes, which can be disruptive to the 
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process and may result in loss of information. This also helps the researcher to 
establish rapport with the interviewee, to concentrate on the flow of the interview and 
formulate appropriate questions to ask next. 
Although some participants might experience `stage fright' and not feel able to talk 
freely during the interview, the presence of the tape recorder should not greatly alter 
the participant's responses. The presence of an attentive researcher is likely to negate 
any influence a tape recorder may have. 
3.6 Issues in qualitative research 
3.6.1 Sampling 
In qualitative research sample sizes are not determined by specific rules. Rather than 
aim for statistical representativeness, the number of participants selected tends to be 
based on the depth and duration of the interviews and the nature of the sample (Mays 
and Pope, 1995). 
Ten participants from a fairly homogenous sample is generally accepted as a 
reasonable number to obtain in a qualitative interview study (Greenhalgh, 1999; Riley, 
1996). 30 to 50 participants are more common when there are subgroups of interest 
within the sample (Morse, 1994). 
The sampling procedures adopted tend to be purposive (Miles and Huberman, 1994), 
aiming to obtain a reasonable cross-section of the individuals experiencing the 
phenomenon of interest. This allows the experiences of subgroups within the sample 
to be illustrated and facilitates comparisons between the groups. A purposive 
sampling strategy was adopted in this study in order to represent the experiences of 
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three subgroups of patients and enable the detection of any differences between these 
diagnostic groups. 
3.6.2 Analysis 
There are an abundant array of texts available on qualitative analysis (e. g. Miles and 
Huberman, 1994; Coffey and Atkinson, 1996; Denzin and Lincoln, 1994; Strauss, 
1987; Riley, 1996). Some focus upon a specific school of qualitative research (e. g. 
Strauss, 1987; Giorgi, 1995) whereas others advocate a more eclectic approach to 
qualitative analysis (Seale, 1999; Miles and Huberman, 1994). Despite this, the 
process of analysis is similar across the different traditions. They all involve a 
cyclical rather than a linear process with the various stages of analysis feeding back 
onto one another. 
3.6.2.1 Description 
The analysis of qualitative interviews starts off with reading and re-reading the 
transcripts to ensure complete familiarity with the data. The researcher then notes 
down any striking or interesting patterns and themes that come forth and reflects upon 
what seems to be happening in respondents' accounts. 
3.6.2.2 Organisation 
This stage involves organising the data in a way that helps to answer the research 
question. Codes are applied to each theme and used to pick out occurrences of the 
themes from the transcripts. Each coded segment is cut out from the transcripts (this 
can be done using a word processor) and pasted into files together with all the 
occurrences of each particular theme. This simplification of the data into manageable 
segments eases the retrieval of categorised data (Coffey and Atkinson, 1996), which 
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can be further simplified by indexing the occurrences and location of themes (Smith, 
1995). 
3.6.2.3 Connecting segments and interpretations 
In this next stage themes that have emerged from the ongoing analysis are linked up 
and subsumed into broader categories. This is done through comparing and 
contrasting themes as well as identifying patterns and new meanings in the analysis. 
Following this process, the categorisation system is checked against all the other 
transcripts to ensure comprehensive coverage of themes and meanings in the data. 
3.6.2.4 Corroboration and justification 
This next stage involves checking the analysis to ensure its credibility and increase 
confidence in the results. One way this can be done is to look for unexpected themes 
in the data in order to elaborate on emerging themes and dispute inappropriate 
interpretations. This leads to more refined and detailed descriptive categories. 
Counting techniques (Miles and Huberman, 1994; Riley, 1996) may also be used to 
give an idea of the prevalence of themes (Smith, 1995). However, - the use of this 
technique to reduce data into a simplified quantitative representation is discouraged 
(Miles and Huberman, 1994) and should only be used to verify aspects of the data. 
The use of a second categoriser is one of the. many strategies that can be used to 
triangulate qualitative data. `Triangulation' is the main method used in qualitative 
research to validate findings. This involves using several methods at once to measure 
the same phenomenon with a view to cancelling out any biases that result from the 
other methods (Webb et al, 1966 cf. Seale, 1999). The independent measures that can 
be used include different data sources (e. g. patients and their doctors), methods (e. g. 
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interviews and fieldwork), different researchers, or different types of data (e. g. 
qualitative and quantitative) (Miles and Huberman, 1994). ý"ý 
The second categoriser analyses interview transcripts using the categories emerging 
from the original researcher's analysis. This helps to ensure that the coding scheme is 
comprehensive and may also throw light upon any ambiguities in the analysis or 
difficulties in the application of categories (Riley, 1996). 
3.6.2.5 Reporting Findings 
The process of analysis culminates in writing up the findings of the investigation. 
Writing up further influences the interpretation of the data and often leads to a more 
complete and integrated interpretation. 
3.6.3 Phenomenological analysis 
The stages delineated in the previous section are also utilised by phenomenological 
researchers. However, there are a number of components particular to this tradition 
(Giorgi, 1995; Cresswell, 1998). 
3.6.3.1 Epoche 
`Epoche' is the term used to refer to the first stage in phenomenological analysis. This 
involves the researcher giving a full description of his or her experience of the 
phenomenon, `bracketing' previous any experiences and preconceptions before 
commencing analysis. This allows the `phenomenon' as described by the participants 
to be interpreted with as little bias as possible. 
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3.6.3.2 Horizonalisation 
Horizonalisation in phenomenological analysis constitutes the `organisation' phase 
referred to in the previous section. This process involves finding statements in the 
transcripts about individuals' experience of the subject of interest. These statements 
are listed and any repetition or overlapping minimised. 
3.6.3.3 Clustering of statements into `meaning units' 
This stage comes under the `connecting themes and interpretations' phase delineated 
earlier. It involves clustering together statements that represent the emerging' 
descriptive themes, along with examples of these statements from the transcripts. 
3.6.3.4 Reflection and Description 
This final phase reflects elements of the third (connecting themes and interpretations) 
and fourth stages (corroboration and justification) of qualitative analysis as described 
previously. 
The researcher reflects upon the description of the experience using intuition and 
imagination to search for and provide all possible meanings' and perspectives of the 
data. By looking at the phenomenon from these different perspectives the researcher 
can construct a description of the experiences of those participating in the study. 
These stages should result in a report that increases the readers understanding of what 
it is like to experience the phenomenon of interest. 
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3.7 Using Qualitative and Quantitative Research as complementary exploratory 
research methods 
As expressed by Miles and Huberman (1994) `numbers and words are both needed if 
we are to understand the world'. Indeed, qualitative and quantitative research can be 
used to confirm or corroborate each other via `triangulation', resulting in an ultimately 
more detailed investigation (Miles and Huberman, 1994). For example, surveys can 
be used to corroborate and supplement qualitative data, reaching those not represented 
in the original investigation, for example housebound individuals unable to travel to 
attend a qualitative interview. They can also provide a measure of the prevalence of 
the issues reported in qualitative studies, a valuable statistic when selecting items for 
inclusion in a questionnaire. A survey was therefore adopted in this study to 
corroborate the representativeness of the data from the qualitative study (Chapter 7). 
3.8 Conclusions 
Qualitative research is useful in exploring experiences about which little is known, 
making it ideal for the purposes of this study. Semi-structured interviews were 
adopted and a predominantly phenomenological analytic technique used to facilitate a 
thorough exploration of the experiences of individuals with NMD. 
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CHAPTER IV 
EXPLORATION OF PATIENTS' PERCEPTIONS OF THE IMPACT OF 
NEUROMUSCULAR DISEASE: A QUALITATIVE INTERVIEW STUDY. 
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Chapter 4 
Exploration of Patients' Perceptions of the Impact of Neuromuscular Disease: A 
Qualitative Interview Study. 
4.1 Introduction 
Conducting exploratory qualitative work has been useful in previous studies of 
individuals with chronic disease and disability (Viemero and Krause, 1998; Albrecht and 
Devlieger, 1999) and is also useful in the construction of questionnaire items (Bryman, 
1988). Such methods have been used to generate the life domains covered in other QoL 
questionnaires (e. g. Hunt et al, 1985). 
As little is known about the impact of NMD, qualitative interviews were used to explore 
patients' experiences. It was felt that a QoL questionnaire developed from patients' 
personal experiences would elicit a more representative picture of disease impact in 
individual patients than the measures currently in use. It should also be more sensitive to 
change than questionnaires derived from the opinions and conjectures of health 
professionals. 
4.2 Methods 
In-depth interviews were conducted to explore patients' experiences and perceptions of 
the effects of NMD upon their lives. 
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4.2.1 Patients 
a. Patients involved in the project as a whole 
Muscle diseases involve a combination of weakness, fatigue, stiffness or cramps which is 
usually progressive. Clinical diagnosis of a specific muscle disease tends to be based on 
the age of onset, the mode of inheritance (where there is a family history) the distribution 
of weakness (e. g. whether proximal or distal) and the presence or absence of associated 
features such as pseudohypertrophy in muscular dystrophies, or myotonia in myotonic 
dystrophy (Brain, 1985). 
For the purposes of the study, three groups of patients were sampled as follows; 
1) patients with a congenital, slowly progressive NMD (CSP), 
2) patients with an acquired, relapsing, remitting NMD (ARR), and 
3) patients with an acquired, slowly progressive NMD (ASP). 
Those in the CSP group included patients with non-Duchenne muscular dystrophies such 
as Becker's muscular dystrophy and limb-girdle muscular dystrophy (LGMD). A number 
of patients with genetic muscle conditions that are not always apparent at birth were also 
included. These included patients with facio-scapulo-humeral muscular dystrophy (FSH- 
MD) and myotonic dystrophy. Many of these conditions can occur in mild or severe 
forms, some of which may be associated with a loss of ambulation (e. g. in second or third 
decades for LGMD) (Marsden and Fowler, 1998). 
Patients with Duchenne muscular dystrophy (DMD) were excluded from the study as 
these patients often die before the age of 20 (Marsden and Fowler, 1998). They are 
therefore likely to face different QoL issues than patients with other muscle conditions 
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(e. g. different approach to care and issues of death and dying). 
Those in the two `acquired muscle condition' groups were made up of patients with either 
`relapsing remitting' (e. g. polymyositis (PM) and dermatomyositis (DM)) or `slowly 
progressive' (e. g. inclusion-body myositis (IBM)) disease. These conditions are primary 
inflammatory muscle diseases but DM can also involve other organs including the 
cutaneous, gastrointestinal, pulmonary, and cardiac systems (Miller et al, 2001), while 
PM has only occasional extra-muscular involvement (e. g. pulmonary) and IBM has no 
systemic involvement. PM and DM are amenable to treatment with steroids or other 
immunosuppressive drugs but they can go through periods of remission and relapse as the 
treatment is altered. IBM tends to have a later onset than PM and DM, being more 
commonly diagnosed in patients over 50 years of age. It has thus far been resistant to 
treatment and so pursues a progressive course (Griggs and Rose, 1998). 
Patients were split into these groups as it was predicted that there might be differences in 
experience depending upon individual characteristics of the different conditions. For 
example, patients with congenital conditions are likely to have lived with the effects of 
their condition from a young age. On the other hand, patients in the ARR group are likely 
to have an unpredictable disease course. Finally, in the ASP group the onset of disease 
tends to be later in life. It was predicted that these patients might be faced with problems 
and ways of handling their condition that differ from those in whose condition starts at a 
younger age. 
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b. Patients involved in the qualitative interview study 
41 patients took part in the interview study. A purposeful sampling strategy was used to 
select a minimum of ten patients from three diagnostic groups in order to enhance the 
likelihood of obtaining a representative picture of disease impact (Greenhalgh, 1999; 
Miles and Huberman, 1994; Smith, 1995; Crabtree and Miller, 1999). 15 male and 26 
female patients ranging from 20 to 80 years of age were interviewed (mean= 49 years) 
(see Table 4.1 for full description of patients). These included 21 patients with a 
congenital, slowly progressive NMD; 10 patients with an acquired, relapsing, remitting 
NMD; and 10 patients with an acquired, slowly progressive NMD. 
Table 4.1: Patients involved in interview study 
M: F ratio Age range 
CSP group 3: 4 Facio-scapulo-humeral muscular dystrophy (2M, 1F) 20-75 years 
Limb-girdle muscular dystrophy (2F) 
Myoshi distal myopathy (1F) 
Becker's muscular dystrophy (1M) 
Muscular dystrophy (1M, 2F) 
Myotonia congenita (1F) 
Myotonic dystrophy (4M, 5F) 
Mitochondrial myopathy (1 M) 
ARR group 1: 4 Polymyositis (6 F) 43-80 years 
Dermatomyositis (2 M, 2F) 
ASP group 2: 3 Inclusion-body myositis (4M, 6F) 20-67 years 
4.2.2 Data Collection I 
In-depth, tape-recorded interviews were conducted in a quiet room in the outpatient 
clinic. Each patient was informed of the rationale behind the study and about the 
interview process before the interview commenced. Three patients requested to be 
accompanied by their spouse and one by her daughter. This was granted, as although 
patients' responses might be influenced by the presence of a close family member, it was 
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considered more important for patients to feel confident and at ease. 
Patients were encouraged to explain in as much detail as they could, how their muscle 
condition had influenced their lives. Open, non-leading questions guided by an interview 
schedule (Table 4.2) enabled patients to respond in their own words. 
Table 4.2: Interview guide for qualitative interviews with NMD patients 
Interview guide 
" Tell me about your condition and the effect you feel it has had upon your life. 
" How are your daily activities affected by your condition? 
If not mentioned/volunteered, probe for : 
General activities (e. g. getting around, household tasks) 
Employment (working practices, relationships at work, financial 
concerns) 
" Tell me about your social/leisure activities. 
Impact of NMD on these activities 
Friendships and social interaction 
" How has your family life been affected by your condition? 
" How has your condition affected how you feel other people see you? 
" What effect has your muscle disease had upon your outlook on life? 
The guide was constructed with the aim of encompassing all the life areas that could 
potentially be influenced by NMD. It was acknowledged that although the use of an 
interview guide might prompt issues reported, a semi-structured approach was more 
likely to ensure thorough exploration of patients' experiences (Britten, 1995; Riley, 1996; 
Smith, 1995). Expansion on reported experiences was encouraged by using phrases, such 
as "How did that make you feel? " and "Could you tell me more about that? " along with 
the use of prompting and pauses. 
During the interviews it became evident that the line of questioning generated by the 
88 
interview guide was not always fruitful in exploring the experiences of patients with 
congenital conditions. Some patients found it difficult to explain their experience of 
NMD in terms of an "effect" or "effects", as they had not experienced a change in their 
physical condition. In many congenital patients no such change had occurred, or if it had, 
it was imperceptible to them given that they had lived with the physical effects of their 
condition from a young age. A modified interview guide (table 4.3) was used in 5 
interviews to explore conceptual issues of disease impact in congenital patients, namely 
what it meant to them to be diagnosed and living with NMD. 
Table 4.3: Modified interview guide for qualitative interviews with NMD patients 
Modified interview guide 
" How did you find out about your muscle condition? 
" How are you affected by your muscle condition in your everyday life? 
" How do you feel others see you? 
" How does your muscle condition affect how you see yourself? 
" Do you feel your muscle condition has stopped you from doing anything you would 
have done otherwise? 
" Do you feel your muscle condition influences who you choose to spend your social 
time with? 
The original interviews lasted between 21 minutes and 1 hour and 13 minutes and the 5 
supplementary interviews lasted between 12 and 30 minutes. All interviews were 
transcribed verbatim, including details of intonation and non-verbal communication. 
4.2.3 Analysis 
Principles used in the management, organisation and analysis of qualitative data were 
adopted (Bryman, 1988; Marshall and Rossman, 1999; Cresswell, 1998; Giorgi, 1995; 
Miles and Huberman, 1994; Seale, 1999; Silverman, 1993; Smith, 1995). In order to 
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achieve an idea of what it is like to have NMD the theoretical approach of 
phenomenology (Smith, 1995; Giorgi, 1995) was considered to be the most appropriate 
analytic method. This was used to guide the analysis and facilitate the exploration of 
patients' perceptions and experiences. 
Following repeated reading of the transcripts, underlying themes were extracted and 
clustered together into categories representing life domains influenced by NMD. A 
coding scheme was devised to represent the individual domain and subdomain categories 
and applied to the data (Appendix A). Modifications were made to the scheme during 
analysis to ensure consistent and comprehensive coding of the data. This was achieved 
through comparing and clustering life domains and the effects of NMD within these 
domains. 
Finally, the comprehensiveness and validity of the coding scheme were further verified 
(Riley, 1996; Miles and Huberman, 1994) through inspection by a second researcher who 
independently applied the scheme to a sample of the interviews. 
4.3 Results 
The physical effects, their consequences, and the expected consequences of NMD had an 
important impact upon psychosocial aspects of patients' lives, including their emotions, 
self-image and perceived ability to fulfil their aspirations. 
The broad life domains influenced by NMD will be described in the next section followed 
by a more detailed account of how NMD affects quality of life. 
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4.3.1 Life domains affected in NMD patients 
The analysis of the interviews showed that NMD has a profound influence in patients' 
lives. (The numbers in brackets next to each excerpt indicate different patients). 
.... it's just there every minute of the day, everything you do (1) 
A number of broad life domains (Table 4.4) reported by patients to have been affected by 
NMD emerged from the analysis. Most patients reported an impact in each of these life 
domains. 
Table 4.4: Life domains reported in interviews with NMD patients 
Symptoms Activities Psychological domain Social domain 
Physical symptoms Daily activities Emotions Social interaction 
Leisure activities Self perception Relationships 
Employment/work Perception of the future Dependence 
Many of the specific effects within these dimensions were unique to individual patients. 
These depended on the specific physical effects of their muscle condition, but also on 
individual characteristics and life situation. For example, reported effects upon 
relationships varied according to factors such as life stage and individual circumstance. 
This is demonstrated in the following quotations. The first is from an elderly gentleman 
diagnosed with Inclusion Body Myositis and the second from a 36-year-old woman with 
Polymyositis. 
I have grandchildren who want me to pick them up and I can't even lift a baby up, which is very 
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upsetting for me. They now say Granddad in the chair, I'm Granddad in the chair..... it upsets 
me. (2) 
... I feel like he feels he has to stay..... I don't want him to stay just because I'm not well... And 
because it's a long going thing, does he feel trapped?..... I feel insecure, whereas I never did 
before, I just feel that maybe he feels sorry for me, and I don't want him to. " (1) 
4.3.2 Physical effects of NMD and its treatment 
4.3.2.1 Symptoms 
Some of the physical effects of muscle disease directly influenced patients' well-being. 
Fatigue, muscle weakness and pain were commonly reported. 
you're always very tired, lethargic, you know. You're always achy, you know in your muscles. If 
you try and do anything, your muscles tend to ache even more. It's quite demoralising In a 
way'cos the more you do the worse you get... (3) 
If I lay in bed too long, I start to ache... I don't often sleep late 'cos when I'm awake I start to 
ache. So most days I'm up by four. (4) 
Symptoms more specific to diagnosis were also reported. For example, a larger 
proportion of congenital NMD patients reported problems with vision and with speech. 
4.3.2.2 Effects of Treatment 
The side effects of drug treatment were important to those who had experienced adverse 
effects. Patients with Polymyositis and Dermatomyositis (in the acquired, relapsing, 
remitting subgroup of patients) reported side effects more commonly than patients with a 
congenital or an acquired, slowly progressive condition. This is because more drug 
treatments, notably steroids are used in these patients. Side effects took the form of 
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physical complications, effects upon mood, and changes in physical appearance brought 
about by steroid treatment. Some patients perceived their treatment to have caused as 
many problems as their muscle disease had done. 
I think really, the medication has done as much to wreck my life as the actual disease has 
done. Steroids particularly are quite awful to be on. (1) 
The negative effects of weight gain caused by steroid treatment in patients with myositis 
were a particularly important feature in the interviews. Some patients also expressed their 
feelings about the potential consequences of steroid treatment, such as this patient with 
Dermatomyositis. 
I would like to come off the drugs eventually because I know that it's causing other problems 
by being on them, like osteoporosis. I had a bone scan just before Christmas and they said 
then that my bone density wasn't what it should be for my age and you think "well, if that's 
what it's like now, what is it going to be like in ten years time if I'm still taking the steroids? " (5) 
4.3.3 Control & Independence 
The amount of control and independence patients' had in their lives was important to their 
perception of NMD effects. 
4.3.3.1 Control 
Many of the negative consequences reported could be framed in terms of a loss of control. 
In many cases the loss of control described was of a physical nature, encapsulated in the 
frequent accounts of falling. 
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I fall down in the street, crashing my head on the ground, and I find I can't lift myself up. So I 
have to rely on passers-by to help to lift me up, which is OK on a couple of occasions, but... (2) 
These and other instances of physical loss of control were a source of extreme distress to 
many patients often representing a serious threat to their psychological or physical well- 
being. 
You're in a situation where you can't breathe, you've got food wedged in the throat, and the 
muscles have been weakened..... and so you've got this wad of food in the gullet and the 
damn thing won't go down and it won't come up and you can't cough it up, because it's not in 
the windpipe. It feels exactly as if you've got food choking you, stuck in the windpipe, but it's 
not, it's in the foodpipe, and so you're stuck there trying desperately to breathe and that can be 
very, very worrying. (6) 
Symptoms and physical disability impinged upon the degree of control patients had over 
other aspects of their lives, notably their emotions. 
... and with these disabilities you can't, sometimes you can't cope and sometimes you just 
explode, you know, you get very angry and uptight at the wrong times. (7) 
Loss of control in the context of working practices and the implications of this for future 
job prospects led to feeling of helplessness. 
I mean we had to escort somebody out of the building the other day'cos he was drunk, and I 
couldn't get hold of him, he just shook me off..... and our jobs are on the line... then I think 
... 'what am I supposed to do to get another job? ' (8) 
This kind of loss of control also had implications for fulfilling roles, such as the role of 
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employment. 
it feels a bit of a daunting prospect, leaving work. It doesn't feel right, does it? You're working, 
and not to be working, it doesn't quite feel right in my mind. (9) 
One man described the psychological impact of his perceived loss of control in fulfilling 
his family role. 
I've been through a period quite recently where I was having different dreams, one after the 
other, where I was in a scenario that I couldn't look after my kids in a physical sense. I think it 
was obviously playing on my mind but especially because I'm one of these people that takes 
on everybody's problems..... It's always me that has to take control and sort everybody out 
and over the last six months I've really, sort of, lost the will to fight, if you like. (10) 
4.3.3.2 Independence 
Independence was an important issue in patients' reports. Dependence upon other people 
to perform certain tasks had a notable effect upon well-being. For some patients, 
dependence on other people influenced the amount of control they felt they had over their 
lives and the amount of freedom they could exercise. Independence was clearly 
important to patients' sense of identity and self-esteem with many striving to retain their 
independence. Some described their desire to retain as much normality in their lives and 
in how other people perceived them as possible. 
It's like with a can of coke and I'm having trouble, you'd feel the urge to take it off me and open 
it for me, you can understand that (laughs), 'cos you'd see I was in trouble... but I'll 
manage... That's the kind of thing I'm trying to get at. It's nice of them but it's annoying at the 
same time. I want them to be the same as they were before I found out I had this. (8) 
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Patients in the ASP group most commonly reported discontentment about their level of 
independence. On the whole these patients were older than the other patients with more 
of them living alone meaning that more of the help they required came from professionals 
and family members who could not always be available to help. 
[I have] to rely on being carried about. Whereas I just got in my car and I went. So, I can no 
longer make my own decisions about when I want to go, where I want to go... and so on. (11) 
4.3.3.3 Maintaining Control and Independence 
Efforts to regain or maintain control were reported by all patients. Patients commonly 
reported the measures they had taken and adaptations they had made to maintain control 
and as much freedom as possible. These adaptations included changing their 
accommodation, as described by one lady. 
I had a lot of building work done and I've arranged it, keeping in mind that there will be 
wheelchairs. I've made all my accommodation downstairs, and I have got two rooms upstairs if 
anyone lived in. I'm trying to keep the garden, so I could just have a man in to do the grass 
and the borders. (12) 
Changes were also made in employment practices, such as cutting down the number of 
hours worked. 
I have recently cut my hours. I work more part-time now. Three and a half days a week, which 
I've found helps 'cos it was, I was working long days, sort of 8 'til 6 o' clock and, which is tiring. 
Get home and that was it, I just wanted to go to bed then. So cutting my hours has helped. 
(13) 
Maintaining independence also necessitated more careful planning of activities. 
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I found I have to think a lot more about whatever I do. Plan a lot more about how I do things. I 
try not to let it stop me doing things.... and I have to think a bit more about how I am going to 
do them and who's going to go with me. I don't feel particularly safe on my own anywhere. 
(13) 
4.3.4 Restrictions in Participation 
The adaptations patients made to minimise the influence of their condition upon well- 
being enabled them to manage their lives and retain as much autonomy as possible. 
However, patients' avoidance of situations in which they might lose control restricted 
them in their activities. In many cases patients' social interaction and their personal 
relationships were influenced, which was detrimental to their emotional well-being and 
self-image. 
I've been flat on my face in Soho Square in the early hours of the morning. I used to fall over 
everywhere I went. Something would trip me up or I'd lose my balance (laughs)... and to avoid 
those situations ... you just stop going and if you stop going you become quite a boring friend. 
(14) 
Loss of control, and efforts to maintain control also had implications for carrying out 
activities and plans of choice. 
Our idea, years ago, was to buy a little bar in Spain and live out there. So a few years ago we 
was looking at different bars and things ..... of course, I wasn't feeling great so we stopped 
looking and now I've got this, that's gone out of the window. (15) 
Fulfilment of aspirations such as having children was also restricted, particularly in 
patients with a CSP condition. 
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I actually feel quite cheated that, even though I'm not going to have another baby, 'cos I'm not 
up to it...... if I did have, I couldn't look after it on my own, which wouldn't be fair. 
I would've liked to, you know. (14) 
Restrictions to participation were also experienced in activities such as employment and 
family activities 
I went on a firefighting course back when I was a gas technician and ... I got to the stage 
where I couldn't lift up one of the fire extinguishers and fire it at the fire and they said, "you've 
got a problem haven't you? " and of course I had to tell them... I had to go and see one of 
British Gas's doctors..... and he said, "well, you've obviously got a problem, I don't know what 
it is. Do you? " and I explained it to him and he said, " I'm sorry", he said, " but we can't employ 
you any more".... and I'd done thirty-two years up 'til then and he said "well, you've got a very 
good record, we'll put you up to forty years and medically retire you" (16) 
I'm just not so much fun because I don't rough and tumble with them. I mean, they like to climb 
trees and play chase and all that and I just can't do it and so it's just like, "Mummy's no fun" 
you know, they sort of have that feeling of, " oh Mummy can't do this and .... " you sort of think, 
"I wish I could, I wish I could just run around with you and play but I just can't. (17) 
Barriers in the physical environment also hampered participation in social activities. 
My friend down the road used to take me to the theatre. Well, last time it was such a fiasco, we 
had half the audience trying to get me up from the seat. So of course, I haven't been since. I 
can't go to the theatre, I can't to concerts, I just don't go out (18) 
4.3.5 Effect upon relationships 
The consequences of NMD also affected the relationships of many patients interviewed. 
Of course it's not only stress on me it's stress on my wife as well because when I get uptight 
and angry I take it out on the closest one, which is my wife. (19) 
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This had further implications for patients' emotional well-being. 
it is funny with family,.... sometimes you want to say something, but you don't want to upset 
them by talking too much about it... So I stand back a little bit and bring it up when it's brought 
up, not too much. It's a very difficult thing. (9) 
Some patients reported the effect that the physical effects of NMD had upon their sex 
lives. 
We've got to the point now where I can only really be in one position, that I can't get into by 
myself and I can't maintain for very long. But I mean, we do still try (both laugh). It's not as if it 
doesn't happen, but it's not necessarily very erm, very adventurous (3), or particularly exciting 
but, you know, it's, it's OK (both laugh). Erm, (4) but it can be frustrating because obviously I 
have to say, you know, "you're going to have to move my leg", or "get off that", you know, 
"you're hurting" (laughs) "move your arm, you're hurting me" (laughs). It's not very, erm... 
romantic on occasions. (14) 
This influenced the self-image and emotional well-being of some patients. 
And our sex life, you know, it's a bit embarrassing really, but I used to love, making love to ----. 
You know, we had a good sex life.... and all of a sudden it's gone, you know. ----- says she 
doesn't mind, it doesn't bother her. I don't know whether it does or not. I can't tell really how 
she feels about it, but it makes me feel less of a man. I know that's silly, it's not the way to 
look at it, but it makes me feel, you know, like I'm not really... like I'm not really a proper 
husband. (15) 
4.3.6 Impact of NMD on Social Participation and Integration 
The visible physical impact and diagnostic label of muscle disease caused difficulties on a 
social level, which also influenced many patients' emotions and self-image. 
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4.3.6.1 Negative Social Reactions 
Negative reactions from other people inhibited a number of patients in participating in 
activities of their choice. 
I did actually join a local gym, 'cos I felt like that was something that I could still do. But I just 
felt too out of place, I couldn't do the things I used to be able to do and there were a lot of 
posers in the gym and it was all glass fronted, so everyone walking past could see you and I 
just felt too self conscious ... 
(13) 
4.3.6.2 Social Stigma 
Negative social reactions reported were commonly due to other peoples' prejudices and 
misconceptions. For example, wheelchair users or those who were affected in their 
mobility orý physical appearance were treated as if they were intellectually as well as 
physically impaired.. 
You do get stared at to a certain extent, or people treat you as though you're an imbecile 
almost. They look at you and you almost feel as if they're going to pat you on the head. They 
do make you feel different yes, some do. (16) 
I was in the wheelchair at the hospital and the woman taking the appointments called over and 
asked a question... I answered and she said, "no, I am talking to your carer", and that really 
annoyed me because she was talking down to me and this is what hurts (2) 
Patients in the CSP group reported this social stigma most commonly. One man 
attributed the negative reactions to other people's lack of understanding. 
they class you as..., they all put a name on everybody like, you, know, "weirdo" or whatever, 
you know. They don't understand, well ... I didn't 
understand, still don't sometimes... (20) 
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Even patients with a congenital muscle condition who did not have obvious physical 
symptoms, reported stigma relating to the genetic nature of their condition. Some patients 
expressed guilt about having passed on their condition to their children, and patients 
reported sensing guilt in other family members. This further suggested the social stigma 
prevalent with regard to congenital muscle conditions. 
I almost sort of have this guilt thing, I was frightened of passing it on to his children, you know, 
poisoning his children with this horrible disease that I've got (17) 
My mother now has feelings of remorse that she's created these less than perfect children and 
she applies fault to herself..... (21) 
4.3.6.3 Lack of knowledge & understanding 
Other people's lack of understanding about disability and muscle conditions in particular 
were reported to cause problems in explaining their condition and distress in certain 
social situations. 
people don't like to talk about it, you know "don't mention it but she's got this muscle disease" 
and all this sort of thing. It's not a condition that people understand or know anything about. 
You can say "oh, I suffer from migraines" or "I suffer from hayfever" and everybody can 
understand ... but because it's a condition that is so rare... nobody understands it and, they 
don't know what you're talking about... (17) 
Some patients suspected other people believed their ill-health to be feigned, which was 
also upsetting. 
One thing I do find is that people look at me, they think, "you're young, there's nothing wrong 
with you"..... A lot of people just assume that you're lazy, you don't work "Ah, there's nothing 
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wrong with you, what's wrong with you? " and that makes me feel angry that people are so 
shallow minded... (22) 
This lack of understanding, also perceived in close family members, led to feelings of 
isolation as portrayed by one man with Myotonic Dystrophy. 
There's no real support group I can contact, you know to find out... "Oh, you got the same as 
me, oh fine" .... if I've got somebody to talk to, it's nicer'cos I can get it out, you know (laughs). 
This, just having somebody to talk to about it, I can't talk to the wife 'cos she doesn't really 
understand (8) 
4.3.6.4 Stigma and discrimination 
The fear of being stigmatised led some patients to cover up their condition. 
There's no point in keeping it a secret 'cos they're going to find out eventually.... "Why can't 
this geezer shake hands? What's the matter with him? " "Oh sorry yeah, I get cramps". I don't 
tell them it's a muscle wasting disease, I don't say things like that, I just say "I've got cramp". 
(8) 
Discrimination was reported, particularly with regard to employment and financial issues. 
Some patients felt that their having a NMD influenced their job prospects. 
I wait until I've proved I can do the job before I'll tell them. I don't usually tell people 'cos 
people just they think, "Ah, poor her" and I don't wanna be looked on as being different to 
everybody else 'cos in my view I'm not. People think, "oh God, she's got this" and I think it 
could affect things like promotion, so I just don't tell. If I feel that they need to know then I'll tell 
'em, but most of the time I don't. (23) 
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4.3.6.5 Physical difference and associated social impact 
The visible effects of NMD had a particular impact upon the self-image and confidence of 
a number of patients. 
I hate looking like this. I hate photographs of myself. I only, ever look in the mirror if I 
absolutely have to. I don't like going out. I just hate the way I look, I hate being in this 
(referring to wheelchair). (14) 
Negative body image was most evident in those who had undergone steroid treatment. 
I feel slightly embarrassed by being overweight. Just don't want to have people see me as 
getting overweight for the sheer hell of it .I feel quite strongly about that, 
'cos I've always 
taken care of myself and I feel like I haven't had any control over that ...... It's like when you 
see somebody you haven't seen for a long time and you think, "gosh, haven't they changed", 
you know, and I hate the thought that people just might say "gosh, have you seen ------ lately? 
Hasn't she got fat" (1) 
The impact of NMD and treatment side effects upon body image influenced the self- 
confidence and self-image especially in social situations. One lady diagnosed with 
Dermatomyositis reported the very specific symptom of skin rash and its influence upon 
her self-image. 
When I did go out when I was ill in the first place, I was extremely self-conscious about the 
rash and I knew I looked horrible, I just knew it. I hated myself and my self-confidence really 
went down... to me the rash was all there was of me, that's all I was, a walking rash. (24) 
4.3.7 Expectations 
Patients' expectations of the effects and consequences of muscle disease also influenced 
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their emotional well-being. Fears about losing independence and freedom were 
widespread in the interviews. 
It's very worrying 'cos up to now, I have steadily deteriorated, which means that in the 
future.... I probably will need even more help, which is very worrying... because, I know with 
the people I've visited in residential homes, their brain goes, they're in zombie-land. When 
you're in your own home you've got to do a certain amount of things for yourself, even if it's 
only to manage to go and make a cup of tea .... (11) 
Many patients also made comments about the implications of a loss of independence for their 
partners or spouses. 
the only worry Is in the future what my husband's got to cope with, looking after me. You 
know, if I deteriorate he might have to do more and more for me, that's my worry, but not 
myself personally..... (25) 
4.3.8 Positive Experiences 
Positive experiences were also reported and accounts given of how they had adapted to 
and learnt to accept their condition. 
4.3.8.1 Relationships 
Although dependence on other people was a common source of negative emotions, it also 
had a positive effect on some relationships. Some patients reported how their condition 
had brought them closer to other members of their family, particularly their partners or 
spouses. 
104 
I think it's brought us a lot closer really. I mean, my father brought me here today (laughs). 
They're always there to help me out and listen. I've sort of put them through a lot really and 
they stick by me...... My husband, it's probably put a lot of strain on our relationship, but I think 
in a way it's brought us closer as well ...... There's things that 
I want to do, around the house, 
maybe even something simple, like putting a picture up, that I can't do but I have to rely on him 
to do it, and he'll feel I'm nagging him because I'm asking him to do things all the time, but we 
find ways to work through it and I think in that way it's made us closer, 'cos we do talk about 
things more. (13) 
4.3.8.2 Adaptation, Acceptance and Positive Outlook. 
Some patients reported that their condition had enabled them to concentrate upon areas of 
their life in which they could achieve fulfilment. Many patients maintained a positive 
attitude and outlook. 
I think it's made me more determined, in a lot of ways to actually get on. I'm more determined 
than my brothers and sisters.... they're not really bothered about jobs and careers and things 
like that really. It makes me want to be the best at everything that I can do. I'm quite a 
competitive person, but I'll only attempt things that I know I can do. (26) 
as soon as we retired, I wanted to join dancing classes, well that's out of the window....... but 
there's lots of things that that's compensated by..... because I have to take extra rests then I 
can do my tapestry, I can do my oil paintings. So there's benefits that way. (27) 
4.3.9 Disease `impact' in congenital NMD patients. 
Unlike patients with an acquired condition, some congenital NMD patients found it 
difficult to express how they had been `affected' by their muscle condition in terms of 
any change in their physical functioning. They instead shared experiences of how they 
approached activities differently from other people and how they compensated for these 
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differences. One man reported how he lived with the condition without it having any 
perceptible impact upon his life. 
It's an odd condition... it's like it's a part of me... just like a leg or something and I don't miss 
being able to do the things a truly able bodied person is able to do... some of the functions I've 
lost I've managed to compensate for without even thinking (21) 
To elucidate the experiences of muscle disease in patients in the CSP group, five 
supplementary interviews were conducted in these patients. From these it became clear 
that the influence of NMD on patients' lives were often experienced in terms of 
differences from the `norm' or as a disadvantage compared to individuals not diagnosed 
with NMD. This was illustrated by the recollection of a young woman with Myotonic 
Dystrophy. 
When I was in school, teacher would say, I can't read your work.... write it again and again and 
again and I was like the only one and that sort of made me different from everybody else as 
well... (28) 
The implications of having a muscle condition and its diagnostic label were relevant to 
the experiences of all NMD patients, but particularly those with a congenital condition. 
For some patients, being given a diagnosis provided an explanation for differences that 
the patient had always been aware of, for example in participating in sports at school. 
.... I sort of knew from an early age that there was something different about the way my body 
moved and I didn't know what it was. (18) 
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For example one lady with muscular dystrophy described the influence that being given a 
diagnosis had in providing a reason for a number of falls. 
I- What's it like having an explanation for those things now? 
P- Well I like it, I prefer to know why, rather than it just being that I'm clumsy, 'cos I used to 
think I must be stupid and clumsy for that to happen. (29) 
4.4 Discussion 
The analysis of the interviews revealed that the experience of muscle disease influences 
many areas of life. There were similarities across patients, but no set pattern of disease 
impact, particularly across the predefined subgroups of patients. Factors including age, 
gender, marital status, life circumstances, disposition and type of muscle disease 
undoubtedly influenced individual patients' experience and perception of NMD effects. 
The life domains that emerged correspond to the broad domains believed to make up the 
QoL spectrum (physical, psychological and social functioning) (Bowling, 1995; Group, 
1995; Price, 1996). 
The underlying determinants of the negative feelings expressed by patients included: 
1. The physical symptoms of pain, fatigue, and muscle weakness and the effect of 
treatment upon these symptoms. 
2. Perceived degree of control over physical functioning, social roles and emotions. 
3. Ability to participate in activities and carry out plans of choice. 
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4. The effect of NMD upon relationships. 
5. Negative social reactions and, stigmatisation in response to the patient's physical 
appearance, their physical ability or to knowledge about the existence of their muscle 
condition. 
6. Patients' expected consequences of their condition. 
These issues have been documented in studies of patients with illness and disability. For 
example, physical symptoms of pain and fatigue have previously been found to contribute 
to lower levels of QoL (Albrecht and Devlieger, 1999). The effects of social 
discrimination and of an unaccommodating social and physical environment upon 
patients with disability are also well documented (Waddington, 1997) (Steinfeld and 
Danford, 1999). The stigma associated with physical differences and disability has also 
been discussed in depth (Goffman, 1963). 
Patients with disability who report high levels of QoL have attributed this to having 
control over their bodies, minds and lives in general (Albrecht and Devlieger, 1999). 
4.4.1 Relating findings to QoL Assessment 
The life domains emerging from the interviews go beyond those captured by generic 
measures used in previous studies of muscle disease patients (Bach et al, 1991; Pehrsson 
et al, 1994; Ahlstrom and Gunnarsson, 1996; Ahlstrom and Sjoden, 1996; Ahlstrom et al, 
1994; Drouet, 1996; Alexanderson et al, 1999; Chung et al, 2001) (See Table 4.5). 
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Table 4.5: List of domains emerging from in-depth interviews which have and which 
have not been incorporated in two generic QoL questionnaires 
Domains incorporated in commonly Domains not incorporated in commonly 
used generic measures (NHP (Hunt et used generic measures (NHP (Hunt et 
al, 1985), and SF-36 (Ware and al, 1985), and SF-36 (Ware and 
Sherbourne, 1992 Sherbourne 1992 
Daily activities (ADL) Physical symptoms (specific to muscle 
disease) 
Social interaction Relationships 
Leisure activities Perceptions of the future 
Emotions Em to ent 
Self-perception 
This challenges the use of such measures, as any change in domains that are not included 
in these generic questionnaires would not be detected. Furthermore, certain items within 
generic questionnaires might not be relevant to the experience of NMD. For example 
items such as "Have you accomplished less than you would like? " (SF-36 Q5b) and 
"Have you been a happy person? " (SF-36 Q9h) are unlikely to be of specific relevance to 
NMD patients. These findings affirm the need to develop a new QoL measure, specific to 
patients with NMD. 
Psychological adaptation and coping were exemplified in patients accounts of their efforts 
to maintain control and independence. Such processes are likely to influence patients' 
responses to QoL questionnaires along with factors such as disposition and life 
circumstances (Headey and Wearing, 1989; Brief et al, 1993; Feist et al, 1995; Allison, 
1997; Albrecht and Devlinger, 1999). As patients reported varying degrees of acceptance 
and adaptation to their condition, a questionnaire developed for muscle disease should 
also take account of the dynamic nature of QoL. 
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The conceptualisation of QoL as `the discrepancy between an individual's perceived 
current state and how s/he would like to be' (Calman, 1984; Cella and Tulsky, 1993; 
Group, 1995; Price, 1996) is consonant with idea of personal control and its influence 
upon patients' freedom, independence, self- image and emotional well-being. Patients 
with a high degree of control in their lives, regardless of physical disability, are likely to 
be able to fulfil many of their aspirations or conduct their lives the way they wish. This 
definition has already been used as the basis for a number of new questionnaires (Ruta et 
al, 1994; Group, 1995; Bradley et al, 1999) and provides a good foundation on which to 
develop questionnaires that will help to explain fluctuations in reported QoL. 
It may be also be useful to delineate and separate the various stages of disease impact in 
QoL questionnaires. This could be done by questioning patients about the various stages 
of disease impact from symptoms and functional impact to effects upon self-image and 
emotions through to their overall evaluations of HRQL (Leventhal and Coleman, 1997; 
Hyland, 1992). Breaking down the process of HRQL evaluation (see section 1.8.2) should 
elucidate reasons for any change in HRQL and may indicate whether changes are due to a 
specific intervention or to adaptation. 
4.4.2 Social Perspective 
From the reported experiences of patients with NMD, it is clear that it is not only physical 
impairment and functional disability that cause difficulties in patients' lives. The patients 
interviewed, particularly those with congenital muscle conditions, did not always perceive 
muscle disease to have a particularly detrimental effect upon their lives. Instead they 
described how they approach certain activities differently to the able-bodied and avoid 
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some other activities altogether. In these cases the societal perspective is often more 
important in determining HRQL. 
In light of the psychosocial impact evident in the patients interviewed, the revised ICIDH 
disability classification framework (ICIDH-2) promises to be of great value in enhancing 
the treatment and care of muscle disease patients. This framework acknowledges the 
contextual factors of the social and physical environment and also of patients' personal 
characteristics upon how disablement is experienced. The availability of social support 
(friends, family, patient support groups), technical aids and devices, high quality medical 
care and advice as well as accessible public facilities are just some of the factors that 
influence the degree of control and freedom that patients have in their lives. 
By going beyond treatment at the level of physical symptoms and continuing to challenge 
misconceptions and prejudices and also social and environmental barriers, the impact of 
disease and disability may be significantly reduced. The more control and freedom 
patients have and the more opportunities there are for patients to integrate into society, 
the easier it will be to tackle the negative social attitudes that still isolate many people 
with illness and disability. 
4.5 Conclusions 
Exploration of patients' experience of NMD uncovered numerous effects that have 
previously never been recounted. These findings were helpful in designing the new QoL 
questionnaire. The life domains that emerged from the interviews influenced the content 
111 
of the questionnaire and the different ways in which disease impact was reported, from 
effects upon activities to influences upon patients' self image, supported its theoretical 





Chapter 5: Constructing Questionnaires 
5.1 Introduction 
Following the exploration of patients' experiences in the qualitative interview study a 
postal survey was conducted to investigate the importance and prevalence of the life 
domains reported. Findings from the survey were used along with the interview 
results to develop the new QoL scale. 
The project therefore involved constructing two questionnaires, a postal survey 
instrument and the final QoL questionnaire. It was therefore important to consider the 
issues involved in constructing the individual items and structure of questionnaires. 
5.2 Composing questions 
It is important that questionnaire items are easy to follow and understand. This can be 
achieved` by making sure the questions are relatively brief, have straightforward 
phrasing and are free from jargon or ambiguity (Streiner and Norman, 1995; 
Mangione, 1995; Sudman and Bradburn, 1982). 
5.2.1 Open-ended versus closed-ended questions 
There are two main types of question that can be asked in questionnaires; closed and 
open-ended questions. Open-ended questions allow the respondent to provide his/her 
own answer whereas closed-ended questions require respondents to select a response 
from predetermined categories. 
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Standardised questionnaires customarily adopt closed-ended questions, whereas 
individualised scales tend to use more open-ended questions that allow respondents to 
voice individual concerns. 
5.2.1.1 Open-ended questions 
Open-ended questions can be useful in exploring a topic when developing new 
questionnaires (Sudman and Bradburn, 1982). However, they involve greater effort 
to complete and may be intimidating to respondents with lower levels of education or 
literacy. It has therefore been suggested that open-ended questions be included only 
as an appendage to closed-ended questions (Mangione, 1995). However, the 
provision of space for comments may be an incentive to respond as it allows 
respondents to voice their opinions without being constrained by predefined response 
options (Moser and Kalton, 1971). 
5.2.1.2 Closed-ended questions 
Closed-ended questions require people to respond within predetermined categories 
and therefore risk forcing answers into inappropriate categories. Despite this, their 
completion involves less effort than for open-ended questions, which means they are 
more likely to be completed. They are also easier to analyse as scoring schemes for 
closed-ended questions are predetermined. 
5.3 Scaling Response Categories 
5.3.1 Binary Scales 
Binary scales, (e. g. scales that offer response options of `yes' or `no') such as the 
Quality of Well-Being (QWB) Scale (Kaplan et al., 1976) and the Sickness Impact 
Profile (SIP) (Bergner et al., 1981) are simple but do not represent intermediate points 
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between the extremes of a continuum (e. g. depression). This means that they are less 
sensitive to change and they are less acceptable to respondents given that the effects of 
illness upon QoL are unlikely to be experienced in an all or nothing way. 
5.3.2 Categorical/Likert Scales 
Likert scales (Likert, 1952) ask respondents to indicate their agreement or 
disagreement with a statement on a scale consisting of adjectival categories that range 
from, for example; `strongly agree' to `strongly disagree' or `not at all' to `extremely' 
(Figure 5.1). 
Figure 5.1 
Please circle one of the boxes from the scale below 
STRONGLY 
AGREE 
AGREE NO OPINION DISAGREE STRONGLY 
DISAGREE 
These scales are used in questionnaires such as the SF-36 (Ware and Sherbourne, 
1992; Brazier et al., 1992) and have the advantage of being simple and almost 
universally understood. 
Unfortunately, Likert scales are labelled with adjectives that may be interpreted 
differently by different respondents. This may addressed by numbering the scale in 




AGREE NO OPINION DISAGREE STRONGLY 
DISAGREE 
1 2 3 4 5 
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However, numbering categories may add additional bias and may influence responses 
depending upon the numbering applied to the scale. For example, scaling the item 
from -5 to +5 has been found to result in fewer respondents using the lower half of the 
scale compared to a scale ranging from 0 to 10 (Schwarz et al., 1991). Care should 
therefore be taken to ensure that scale numbering does not result in skewed data. 
5.3.3 Visual Analogue Scales 
Visual analogue scales (VASs) are lines of a fixed length (usually 100mm), anchored 
at either end by the extremes of the scale (e. g. `none at all' & `extreme'). Responding 
involves marking a line or a cross on the scale at the point that represents their 
position between the anchor points (Figure 5.3). 
Figure 5.3 
Please mark a cross on the scale below to indicate how bad your pain is. 
NO EXTREME 
PAIN PAIN 
VASs do not confine responses to previously defined categories and as such were 
adopted to achieve greater accuracy and sensitivity to change than categorical scales. 
VASs have become popular over the last couple of decades in rating symptoms such 
as pain (Huskisson, 1982) and they are also used to measure other subjective states, 
including depression (Lees and Lloyd-Williams, 1999) and fatigue (Brunier and 
Graydon, 1996). 
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5.3.4 Graphic Rating Scales 
Graphic rating scales (GRSs) are similar to VASs except that they are graded with 
numbers or adjectival labels at intervals along the line (Figure 5.4). 
Figure 5.4 
Please circle the number that best describes your degree of pain on the scale below. 
No PAIN 10 1 12 3 14 56789 10 EXTREME PAIN 
These scales are easier to complete than the VAS, involving circling a number or 
descriptive label. They are also easier to score as, rather than measuring the distance 
between the line or `X' and the anchor point at the low end of the scale, scoring 
simply involves taking note of the number selected. 
Numerical rating scales (e. g. Figure 5.4) have been found to be more responsive to 
change in pain than VASs or verbal rating scales (Bolton and Wilkinson, 1998) which 
suggests their usefulness in evaluative studies such as treatment trials. 
5.3.5 Visual Analogue versus Categorical Scales 
A number of studies have found little difference in the efficacy of visual analogue and 
categorical scales (Remington et al., 1979; Slevin et al., 1988). However, the lack of 
familiarity with the VAS has resulted in more inaccuracies in completing these scales. 
One'study found that 7% of respondents had completed VASs inaccurately, compared 
to 3% for graphic rating scales (Huskisson, 1974). It has therefore been recommended 
that respondents be taught how to complete these scales. However, this is more time 
consuming and means that VASs are inappropriate for use in postal survey 
instruments (Guyatt et al., 1987). 
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Bias has also been reported in the completion of VASs. Factors such as the 
orientation of the scale (either horizontal or vertical) and labelling (e. g. with lines or 
verbal descriptors) have been found to influence the distribution of responses on these 
scales (Paul-Dauphin et al., 1999), casting doubt on the validity of this scaling 
method. 
Another disadvantage is that changes on VASs are difficult to interpret clinically. For 
example, the meaning of a change of 10mm or 20mm on a VAS is not clear, whereas 
changes on a Likert scale demonstrate an interpretable shift from one category to 
another (Guyatt et al., 1987). 
Given the problems with VASs and the greater familiarity and ease with which 
categorical scales can be completed and scored (McQuay, 1990), categorical scales 
are often a more attractive choice for clinicians and researchers. 
5.3.6 Is there an optimal number of response options? 
It is beneficial to adopt a scale with more than two response categories (e. g. `yes/no'). 
Binary scales can be frustrating for respondents and as they often do not represent the 
full spread of variation between individuals. Reliability has been found to decrease 
the fewer the categories are used in the scale, although the loss in reliability was found 
to be small in scales of more than 7 categories (Nishisato and Torii, 1970). 
People also have difficulty discriminating between more than seven categories 
(Miller, 1956), although the tendency for respondents to avoid extremes on the scale 
('end aversion bias') has resulted in recommendations of a9 level scale (Streiner and 
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Norman, 1995). This is less appropriate for Likert-type scales in which adjectival 
descriptors for each level would result in a cumbersome scale. Even reducing the 
number of levels to five ' or even three is unlikely to result in a significant loss of 
information when there are a large number of items on the scale (Streiner and 
Norman, 1995). Between 5 and 7 categories are therefore recommended as the optimal 
number of response options (Streiner and Norman, 1995; Fowler, 1995). 
In categorical Likert scales, odd and even numbers of categories have been shown to 
have similar efficacy (Remington et al., 1979) and are suited to different purposes. 
Scales that provide an odd number of categories allow respondents to provide an 
answer in the middle of the scale (i. e. indicating "no change", or "neither good nor 
bad"). However, the use of an even number of categories to force choices one way or 
the other may be appropriate in the likes of opinion polls or attitude surveys. 
5.4 Timeframe 
Some measures do not define the timeframe (period of time referred to in 
questionnaire items). Others may ask the respondent to consider the previous day, 
week, or month with regard to his/her response. Specifying the timeframe ensures 
that respondents refer to a particular point of time in order to give a representative 
picture of the situation since that time. This means that the information gathered will 
be more valid and changes over particular periods of time are more likely to be 
detected. It has been suggested that timeframes of a few days are preferable to those 
that ask about the past few weeks as they are less subject to inaccurate recall (Osoba, 
1998). 
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5.5 Questionnaire Length 
Shorter questionnaires are believed to yield better response rates than longer 
instruments (Mangione, 1995). Brevity is a particularly important attribute in health 
status scales as it is estimated that patients in ill health become tired after about 15-20 
minutes (Osoba, 1998). On the other hand, longer questionnaires may be seen as 
more important or interesting (Mangione, 1995) and may motivate more people to 
respond. 
Despite this, the influence of questionnaire length is likely to be negligible once a 
certain number of pages have been reached. For example, there was no difference in 
response to a 28 page questionnaire, compared to a 32 page questionnaire that 
contained 59 extra questions and took an extra 5-10 minutes to complete (Kolowski, 
2001). It is believed that as long as the subject of the questionnaire is salient and 
respondents have a reasonable level of education it is possible to maintain response 
levels to questionnaires of 12-16 pages (Sudman and Bradbum, 1982). 
5.6 Format of the questionnaire 
Questionnaires should have a short and simple introduction, questionnaire items 
should be easy to read and uncluttered and completion of the scale should be easy, 
with tick boxes or numbers to circle. A booklet format looks more professional and 
should minimise loss of information through respondents missing pages (Sudman and 
Bradburn, 1982). Finally, a thank you statement should be provided at the end of the 
questionnaire. 
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5.6.1 Branching questions or `skip' patterns 
In most questionnaires or surveys individuals may be required to skip over questions 
that do not apply to them (e. g. unmarried individuals to skip the questions on 
relationship with spouse). The problem with this is that branching questions can be 
confusing and may result in missed items (Fink and Kosekoff, 1998). It is therefore 
important for instructions to be clearly presented, with the use of arrows, boxes or 
bold font. Instructions to skip to a question on the same page or the top of the next 
page are also helpful. Such measures should save respondents the time and effort 
required in attending to irrelevant questions. 
5.6.2 Ordering of questions 
Questions should be placed in a logical order and grouped together with transitions 
provided to describe the upcoming set of questions (Fink and Kosekoff, 1998). In 
order to minimise item non-response, non-threatening, salient questions should be 
placed at the start (Sudman and Bradburn, 1982) as respondents may be put off by 
more challenging questions. However, sensitive or difficult questions should appear 
well before the end, as respondents may become tired particularly if the questionnaire 
is long and difficult. Demographic questions (e. g. gender, age) should be placed at the 
end (Sudman and Bradburn, 1982). These tend to be easy to answer but may also be 
threatening or off-putting to some respondents. Placing them at the end means that 
they will be completed without influencing responses to the other items. 
5.7 Conclusion 
The principles outlined here were put into practice in constructing both the postal 
survey instrument (chapter 7) and the new QoL questionnaire (Chapter 8). 
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CHAPTER VI 
CONDUCTING POSTAL SURVEYS 
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Chapter 6: Conducting postal surveys 
6.1 Why conduct a postal survey? 
Postal surveys are an efficient and cost-effective way of investigating an issue in a 
large number of people within a short space of time. They require minimal staff and 
facilities and are particularly useful in gathering information from rare populations 
and widely dispersed samples (Fowler, 1995). 
The survey method was particularly useful in this study as surveys can help to verify 
the analysis of qualitative studies in a larger, more representative sample. If surveys 
also incorporate open-ended questions, they can provide supplementary qualitative 
data about the opinions or experiences that may not have emerged during qualitative 
investigation. 
Surveys also have the advantage of giving respondents time to provide thoughtful 
answers (Mangione, 1995; Moser and Kalton, 1971). They also avoid the biases 
introduced with the use of an interviewer as respondents are more likely to answer 
questions of a personal or embarrassing nature and give less socially acceptable 
responses (Moser and Kalton, 1971). 
6.2 Pilot testing 
Reading through questionnaire items and trying to hear them from a naive perspective 
can be useful in detecting any confusing questions or instructions, or issues that may 
have been left out. Feedback from colleagues prior to the pilot study may also be 
helpful. 
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Pilot testing is essential in the development of postal survey questionnaires as it 
allows the investigator time to reorganise any' problematic parts of the instrument 
(Litwin, 1995) and determine whether the survey will provide the information 
required (Fink and Kosekoff, 1998). 
Pilot studies allow the detection of any typographical errors in the questionnaire, 
problems in layout or ambiguity in the instructions or questions (Litwin, 1995; Fink 
and Kosekoff, 1998). They are also useful for ensuring that the vocabulary used and 
content of the questionnaire is appropriate, the format flows well and that the 
questionnaire is of a reasonable length (Litwin, 1995). 
Pre-testing should also minimise the use of awkward or embarrassing questions, or an 
unhelpful layout. This should help enhance response rates and avoid biased responses 
(e. g. social desirability bias) (Fowler 1995). 
6.3 Conducting the Survey 
6.3.1 Timescale 
It is recommended that one month should pass between the original mail out of the 
survey to the analysis of the data (Moser and Kalton, 1971). A large number of 
responses will be received within two weeks but as many will be returned late, time 
should be allowed for responses to follow-up attempts. 
6.3.2 Sampling 
The sampling method adopted in postal surveys depends largely upon the population 
of interest. If the general population is being surveyed, it may be more appropriate to 
use a stratified sampling method (Coolican, 1994) so that the general population can 
be adequately represented. This involves delineating all the subgroups within the 
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population for demographics such as gender, age, race and socio-economic status and 
attempting to represent each of these in the sample selected. 
In this study a convenience sampling method was adopted which involved drawing the 
sample from a group that was ready and available. This was appropriate given the 
relatively small number of NMD patients and consequent need to sample patients 
from a large geographical area. 
6.3.4 Confidentiality 
Coding for identity is helpful in enhancing confidentiality (Fink and Kosecoff, 1998). 
Forms or return envelopes can be marked with an identification number rather than 
the respondent's name. These numbers can then be linked with the list of names to 
whom the survey was sent and reminders can be sent to non-responders. 
6.4 Difficulties in Postal Surveys 
6.4.1 Item non-response 
Item non-response occurs when respondents do not know the answers to particular 
questions or when they refuse to answer confusing, embarrassing or irrelevant 
questions (Fowler, 1995). Respondents may also miss questions out or provide their 
own answers if presented with too few response categories or if the categories do not 
represent their opinion or position. This is problematic if a large number of 
respondents leave certain questions unanswered. Rigorous pilot testing should ensure 
the acceptability and lucidity of the questionnaire and help to minimise non-response. 
Other methods used to address the issue of item non-response include imputing scores 
for missing items based on responses to other items on the scale. This can be useful if 
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a few items are left incomplete but is less appropriate if a large proportion of 
responses are missed (see Fowler, 1995). 
6.4.2 Low response rates 
Compared to interview studies, postal surveys do not have the immediacy and 
incentive to ensure a good response rate, making non-response a common setback in 
postal survey studies. 
There have been postal surveys reported in which only 5% to 20% of the sample 
responded. These are unlikely to give a fair representation of the population under 
study (Fowler, 1995). Researchers tend to aim for a response rate of 70% or more 
(Fink and Kosecoff, 1998) in order to achieve a representative picture of the issue 
under study. 
6.4.3 Non-responders 
People not responding to surveys include: 
" Those who did not receive the questionnaire, for example those who have changed 
address. 
" Those unable to complete or respond to the survey due to ill health, inadequate 
reading or writing skills, or skills in the language of the questionnaire. 
" Those who did not wish to complete and return the survey 
" Those who did not get around to completing or sending off the survey 
It is therefore important to check the list of respondents to ensure that it is up to date. 
Unfortunately, little can be done to address non-response from the illiterate or those 
physically unable to respond. By conducting pilot studies to ensure that the 
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questionnaire is straightforward and easy-to-complete more people will be able to 
respond. 
Making the survey more attractive and interesting, and emphasising its importance 
also encourages respondents to reply. Finally, a rigorous follow-up- of the initial mail 
shot with reminders and repeat mailings should help to minimise non-response. This 
should be particularly helpful in maximising response from those who fully intended 
to reply but may not have got around to doing so. 
6.4.4 Bias due to Non-response 
Postal surveys exclude certain respondents and may lead to bias in the results and the 
conclusions drawn from them. 
Response may be influenced by: 
" The respondents' ability to complete the scale 
" The area in which the individual or sample lives. For example, response rates tend 
to be higher in rural areas than in cities. 
" Income level and social class. 
" Level of education. For example, those who are less educated may be less able to 
complete certain scales or may feel intimidated by the survey process. 
" Age. For example, the elderly may have more trouble in completing the form. 
" Gender. It is has been suggested that males may be less co-operative as a group 
than females. 
" Level of motivation and degree of interest in the research. 
(Fowler, 1995; Moser and Kalton, 1971). 
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Therefore, if the survey is interesting and of relevance to the population of interest 
there is likely to be a better response. The researcher has less influence over 
demographic factors such as age, gender and social class. However, a rigorous 
follow-up should encourage response from the subgroups that tend to be 
underrepresented. 
The limited control that researchers have over surveys means that there is no way of 
telling whether someone other than the intended recipient completed the 
questionnaire. This is another important source of bias in survey research. 
6.5 Achieving good response rates 
The main difficulty in postal surveys is inducing respondents to complete the 
questionnaire without the intervention of an interviewer. A 20% response rate for the 
first mailing is not uncommon. However, it is suggested that this can be elevated to 
70 or even 80% through repeat mailings and reminders (Fowler, 1995). 
6.5.1 Appearance of the Questionnaire 
Measures that can be taken to improve response rate include making the questionnaire 
look more attractive (e. g. using a visually attractive layout, coloured paper) and 
professional (e. g. printing the questionnaires professionally) (Fowler, 1995). This 
may make respondents see the project as more important and worthy of their time. 
Including a good covering letter and a stamped addressed or business reply envelope 
along with the questionnaire should also help. The letter should convey the 
importance and usefulness of the research, explaining the study as well as motivating 
respondents to take part. Emphasis should be placed on confidentiality and that 
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participation is voluntary (Mangione, 1995). The covering letter should also be brief 
(one page), and typed on the headed notepaper of the supporting institution. 
Providing a contact name and telephone number ensures that respondents can contact 
the researcher if they need assistance in completing the form and signing the letter in 
blue ink makes it seem more personal and may increase incentive to respond. 
6.5.2 Incentives 
Prepayment to individuals has been found to enhance response rate but may not be 
appropriate for certain studies. Monetary or other material incentives are better 
reserved for more consumer-oriented, or market research-style surveys rather than 
those enquiring about peoples' experience of disease. 
6.5.3 -Ensuring confidentiality of responses 
Measures to ensure the confidentiality of participants' answers are also believed to 
enhance response rate (Mangione, 1995). However, complete anonymity may be 
impractical as it means that identification numbers have to be left *off the forms and 
the survey resent to those who have already responded, as well as non-responders. 
6.5.4 Repeated contact 
Repeated contact with respondents is the most important factor in enhancing response 
rate (Fowler, 1995). In order to achieve a 75% response rate it is recommended that at 
least four mailings are performed (Fowler, 1995) enclosing the complete package 
(questionnaire etc) in the first and third mailings (Fink and Kosecoff, 1998) and a 
postcard or letter reminder in the second and fourth (Mangione, 1995). 
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Contacting non-responders by telephone may also encourage response (Kolowski et 
al., 2001). However, this may be costly and difficult to implement if potential 
respondents can not be contacted or if telephone numbers are unavailable. 
6.6 Addressing low response rates 
If a low response rate is achieved despite measures to maximise response, proxy 
respondents can also be surveyed. Unfortunately, this is not as good as self-report 
particularly for topics involving subjective information such as feelings, knowledge or 
opinions (Fowler, 1995). 
In order to gauge whether the data is representative, non-responders can be surveyed 
and their characteristics compared to those who respond to the first round of data 
collection (Fowler, 1995). Data gleaned in repeat mailings can also be used to 
estimate the direction and amount of bias in the data from the first phase of data 
collection. If the new round of data collection replicates the initial phase, the 
researcher can be more confident that the data are representative. 
6.7 Conclusions 
It is clear from the literature that careful planning and a rigorous approach to the 
mailing and follow up of questionnaires is essential to the success of a postal survey 
study. 
Having explored the experiences of individuals with NMD it was important to verify 
these findings in a larger group of individuals and glean any additional information for 
use in the new QoL questionnaire. 
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The postal survey was conducted following the recommendations outlined in this 
chapter and is described in chapter 7. 
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Chapter 7: Exploration of Patients' Perceptions of Neuromuscular Disease 
Impact: A Postal Survey Investigation. 
7.1 Introduction 
It has already been established that QoL questionnaires should be constructed on the 
basis of both theory and exploratory research (Chapter 2). The results of the initial 
exploratory interview study engendered a better understanding of patients' 
experiences and provided a basis upon which to conduct more quantitative 
exploration. This survey aimed to confirm and elaborate upon the findings of the 
interview study and to uncover any issues that may have been neglected. It was felt 
that investigating the effects of NMD in a larger sample would provide a more 
representative picture of disease impact. In order to achieve this the prevalence of 
impact across life areas and the importance attributed to this were investigated. This 
also facilitated the selection of the most relevant items for the final QoL questionnaire, 
ensuring as accurate and responsive a scale as possible. 
Respondents were also asked whether the effect of their NMD upon each aspect of life 
was positive or negative. This method was adopted as positive effects of illness are 
commonly overlooked in QoL assessment despite findings of high levels of QoL in 
cancer patients (Watson and Pennebaker, 1989; Fromm al, 1996; Taylor et al, 1984) 
and patients with disability (Albrecht and Devlieger, 1999). Symptoms such as pain 
have been also been found to have a positive effect upon family relationships (Padilla, 
et al, 1990), therefore it was considered important to include this method. 
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7.2 Methods 
7.2.1 Devising the Postal Questionnaire 
The postal questionnaire (Appendix B) was designed around the life domains 
extracted from the interviews. The survey questions probed the following domains. 
1. Daily activities 
2. Employment / working life 
3. Social & Leisure activities 
4. Relationships with friends 
5. Family relationships 
6. Relationship with spouse/partner 
7. Relationships with other people (strangers, acquaintances and colleagues) 
8. Independence 
9. Emotions 
10. Body image 
11. Perceptions of the future 
12. Treatment 
These questions relate to the domains listed in Chapter 4 (p. 91, table 4.4). The only 
difference is that, for the purpose of the survey, the relationships domain was split into 
the sub-domains of friends, partner /spouse and family. 
Questions about treatment were also included, facilitating the investigation of 
beneficial effects as well as the side effects of treatment, issues that were touched 
upon in the interviews. 
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7.2.2 Format of the Questionnaire 
The survey posed a series of closed ended questions to determine the extent to which 
people are affected by their condition and the importance they attach to disease impact 
across various life domains. 
Boxes for comments were also incorporated to allow respondents to share their 
individual concerns and experiences. This was done to ensure comprehensive 
coverage and the detection of any additional issues that may not have emerged in the 
interview study. 
7.2.2.1 Impact of NMD 
The degree of impact in each area was measured by responses provided on a five point 
Likert scale. Response options ranged from `not at all' affected to `very much' 
affected. Five point scales were believed to be suitable for registering whether patients 
experience an impact, the degree of the impact and its perceived importance. Any 
additional scale categories would have been unnecessary for this type of survey 
instrument. 
7.2.2.2 Positive or Negative effect 
The nature of NMD impact was probed further with respondents asked to indicate 
whether the overall effects of their condition were positive or negative. 
7.2.2.3 Importance of Impact 
Questions about the importance of disease impact were incorporated, one for each life 
area. Again, responses were scaled along a five point Likert scale, ranging from `not 
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at all important' to `extremely important'. This was done to give an idea of the 
salience of the issues reported by patients, an important consideration when selecting 
items for inclusion into the questionnaire. 
7.2.3 Pilot Study of the Postal Questionnaire 
The postal instrument was piloted to test the acceptability of the scale and ensure 
patients' comprehension of question wording, layout and rating scheme. 
7.2.3.1 Methods 
The questionnaire was piloted in 11 patients attending a routine follow up muscle 
disease clinic or for a separate research appointment. 
Patients were questioned about the clarity of the instructions, the length of time taken 
to complete the scale, and the appropriateness of the questions (Litwin, 1995). They 
were also asked whether there were issues that they would like to have been asked 
about that were not included in the questionnaire and if there were any questions that 
they felt were irrelevant. Changes that were made following completion by the first 
five patients were piloted in the remaining six respondents. 
7.2.3.2 Results 
Respondents found the survey instrument to be easy to complete, although a few did 
not easily understand questions about the positive or negative effects of NMD. Some 
patients also found it difficult to classify the effects of their condition as simply either 
`positive' or `negative'. 
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The treatment section caused no problems although two patients expressed a desire to 
comment upon why they did not receive treatment 
7.2.3.3 Adaptations to the Postal Survey Instrument 
Minor changes were made to the survey instrument as a result of the pilot study 
(Appendix Q. To address difficulties with questions about the `positive' or `negative' 
effects of NMD, these words were substituted with the words `good' and `bad'. 
Furthermore, in order to address difficulties in expressing the effects of NMD as either 
good or bad, an additional option was included, allowing patients to tick an `other' 
category and then to express the impact of their condition in their own terms. 
The treatment section also changed to include a question to allow those not in receipt 
of treatment to express why they did not receive treatment and how they felt about 
this. 
These changes were found to be acceptable to the remaining six patients taking part in 
the pilot study. 
7.2.4 Postal Survey 
The postal questionnaire was sent out to 537 patients with NMD. 480 of these were 
sent through patient support groups in order to reach a large number of patients. This 
also maintained patient confidentiality. The remaining 57 were sent to patients from 
King's College Hospital (KCH) clinics. 
380 questionnaires, coded to ensure the respondents' anonymity, were sent through 
the Myositis Support Group (MSG) to their adult members (all those age 18 years and 
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over). The MSG estimated this membership to comprise 200 Dermatomyositis 
patients, 150 Polymyositis patients (ARR subgroup of patients), and 30 or more 
patients with Inclusion Body Myositis (ASP subgroup). 
100 questionnaires were sent to patients with facio-scapulo-humeral muscular 
dystrophy through the FSH-MD support group and a further 57 questionnaires to 
patients with a variety of congenital NMDs, from King's College Hospital (KCH) 
clinics. 
A second mail out of the questionnaire took place three weeks after the first. The 
identification codes marked on the questionnaires ensured that the second 
questionnaire was sent only to those patients not responding within the three-week 
period. Both mailings included prepaid envelopes in which the respondents could 
return the questionnaire. 
7.2.5 Analysis 
7.2.5.1 Quantitative Analysis 
The quantitative data was analysed using the Statistics Package for Social Scientists 
(SPSS). Descriptive statistics were used to calculate the prevalence and importance of 
NMD impact to patients across the life domains covered in the survey. 
7.2.5.2 Qualitative Analysis: Comments about specific life areas 
Thematic analysis was conducted upon the comments written in the survey 
questionnaires to corroborate and verify the qualitative interview data. The analysis 
followed the same principles as the analysis of the interview transcripts (see chapter 
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4). Themes were drawn out and clustered into broader categories representing 
different reported effects of disease and impact upon specific life domains. 
7.3 Results 
7.3.1 Sample 
252 completed questionnaires were returned in total (response rate 47%). There was a 
50 % (n= 78) response rate from the 157 patients with a CSP NMD. 42% (n=146) 
responded from the estimated 350 patients with an ARR disease, and approximately 
93% (n=28) responded from the estimated 30 or so patients with an ASP NMD. 
The male to female ratio of the sample was: - 1: 2.8 
Table 7.1: Age of the survey sample and duration of NMD 
Group (Number disclosing 
date of birth. 4 respondents 








Duration of condition 
- estimated from reported 
time of diagnosis 
(Mean in years) 
All respondents =248 52.6 16 16-96 11.8 
Male (N= 65) 55.9 16.3 22-82 14.1 
Female =183 51.4 15.8 16-96 11.1 
CSP =76 44.4 15 16-82 19.8 
ARR =145 53.6 14.4 22-82 9.5 
ASP =27 70.5 10.2 44-96 7 
7.3.2 Positive and Negative Impact 
All the items in the survey included a question that probed to see whether the impact 
upon each life area was positive, negative or whether it had an `other' kind of effect. 
The proportion of respondents rating the impact upon any one domain as positive was 
very low. For all the domains except the relationship and social -interaction items, 
only 2 to 4% of respondents reported a positive effect of NMD. For the social 
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interaction and relationship domains between 5% (for impact upon partner/spouse 
relationship) and 11 % (for Friends item) and patients rated the impact of NMD upon 
these as `good'. A few more respondents selected the `other' option but almost 
exclusively described the effect of NMD as being in some way negative (e. g. 
`devastating', `difficult') or as `mixed'. 
7.3.3 Life Domain Items 
Over 60% of all respondents reported an impact upon the life areas included in the 
questionnaire (Figure 7.1). Indeed, in all the domains except family, friends and 
social interaction, over 75% of the respondents reported being at least `slightly 
affected'. The highest impact ratings of `quite a lot' and `very much' were selected 
by a large number of respondents across all the domains (Figure 7.2), especially the 
activity domains and the psychological impact domains of independence and 
emotions. The relationship and social interaction items received fewer ratings in the 
highest impact categories, although ratings were still high. Around 30-40% of 
respondents selected these categories. 
Over 90% of all those who reported an impact also reported this impact to be 
important (Figure 7.3). The chart showing the number of respondents selecting the 
highest importance ratings of `very' or `extremely important' (Figure 7.4) is 
somewhat more telling. Independence received the highest importance ratings 
following by Perception of the Future and Working Life. Social Interaction received 
the fewest ratings of `very' or `extremely important', with 5061o of respondents 
selecting these ratings. 
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Figure 7.3: Patients rating impact on each domain as important 
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7.3.4 Activities (questions 1-3) 
The percentage of respondents reporting an impact was high across all the activity 
items (figures 7.5-7.10). The majority of respondents reported being at least `slightly' 
affected in each of the activities and well over half of the respondents reported being 
affected `quite a lot' or `very much'. Importance ratings were also very high. Most of 
the patients who reported an impact upon activity items considered this to be at least 
`quite important' and well over half reported the impact in each activity area to be 
either `very' or `extremely important'. The impact ratings for the Working Life item 
were a little lower than for the other two activity items. However, the importance of 
NMD effects upon this domain in those working was very high. 
Qualitative Data 
Comments noted down by respondents in the comments boxes that relate to activities 
are summarised by category (table 7.2). 
Table 7.2: Activity themes emerging from postal survey comments 
Domain Subdomain Specific Issues 








Visiting friends & family 
Employment Work activities 
Stopping work 
Limitations to career/ job prospects 
(Discrimination) 
Change in job/ occupation 
Financial considerations 
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Figure 7.5: Impact on daily activities as reported by survey respondents 
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Figure 7.7: Impact upon working life (in those employed, n=142) 
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Figure 7.8: Importance of impact on working life as reported by survey 
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Figure 7.9: Impact on social and leisure activities 
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Respondents' comments tended to reiterate the experiences and concerns expressed by 
patients in the interview study. 
Remarks about daily activities ranged from those about personal care to others about 
housework, getting around and shopping. Examples of this are provided below. 
I do have problems still when blow-drying my hair. When I hold the hairdryer for a long 
period, my arms start to feel heavy and tired. 
The effect of symptoms upon all kinds of activities was also made clear. 
I do not have the strength/energy to sustain normal day to day living activities for more than 
a couple of hours. I become overwhelmingly tired and my muscles ache so much I cannot 
do anything or even concentrate on sedentary activities. This is despite painkillers- I only 
recover after lying down for a couple of hours. It takes so much effort to get through the 
basic needs of living that there is no energy/time left for social activities. The almost 
constant pain affects concentration too. 
Employment 
Many comments were made about respondents' working life. These related not only 
to the effects of NMD upon working activities but also upon job prospects. 
I was made redundant three years ago when the company I had worked with for 17 years 
relocated. I firmly believe that the reason I was not able to get another permanent job was 
because of my condition. 
This disability has prohibited me from achieving my full potential career-wise. I have been 
informed that I have been not considered for career moves on the grounds of physical 
limitations only. 
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Many respondents commented on their having to take early retirement on ill health 
grounds, or upon the adaptations they had made to their jobs or career path. The 
impact of stopping work upon self-identity was clear. 
Had to retire from work at age 35 - had a huge impact on how I saw myself as a contributing 
member of society. 
Social and Leisure Activities 
Respondents also commented upon the impact of their condition upon leisure and 
social activities. Both sporting and sedentary activities were influenced. Socialising 
and visiting with friends and family were commonly reported and linked to transport 
problems and difficulties in accessing buildings and homes. 
This illness affects all my leisure activities, as I'm in a wheelchair. I've had to give up 
dancing, gardening and even visiting friends and shopping. Even my son and daughter I 
can not visit as there are steps which I cannot get up over. Some shops have a ramp or 
are level but a lot aren't. I have been confined to the house for 5 months due to the fact I 
could no longer transfer from the car to my wheelchair. After 5 months of worry and 
expense we have just had a car converted for me to drive 
I used to be physically active with ice hockey + keep fit + badminton + squash. All now 
impossible. Sitting in theatres is often uncomfortable + stairs in theatres difficult. All 
outings, even car boot sales I find exhausting. 
7.3.5 Relationships and Social interaction (questions 4-7) 
The impact of NMD upon relationships (figures 7.11-7.18) was also very evident, 
with more than half of the respondents reporting an impact in all the relationship 
items. Nevertheless, the reported impact was not as elevated as it was across the 
activity items. Considerably fewer rated this impact as being `quite a lot' or `very 
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much', although more than a quarter of respondents still responded using these 
ratings. Relationship with partner/spouse (figures 7.11 & 7.12) was clearly the 
relationship influenced most by NMD and the one believed to be most important. 
Conversely, the `not at all' option was most frequently selected for relationships with 
family (25%), with friends (31%) and in general social interaction (48%). 
Respondents in the congenital group also reported less impact and importance of 
impact in partner relationships (figs 7.11 & 7.12), family relationships (figs 7.13 & 
7.14) and friendships (figures 7.15 & 7.16). 
Qualitative Data 
The themes emerging from the analysis of the comments made in the postal 
questionnaire were, again, similar to those that came out of the interviews. 
Table 7.3: Relationship and social interaction themes emerging from postal 
survey comments 
Domain Subdomain Specific Issues 
Social impact Partner Meeting potential partner 
Strain on relationships 
Sex life 
Support from partner (positive) 
Family Lack of support 
Worry about being a burden 
Worry about passing on gene 
Support from family (positive) 
Friends Difficulty in visiting friends 
Loss of contact 
Support from friends (positive) 
General social interaction Avoidance of situation 
Lack of understanding 
Difficulty explaining condition 
Other people's perceptions 
Problems of access 
Discrimination 
Encouragement of others (positive) 
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Figure 7.15: Impact upon relationships with friends as reported by survey 
respondents 
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Figure 7.16: Importance of impact upon relationships with friends as reported by 
survey respondents 
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Some respondents commented that friendships had faded as a result of difficulties 
taking part in activities previously shared with friends. 
A lot of "friends" simply drift away when it is obvious there is a chronic condition which is 
unlikely to change, and when one can no longer go out and about to mutual interests or be 
relied on to entertain at home. Someone who would rather go to bed than even sit and talk 
becomes of little interest to any but the most long suffering of friends. 
Social impact 
Many respondents felt that there was a lack of understanding about NMD and its 
effects. This made the condition difficult to explain. In particular, patients with 
Myositis frequently commented upon the difficulty they had in explaining their 
condition to other people. They tended to believe that this was because they looked 
well and therefore people didn't understand or empathise with their condition. 
The main problems lie with the condition not showing any visible signs and symptoms and 
often having to explain oneself or making excuses for inabilities. 
Because my muscle problem is not obvious to people they see nothing wrong with me and 
treat me accordingly which is very annoying and upsetting. Near friends know this and can 
see I walk badly and slowly and are sympathetic, which helps. 
Some patients also commented upon the lack of understanding about their condition, 
not only in other people but also in the in medical profession. This was inevitably a 
source of great distress. 
Contact with other people and even my relatives, I cannot find a word to describe how 
terrible it is. 
1. People cannot understand the muscle illness 
2. They and also medical staff have never heard of "Inclusion Body Myositis" 
3. They cannot understand why I can't have an operation. 
4. They cannot understand why I take no medication 
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5. They see me in Asda in my wheelchair and say "you look well", little do they know. 
I feel fatigued, lethargic, utterly tired out all ffia time, and there is nothing and nobod out 
there who can help me. I feel very isolated and very much alone with this miserable illness 
Family 
An immediate effect upon some respondents' behaviour towards their family was 
evident. 
I find myself distancing myself from my family. If I am too caring I may be expected to 
physically do something to show that I love them. I used to do it in the past, even though I 
suffered for it- their needs were met whilst I cried alone in pain. I'm continually trying to 
balance my relationships but this year have felt, I just want to be left- alone so that I can at 
least cope and have enough energy to be reasonably cheerful and good company for my 
husband who I am sure you appreciate has had a lot to cope with himself. To be honest I 
don't answer the phone or the door while my husband is at work and when he comes home 
I let him do it. 
Problems of access to public facilities and the homes of friends and family were also a 
source of difficulty (examples in `Social and Leisure Activities' section). 
Partner 
A large proportion of the respondents commented upon the impact their condition had 
exerted upon relationship with their spouse or partner. 
My muscle condition, weakness + tiredness destroyed my marriage in the end. I'm now on 
my own and can see no future with myself ever having a relationship with anyone ever 
again, it's just too hard. 
We don't share activities any more, we can't go on same kind of holidays we used to, I'm a 
nuisance when we go out together, and I've gone off sex completely. I can't see why he 
still bothers with me. 
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A number of respondents also commented upon the difficulties they had in meeting 
potential partners, an issue that was not explicitly mentioned in the qualitative 
interview study. 
When it comes to a partner, everything is fine until I mention my illness, in which case they 
don't want to know. 
However, the support provided respondents' families and partners was also clear from 
a number of comments. 
When I was finally diagnosed my fiance and friends were really supportive and helped me 
to get through the most difficult times. 
7.3.6 Psychological Impact (questions 8-11) 
Patients were most commonly affected `very much' by their muscle condition across 
the psychological impact items, and most frequently rated this impact as `extremely 
important' (figs 7.19-7.26). The psychological items gained higher ratings of impact 
than did the relationship items. However, compared to the activity items they 
received slightly fewer ratings at the high end of the scale. 
Responses to the independence item showed this issue to be of considerable 
importance to all patients with well over three-quarters of respondents reporting the 
impact upon their independence as being either `very' or `extremely important' (fig 
7.20). Similarly, the importance attached by patients to their perceptions of the future 
was also very high (fig 7.26). 
From the data, it was clear that many patients believed their physical appearance to be 
negatively affected by their muscle condition (figs 7.23 & 7.24). Nevertheless, body 
image received lower impact and importance ratings in patients with an ASP 
condition. 
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Figure 7.22: Importance of impact upon emotions as reported by survey 
respondents 
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Figure 7.23: Impact upon body image as reported by survey respondents 
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Figure 7.25: Impact upon perception of the future as reported by survey 
respondents 





























Once again the emerging categories bore similarities to issues that emerged from the 
semi-structured interviews. 
Table 7.4: Psychological themes emerging from postal survey comments 
Domain Subdomain S ecific Issues 
Psychological Emotions Feelings of loss 
Impact Feelings of abandonment 
Guilt 
-about not being able to fulfil social role 





Perception of the future Fear of losing independence 
Fear of passing on gene to children 
con enital patients) 
Identity / Self-image Body image 
Social image/identity/role 
Independence Loss of control 
Coping strategies Determination 
Acceptance 
- of condition 
- that no treatment available 
Focusing on the present 






Avoidance of situations/ people/ places 
Covering effects of condition 
Attempts to carry on as before 
Emotions 
The themes relating to emotions and other psychological issues were very much 
intertwined and respondents tended to comment upon the emotional impact of NMD 
in the context of other life domains. For example, patients' fears about the future had 
a considerable impact upon the emotional feelings expressed. 
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Sometimes I feel well balanced and happy and yet other times I feel sad and lonely even 
though I have a wonderful family. I picture my future as being on my own, ill and more 
dependent than I am now, but I try not to think about the future. 
Independence 
Independence 
was very frequently commented upon in the survey. Frustration at 
being dependent upon others to carry out activities and fears of becoming dependent 
or more dependent upon close family members were prevalent. These themes 
overlapped considerably with those relating to impact upon family and partner 
relationships. 
I am very dependent on my husband and this affects me emotionally. I feel a burden 
sometimes, although he doesn't complain. 
Perception 
of the Future 
Perception 
of the future was frequently commented upon and was closely linked with 
fears of losing independence and of becoming a burden to family members. 
MY thoughts about the future are very fearful. I know this illness is supposed to be slow in 
progressing, but how slow? At the moment I can only stand for a few seconds and if I dare 
bend my knees I'm on the floor in one untidy heap and can only get up with my husbands 
help, with a hoist. So I cannot walk or stand. I cannot lift my head off the pillow when I'm in bed and its very difficult to turn over in bed... what happens if I get worse. My husband is seventy-five. What will happen if he dies? 
Other concerns about the future related to the genetic nature of the congenital muscle 
conditions. A number of respondents were worried about the possibility that they 
had 
passed on their condition to their children. They also had concerns about being able to 
Physically care for their children in the future. 
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I tend to worry a lot about how much of a burden I will become to my family, my wife 
especially, as I get more immobile. Also I worry a great deal about what I have passed 
onto my daughter. They learnt about genetics at school, so they know that it is passed on, 
but I was told by a doctor at an FSH get together not to have them tested unless it was 
absolutely necessary as the tests were not always conclusive. 
I worry about the future. Especially whether I have passed on my condition to my son. 
worry that I will not be strong enough to carry him when he gets heavier 
Self Image, Identity and Body Image 
Loss of independence had a considerable impact upon patients' self-image and sense 
of identity. This impact upon self-image related to the effects on NMD upon social 
role fulfilment 
I don't really have any independence. I think I must have lost the will to even want to be 
independent. I don't feel like I'm a person any more- maybe just an extension of my 
husband most of the time, which is not so bad because he's a really nice guy! 
Effects (of NMD and steroid treatment) upon patients' physical appearance also had 
implications for patients' self-image and confidence. 
I hate the way long-term steroid medication has made me look. I cannot bear to look in a 
mirror and I just cannot look at photos of myself taken before my condition. 
The gradual erosion of the physical being that I am is not a nice thing to contend with. It 
has a debilitating effect on your general persona. 
This impact upon body image also had implications for social and sexual confidence. 
I'm very self-conscious when it comes to the sex side of the relationship and I want to hide 
myself as much as possible. Consequently I find myself "putting off" the physical side of 
the relationship and so not encourage it even though we both still enjoy it when it does 
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happen. I'm a bit overweight because of lack of exercise so I am trying to cut down my 
intake of food. 
Coping 
Despite the impact of NMD on the outlook of many patients, determination and 
optimism were apparent in a number of reports. 
I am optimistic about the future, which will involve study, more sedentary hobbies and 
refusing to be beaten by this disease. 
The desire to find fresh challenges when my sporting life ended prompted me to take 
further study. This has proved very valuable in terms of personal development & 
improvement of self-esteem. I made many new friends and learned there is life after 
disability. I know this has encouraged others. 
Coping strategies were an important issue in responses given by patients. 
The future frightens me, so I have trained myself not to think too far ahead and to enjoy 
what independence I have today. 
I try to be grateful for the things I can do and take each day as it comes. 
Religious faith was another way in which some respondents coped with their 
condition and maintained a positive outlook 
As I believe in life hereafter, I look forward to being without my physical handicaps... 
think! 
Other methods adopted by patients to minimise the possibility of negative outcomes 
included: 
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a) Planning ahead 
Because of the condition it is not easy to do things on the spur of the moment. It is not 
always practical to go to places that are new to me without a bit of forward planning. For 
example, are there stairs or lifts, how far is it to walk, what is the ground like? 
b) Comparing their situation to others they believed to be less fortunate, 
After reading what other folk have gone through I feel very fortunate to be as healthy as I 
am. 
c) Changing their expectations. 
One has to accept that there are many things one can no longer do- if these are very 
important one has to ask for help- if not the there is a conscious decision to do without or 
accept a lowering of expectations and a compromise on previously acceptable standards. 
7.3.7 The effects of treatment 
In those receiving treatment, most respondents reported experiencing `quite a lot' of 
beneficial effects and `some' negative effects. Figure 7.27 indicates respondents 
reported experiencing roughly equal amounts of beneficial effects and side effects. 
Both the good and the bad effects of treatment were also most commonly rated as 
being `extremely important'. Figure 7.28 demonstrates that positive treatment effects 
generally received higher importance ratings. 
Most of those not receiving treatment (mainly patients with a congenital NMD or an 
ASP NMD) stated that this was because there was no treatment available for their 
muscle condition (figure 7.29). Most of the patients who had stopped treatment 
because of side effects were myositis patients. 
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Qualitative analysis 
The postal questionnaire provided a section in which comments could be written about 
how patients felt about their treatment or lack thereof. 
Table 7.5: Treatment themes emerging from postal survey comments 
Medical Treatment Desire for treatment 
(especially physiotherapy) 
Independent search for treatment 
(alternative therapy etc) 
Upset because no treatment 
Side effects Fear of potential side effects 
Bones/ osteoporsis 
High blood pressure 
Thinning of the skin 
Acne 
Diabetes 




Feelings about care Feelings of abandonment 
Inadequate care/support (of medical/ 
social nature) 
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Almost all the patients receiving treatment reported side effects. Most of these were 
due to steroid treatment. 
A large proportion of the comments relating to side effects were about the weight gain 
brought on by steroid treatment. 
The weight gain due to the steroids has taken away all my self-confidence 
The many other problems included the effect of steroids upon bone density, skin, as 
well as stomach upset and cataracts. 
My bone density has become low so have to an osteoporosis therapy. My skin has 
thinned considerably - cannot go out in the sun. Take a tablet for stomach problems and 
have developed sinus troubles. I notice I appear to be more anxious on treatment. I know 
the treatment has caused more muscle wastage. Have developed cataracts in eyes 
(optician says due to treatment). Positive aspect: - treatment makes life bearable. 
7.3.8 Complementary medicine 
Many patients commented upon treatment and therapies they had sought outside 
conventional medicine. The complementary regimens included acupuncture, 
homeopathy, special diets and dietary supplements, hydrotherapy and massage. 
There doesn't seem to be any kind of treatment from specialists or GPs. I have special, 
very light massage and exercises in a hydrotherapy pool 
(Meir Schneider technique) 
My treatment has been homeopathy, acupuncture and I believe the one most important 
factors has been sticking to a healthy diet and taking supplements. 
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Some patients felt there was a lack of support from medical and social services. 
Patients linked their feelings of being abandoned by the medical profession to the lack 
of treatment available for, and limited knowledge about their condition. 
I feel I don't get too much help from doctors. They are supportive to a point but cannot 
help to treat me and (as I have been told) I have to go and "learn to live with" my condition. 
I now feel I know more about my FSH than do GPs and to a point Neurologists and I can 
tell them what I think is going wrong next because they can't know 
Inadequate support from social services and widespread lack of recognition about 
patients with disability was also mentioned. 
N 
Even taking into account the DDA, I feel that people with any disability are not given a fair 
deal. I feel the old image of being disabled must mean "retarded" still stands. I do get very 
passionate in my feelings and write to the PM, TV, papers, all the time in an attempt to get 
those issues discussed more openly. Without these issues discussed, and from primary 
school, I do not feel that we will come very far. 
7.4 Discussion 
Postal survey responses supported and verified the interview data, with respondents 
reporting the influence of NMD across a broad spectrum of life areas. The data 
supports the diversity of impact experienced by patients and shows that the effects of 
NMD are of great importance to patients. These effects, already implied in the 
interview study, were explicitly represented in quantitative data of the survey. These 
data represented the degree to which NMD patients are personally affected by their 
condition. 
The number of respondents expressing a positive impact of NMD across the domains 
was negligible except for the relationship items. The potential for illness to make 
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relationships closer and more satisfying has been documented in other studies (Padilla 
et al, 1990). Further study of this could lead to, the development of techniques that 
might help patients undergoing stresses in close relationships. 
The impact of NMD upon activities was not surprising considering the physical 
disability experienced by many patients. It is inevitable that the most immediate 
impact of muscle disease will be upon everyday activities such as washing, dressing, 
getting around and doing household tasks. The survey data goes further, representing 
the impact of NMD upon social and leisure activities. Even sedentary activities were 
affected as these often involved travelling to attend, or energy to concentrate upon. 
Employment was also affected considerably and was of great importance to those of 
working age. This was unsurprising, given that work tends to be the main activity in 
adult life, taking up the greatest amount of time, providing social contact and 
influencing patients' financial situation. It is also important to the identity of many 
people. 
From patients' reports, the impact of NMD upon relationships was not quite as 
marked as its impact upon activities. This is likely to be because the effect of NMD 
upon relationships depends much more on the individual and their situation. 
From comments made in the survey, important factors mediating this impact include 
the social support available. The personality of their family members, and the 
patient's own disposition is likely also to mediate the impact of NMD upon 
relationships. 
On the relationship items there were a number of interesting differences between the 
groups. For example, respondents in the congenital group reported less impact and 
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importance of disease impact upon their friendships, family and partner relationships 
than the other two groups. This may be because most patients with a congenital 
muscle condition have lived with the effects of their condition for a long time, in 
many cases from childhood. In such cases there is less likely to have been an abrupt 
or dramatic change in the patients' physical condition and the consequences 
associated with this. On the other hand, patients with an acquired condition are more 
likely to have experienced a substantial change in their physical condition. Such a 
change will doubtless put pressure on close relationships. 
Indeed the data showed that there was considerable impact upon, and importance 
attached to patients' relationship with their spouse/partner. This is likely to be 
because this is frequently the closest and most confiding relationship. Patients with 
disability are also likely to depend more upon their partner/ spouse than upon anyone 
else, which may put a particular strain on this relationship. Indeed the QoL of 
caregivers has been found to be negatively affected in numerous studies (Hughes et al, 
1999). This negative impact is undoubtedly linked to changes and adaptations that 
both patients and close family members have to make to their role in family 
relationships (Young and Kahana, 1989; Marks, 1998). Given the closeness of the 
relationship, the respondent's partner/ spouse is also likely to be the person most 
anxious/ worried about the patient's condition. 
The comments made in the survey also revealed the difficulties experienced by some 
respondents in meeting potential partners or starting off relationships, an issue that 
was not explicitly mentioned in the interviews. It may be that these issues are more 
difficult to comment upon in a face to face situation compared ' to a confidential 
survey. 
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Patients' difficulties in explaining their muscle conditions were also frequently 
mentioned. Many respondents, particularly those with myositis found that people 
tended not to understand the nature of their condition and its effects. It may be that 
that this was more of a concern to patients due to the fact that myositis is less common 
than the likes of muscular dystrophy and is seldom heard about outside the medical 
profession. 
The reported impact upon patients' perceptions and emotional well being was also 
high. High ratings were found on the perceived impact and importance of 
independence item and perception of the future item. These findings were 
understandable, given the progressive nature NMD and patients uncertainty about the 
future consequences of their condition. In particular, respondents commented upon 
their fears of becoming increasing dependent on other people. 
Body image was also considerably affected, although less so in the ASP group. This 
might be due to the age of the respondents as these patients were older than the other 
groups. It may be that older people place less emphasis upon physical attributes. 
Their expectations of physical ability and appearance may also be lower than the 
expectations of younger people considering the greater number of older people who 
have physical disabilities that influence their appearance. 
Many respondents commented upon coping strategies although they were not 
specifically questioned about this in the questionnaire. Coping strategies appeared to 
be more predominant in survey comments than they were in the interviews. This may 
be because patients felt they had to explicitly justify their responses to items in the 
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questionnaire, whereas in the interview they could describe their experience of NMD 
within the context of their own lives. 
The issue of drug treatment was of particular importance to patients with an acquired, 
relapsing, remitting condition. Many reported medical conditions that had been 
brought on as a result of steroid treatment (e. g. cataracts, diabetes, high blood 
pressure). For many patients, the beneficial effects of drug treatment outweighed any 
negative effects. However, for a considerable proportion side effects were prevalent 
and held as `extremely important'. It is therefore essential that QoL measures used to 
evaluate treatment in NMD capture negative treatment effects as well as those that are 
beneficial. 
Qualitative analysis of the comments provided insight into patients' feelings about 
drug treatment, which were often very distressing. There were numerous comments 
about the weight gain brought on by steroid treatment and comments about effects 
upon mood and other medical complications. Such issues are of considerable 
importance to HRQL and must be addressed in QoL measures that are to be used with 
patients undergoing treatments that may have such harsh side effects. 
7.4.1 Limitations and Considerations 
The representativeness of the data may have been compromised by a number of 
factors. 
1. Response rate. 
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The 47% response rate to the survey may have compromised how representative the 
data were (Mangione, 1995; Fowler, 1995; Fink, 1995). 
There are a number of possible reasons for this somewhat low response rate to the 
survey. Most of the questionnaires (480,89% of the total number sent out) were sent 
through patient support groups. This allowed larger numbers of patients to be reached 
but decreased control over the survey process. It would have been ideal to have 
conducted a more rigorous follow up to the initial mail-out of the survey as 
recommended in section 6.5.4, for example including postcard reminders as well as a 
second mail-out of the instrument. However this would have been difficult to 
implement given that most of the questionnaires were sent through support groups 
who would not have the time or resources to carry out such a labour intensive process. 
Possible reasons for non-response from some of the support group members are that: 
" Some may not have had a firm diagnosis of NMD. 
" Other members may have been relatives (e. g. parents) or friends of people 
diagnosed with NMD. 
" The questionnaire was enclosed with separate newsletter mailings. This 
minimised postal costs, but may have compromised the salience of the survey to 
support group members and ultimately lessened the impetus to respond. 
" Severely affected patients may have been unable to complete the form 
" Some of the patients receiving the questionnaire may have been very mildly 
affected and therefore not considered their response to be pertinent. 
" Patients with myositis whose condition was in remission may not have considered 
their response relevant to the survey 
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2. Representative sample? 
It may be that those least and those most affected by NMD did not respond to the 
survey. 
Members of patient support groups are unlikely to be representative of patients with 
NMD as a whole. For example: 
" They may not have a firm diagnosis of NMD 
" They may be more severely affected than other patients 
" They may have a better support network. 
" They may be better informed 
" They may have higher expectations than patients who do not join support groups. 
It is also possible that, as with all surveys, someone else, other than for whom the 
questionnaire was intended filled the questionnaire in. This may happen if the patient 
is too ill to complete the questionnaire, or if they have difficulty in holding or writing 
with a pen. 
7.4.2 Implications of the survey 
From the postal questionnaire data, it was clear that NMD has a considerable impact 
in all life domains. Patients also rated this impact to be important. 
The wide-ranging picture of the NMD impact that an individualised measure, specific 
to patients with NMD would best capture disease impact. Such a measure would 
focus upon those aspects of life affected by muscle disease and considered to be 
important. 
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Looking at issues that are of particular relevance and importance to patients should 
make it easier to capture any improvement or deterioration in their well-being. This 
also takes account of any change in the patients' experience of disease and the 
importance attached to particular areas of life. Understanding such changes is likely to 
be beneficial in addressing patients' needs, not only in terms of treatment but also in 
the non-medical interventions and advice provided. 
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CHAPTER VIII 
DESIGNING QOL QUESTIONNAIRES AND THE CONSTRUCTION OF 
THE INDIVIDUALISED NEUROMUSCULAR QUALITY OF LIFE 
QUESTIONNAIRE (INQOL) 
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Chapter 8: Designing QoL questionnaires and the construction of the 
Individualised Neuromuscular Quality of Life questionnaire (INQoL) 
8.1 Introduction 
Following the review of QoL literature and exploration of patients' experience of 
NMD, the new QoL questionnaire was constructed. The model that resulted from the 
literature review influenced the structure of the questionnaire. The interview-and 
postal survey results determined its content. 
Constructing QoL questionnaires involves selecting items and making decisions about 
the scaling, scoring and administration of the scale. These issues were examined in 
order to guide the construction of the Individualised Neuromuscular Disease Quality 
of Life Questionnaire (INQoL). 
8.2 The Generation and Selection of Questionnaire Items 
Item selection is important in ensuring that the questionnaire appears to measure what 
it is intended to measure (face validity) and that it is comprehensive in representing 
what it purports to measure (content validity). 
The initial phase of questionnaire development increasingly involves qualitative 
methodologies to investigate the topic of interest and generate themes to form the 
content of the scale. QoL questionnaire items can be generated from multiple sources, 
including expert opinion, literature reviews, and the experiences of patients explored 
through qualitative interviews and focus groups (Streiner and Norman, 1995). 
Deriving QoL questionnaire items from patients' experiences is especially helpful in 
obtaining a representative view of patient QoL. 
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Item selection involves using either the psychometric method of factor analysis or the 
clinical impact method. These lead to the elimination of redundant or inappropriate 
items, reducing the scale to a feasible length but maintaining comprehensive coverage 
of the construct. Psychometric strategies such as factor analysis are based on 
mathematical techniques and are generally used to develop scales that measure a 
single characteristic or attribute (homogeneous scales) (Nunnally and Bernstein, 
1994). Clinimetric strategies such as the clinical impact method rely largely on 
patients' and clinicians' judgements and tend to be used to develop measures 
comprising several characteristics or attributes (heterogeneous scales) (Feinstein, 
1987). 
8.2.1 Factor Analysis 
Factor analysis can be used to determine which items and subscales belong to which 
underlying `factor' of a construct such as QoL. It also determines the strength of the 
statistical relationship between factors and leads to the elimination of items that bear a 
weak relationship to the factor to which they should relate and items that contribute 
little to the overall questionnaire score. Items that load on (are correlated with) scales 
to which they should not relate may be measuring something other than the scale 
developer intended. Items are therefore not selected if they load on a factor to which 
they should not relate or if they load on more than one factor (Streiner and Norman, 
1995). 
The steps involved in item reduction that involve the use of factor analysis have been 
described in a number of papers (Hyland et al, 1991; Marks et al, 1992; Juniper et al, 
1997; Marx et al, 1999). 
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" The skewness of data is examined and the items that are selected by the fewest 
number of respondents (less than 40%) are eliminated. 
" Items that show low item-total correlation (less than 0.40), i. e. that contribute little 
to the aggregated score of the scale are left out. 
" Items with the lowest item-total correlation from subgroups of items that appear to 
be measuring the same thing (i. e. that are highly correlated with each other) are 
also left out 
" Items that load by less than 0.4 on the first factor (e. g. overall QoL) using 
principal component analysis (Hyland et al, 1991) are also removed. 
8.2.1.1 Limitations of Factor Analysis 
Factor analysis is suited to the analysis of scales that have only a few subscales, such 
as psychological scales (e. g. measures of depression or neuroticism). However its 
application is less appropriate in the examination of QoL scales as they commonly 
involve many subscales that contain just a few items each. This increases the 
likelihood that items from the different subscales will load on more than one of factor 
(e. g. social and emotional items might be closely related). The elimination of items is 
also likely to leave some individual subscales with very few scale items. 
I 
Factor analysis derives the factor structure of a data set using rotation techniques, 
which often results in many different factor solutions (Fayers and Machin, 1998). If 
too many or too few factors are entered into the model the resulting solutions may be 
difficult to interpret. Conversely, it is possible to derive plausible meanings from 
various different combinations of variables making it difficult to determine the most 
accurate factor model. 
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Conducting factor analysis also requires a particular sample size. If the sample size is 
very large there is a risk of extracting too many factors. On the other hand, a small 
sample size may result in insufficient information to enable more than one or two 
factors to be drawn out. 
A further problem is presented by the categorical and asymmetrical nature of QoL 
data as the estimation techniques used alongside factor analysis assume continuous, 
normally distributed data. Taking this and the multidimensional nature of QoL data 
into consideration, it has been recommended that many hundreds of participants be 
used when using factor analysis to select questionnaire items (Fayers and Machin, 
1998). 
8.2.2 Impact Method 
The clinical impact method (Juniper et al, 1997) selects items that patients identify 
most frequently and rate as most important (Feinstein 1987; Lacasse et al, 1999). 
In studies comparing the item reduction methods of clinical impact and factor analysis 
(Juniper et al, 1997; Marx et al, 1999), the clinical impact method involved asking 
patients to rate the importance of each positively identified item on a five point scale 
(1=not important, to 5=extremely important). The frequency with which the item is 
identified and the importance attached to that item are combined into an impact score 
and items are then ranked according to their impact scores. The highest scoring items 
are ultimately selected for use in the questionnaire. This ensures the inclusion of only 
the most relevant and important items, resulting in a questionnaire that is more 
meaningful to patients and more responsive to change. 
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8.2.3 Comparison of clinical impact and factor analysis methods 
Clinical impact and factor analysis both use a combination of empirical methods and 
intuitive judgement in the selection and grouping of questionnaire items. The clinical 
impact method involves the categorisation of items into domains according to clinical 
sensibility. Factor analysis is based largely on the correlation between items but 
involves subjective decisions, for example about the choice of `cut point' for the item- 
total correlation determining the elimination of items and the decision about which 
factor structure is most appropriate. 
Despite their differences, the methods of factor analysis and clinical impact have led 
to scales with largely similar items and domain structure (Marx et al, 1999; Juniper et 
al, 1997). Nonetheless, the clinical impact method may be favoured in the 
development of QoL scales given the problems cited with factor analysis and the 
value of incorporating the items of greatest importance to patients (Juniper et al, 
1997). The clinical impact method also allows more flexibility in determining 
grouping of questionnaire items as it may make sense to group certain items under the 
same subscale (e. g. items on daily activities and leisure activities) regardless of the 
strength of correlation between them (Fayers and Machin, 1998). 
8.2.4 Expert opinion 
Following the application of either method of item reduction it is recommended that 
clinical judgement be used to ensure face validity (Marx et al, 1999). Experts are 
often asked to comment upon and criticise a rough draft of the scale, thereby 
influencing the final selection of questionnaire items. However, it is important for the 
panel of experts to represent a range of different disciplines in order to avoid bias in 
the final questionnaire. Furthermore, the use of expert opinion may not be appropriate 
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for questionnaires that are intended to focus upon patients' subjective experience. The 
face and content validity of QoL instruments should therefore be verified in a pilot 
study. 
8.3 Questionnaire Administration 
HRQL measures can be self-administered or administered by trained interviewers 
depending upon the time and resources available, patients involved in the study and 
the purpose of the investigation. 
8.3.1 Interviewer-administered scales 
Interviewer-administered questionnaires ensure compliance and decrease errors and 
missing items. However, the respondent may be less willing to acknowledge or admit 
problems in a face-to-face situation, which may lead to response bias. Social 
desirability is one of the biases commonly documented in questionnaire responses that 
is more likely when the questions are posed by an interviewer (Cook et al, 1993; 
Wynder,, 1994). Responses are also influenced by the characteristics of the 
interviewer (e. g. gender, age or cultural background) particularly if the topic of the 
interview is of a sensitive or personal nature. For example, a survey of mental health 
in the USA found that male and female respondents were more likely to disclose 
information about their mental health (e. g. depression and substance abuse) to female 
interviewers than to male (Pollner, 1998). Interviewing style and the personality and 
experience of the interviewer may also influence response. This bias may be reduced 
through thorough training of interviewers. However, the time and resources involved 
in this training and in conducting the interviews limits the practicality of interviewer- 
administered questionnaires. 
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8.3.2 Self-administered questionnaires 
The self-administered approach is considerably less resource intensive than 
interviewer-administered questionnaires. Forms tend to be easier to score and some 
can even be scanned by computer and used to provide rapid feedback to clinicians. 
Unfortunately, self-administered questionnaires involve more problems with 
misunderstood instructions, missing items, language and literacy barriers and a higher 
rate of noncompliance (Fletcher et al, 1992; Guyatt et al, 1993; Cella 1995). A 
compromise is to have instruments completed whilst under the supervision of an 
investigator who can check the respondents' comprehension of items and completion 
of forms (Cella, 1995; Guyatt et al, 1993). This is less time and resource intensive 
than interviewing each participant yet ensures higher compliance and more complete 
data. 
8.3.3 Interactive questionnaires 
On-line interactive questionnaires have also been introduced. These are similar to 
self-completed forms except that questions are presented on screen, sometimes even in 
touch-screen format (Velikova et al, 1999). Such questionnaires are quick and easy to 
administer and overcome the problem of missing items as the computer package can 
be programmed so ensure that each item is completed before moving onto the next. 
Respondents have also been found to prefer the more interactive questionnaires to 
paper versions (Velikova et al, 1999). Interactive questionnaires also have the 
potential to overcome literacy constraints if, for example, the scale is presented in a 
spoken format. This means that they may also be more appropriate for children than 
pen and paper measures. 
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Unfortunately limited resources mean that it will be a long time before interactive 
questionnaires are fully integrated into health care and research settings. Some 
patients may also have difficulty in using interactive methods if they are not familiar 
with them or if they are intimidated by the technology involved. Patients with 
physical disability may not be able to carry out the `touch screen' or keyboard actions 
necessary to complete the assessment. However, these patients may have just as much 
trouble in completing a form with a pen or pencil. 
8.4 Scoring QoL Questionnaires 
8.4.1 Index versus Profiling Methods. 
8.4.1.1 Indices 
Despite widespread agreement about the multidimensionality of QoL instruments (e. g. 
Price, 1996; Bullinger et al, 1993), QoL is commonly represented as a single score in 
order to make the QoL data more amenable to statistics. However, the compression of 
such rich information into a single index prevents the identification of areas in which a 
change has taken place (Fletcher et al., 1992) and assumes that the individual 
subscales are equal in weight (Osoba, 1998). Aggregation of scores means that an 
overall QoL score could be identical for two patients despite completely different 
conditions and life profiles. For example, an agoraphobic, yet able-bodied individual 
may obtain the same overall score as a physically disabled patient with muscular 
dystrophy despite very different problems. Aggregated scores are also less sensitive 
to change and mask underlying changes on questionnaire subscales (Bullinger et al, 
1993). 
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8.4.1.2 Single Item (Global) Indices. 
Single item global indices (e. g. visual analogue scale or global improvement scales) 
are widely used to combat the statistical problems arising from the use of subscales 
and multiple scores derived from many different scales (Bech, 1993). The advantage 
of global scales is that they do not depend on the aggregation of unrelated subscales to 
produce an index score. 
However, rating QoL on a single (i. e. global) scale is likely to lead to different 
interpretations about the meaning of QoL according to different respondents. This 
does not allow specific elements of quality of life to be pinpointed (Pearlman and 
Uhlmann, 1991) and presents a drawback in clinical practice where the identification 
of specific areas of concern can be useful in tailoring treatments and monitoring 
patients' progress. 
8.4.1.3 Profiles 
Instruments that result in a `profile' of scores assess different components of a 
particular construct and represent the degree to which each area of life is influenced 
unfavourably by illness. The information provided can therefore be used to help make 
treatment decisions or to determine the changes underlying an improvement or 
deterioration in QoL. 
The difficulties involved in the statistical analyses of profile measures make it 
important to make a priori statements about hypotheses and planned comparisons in 
order to minimise the likelihood of achieving significant results by chance. Statistical 
corrections such as the Bonferoni adjustment can also be used to adjust significance 
levels when carrying out multiple comparisons (Bullinger et al, 1993). 
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8.4.2 Weighting questionnaire items 
Many scales use a weighting method to enhance the sensitivity of the questionnaire. 
This involves the allocation of greater weights to items that are more important to the 
overall end score. For example, if independence were found to be more important to 
patients than body image, the questionnaire item(s) relating to independence would be 
given a greater weighting than the body image items. This means that the item will 
have more of an influence upon the final QoL score. 
A number of methods have been adopted for applying weights to questionnaire items. 
8.4.2.1 Factor Analysis 
Factor analysis has been used to assign weights to questionnaire items (e. g. NHP). 
However, the factors emerging from the analysis of one group may not be appropriate 
for another subgroup of patients (Fayers and Machin, 1998). This is because 
symptoms, side effects and QoL issues are likely to vary across different groups 
depending on factors including stage of disease, the patient's age and sex and the 
treatment adopted. Furthermore, in heterogeneous samples (e. g. different subgroups 
of patients) factor analysis may produce factors that represent group differences rather 
than distinct variables. 
8.4.2.2 Regression methods 
Regression weighting methods can also be employed to derive item weights (Bozzette 
et al, 1994; Diehr et al, 1995). The weights derived using this statistical method 
reflect the relative importance of individual subscales in predicting overall QoL (as 
measured by a criterion measure). 
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8.4.2.3 Importance ratings 
Formal systems of deriving item weights do not guarantee that these weights are either 
clinically meaningful or meaningful to individual patients. A more novel and 
increasingly popular method is to weight the item using an importance rating provided 
by the respondent. Such methods are adopted in individualised questionnaires 
including the SEIQoL (O'Boyle et al, 1992; McGee et al, 1991) and the PGI (Ruta et 
al, 1994). The Disease Repercussion Profile (DRP; Can, 1996), a measure of 
handicap, also adopts this method of weighting to determine the contribution of each 
item to scores on the questionnaire. 
8.5 Construction of the INQoL 
8.5.1 Deriving the content of the INQoL 
8.5.1.1 Exploration of patient's experiences 
Data from the qualitative interviews and the postal survey were used to construct the 
new questionnaire (Appendix E). The analysis of the interview transcripts led to the 
emergence of a number of life domains reported to be influenced by NMD (Chapter 
4). Findings from the interview also supported the QoL model described in Chapter 1, 
which was used to construct the format and scoring scheme of the INQoL. 
8.5.1.2 Item selection 
The domains that emerged from the interview study were incorporated into the postal 
survey. The survey went on to be used to determine the prevalence of impact in these 
life areas and the importance of this impact to patients (see Chapter 7). This clinical 
impact data was used in selecting life domains for the questionnaire. The clinical 
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impact method was chosen over factor analysis as it was considered more appropriate 
to include domains of importance to patients rather than domains derived from a 
statistical model that may or may not accurately reflect NMD patients' concerns. The 
use of expert opinion was also considered inappropriate in selecting items that would 
specifically represent patients' experiences. 
In order to ensure representative scores and thereby enhance questionnaire 
responsiveness, items were selected to cover a wide range of issues relevant to 
respondents at both the severe and mild ends of the spectrum. All the items in the 
questionnaire received high impact and importance ratings in the postal survey (see 
Chapter 7 for a more detailed discussion of the analyses). It was therefore 
unnecessary to rank items according to their impact ratings. Instead, all the domains 
except for one were incorporated into the final questionnaire. The `perception of the 
future' domain was left out as it was considered to be particularly dependent upon 
personality and emotional state and therefore less likely to provide clinically 
meaningful data (i. e. demonstrate any significant response to intervention). 
The `emotions' section of the INQoL incorporates four items that were not 
specifically probed in the postal survey questionnaire. These include anxiety, 
depression, frustration and loss of confidence/self-esteem. These more specific 
emotions were frequently mentioned in the interviews and commonly volunteered in 
the comments section of the postal survey instrument. As these " represented quite 
different types of emotion it was considered important to include them as individual 
items in the INQoL. 
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As both positive and negative effects of treatment were reported in the interviews and 
confirmed as important in the surveys, the final section of the questionnaire asks about 
patients' experienced and expected effects of treatment and the importance of these 
effects. 
8.5.2 Structure of the INQoL and the contribution of the QoL model 
The use of clear conceptual models in QoL assessment is important if the information 
gained from QoL measures is to be used in the application of clinical care (Wilson and 
Cleary, 1995; Carr et al, 2001). It was therefore important to have a theoretical basis 
on which to build the structure and content of the instrument. 
The definition of QoL as the discrepancy between experience and the patients' 
expected or ideal state (Calman 1984; Cella and Tulsky, 1993) was used as the basis 
of the questionnaire. This conceptualisation is central to the QoL model outlined in 
Chapter 1. It is incorporated in questions asking patients to rate their current state in 
relation to their ideal state ('exactly as I would like to be') and the worst state they can 
imagine ('the worst I could possibly be') in the five life areas (questions 5bi, 6bi, &bi, 
iii, v, 8bi and 9bi). 
QoL-as-process accounts (Leventhal and Cole, 1997) and the ICIDH-2 (Gray and 
Hendershot, 2000) are also important to the theoretical model of QoL outlined in 
Chapter 1. In line with these frameworks and findings of the interview study, the 
INQoL was designed to separate out the different stages of NMD impact. The effects 
of symptoms are separated from questions about activities, relationships, emotions, 
independence and physical appearance (body image) in order to determine whether 
changes in symptom scores relate to changes in life domain scores. Responses to the 
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life domain questions are maintained as separate domain scores to enable. particular 
problems to be identified and monitored over time. 
The questionnaire also partially encapsulates the response shift element of the 
proposed QoL model (p. 38). As the items in the scale are fixed, rather than 
individualised, any change in the content of patients' ideals or goals would not be 
detected. However, changes in patients' internal standards and in the value they 
attach to the life domains of the scale should be discernible. Two of the three types of 
response shift may be captured by the questionnaire. Comparing perceived symptom 
severity with the impact upon satisfaction with life domains (questions 5bi, 6bi, 7bi, 
iii, v, 8bi and 9bi) should provide an idea of whether the patients `internal standards' 
have changed independently from a change in perceived symptoms. This should help 
to determine whether any change in disease impact is due to a change in symptom 
severity or to the process of adaptation. Changes in the value of particular domains 
will be evident from changes in importance ratings. 
8.5.2.1 Weighting the items. 
Symptoms affect different individuals in different ways depending upon factors such 
as age, employment status, family situation and role, leisure activities, and 
psychological make-up. This makes it difficult to apply highly standardised 
questionnaires without considerable loss of information, given the differences in the 
contribution of particular issues to an individual's overall QoL. 
The questionnaire therefore incorporates items that ask patients to rate the importance 
attached to difficulties caused by specific symptoms and the importance of NMD 
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impact upon satisfaction with each domain. Patients are also required to rate the 
importance of treatment effects. 
The importance ratings will determine the particular relevance of domain scores to 
individual patients and should thereby enhance questionnaire responsiveness. The 
questionnaire score should therefore reflect whether the influence of NMD becomes 
more or less of an encumbrance upon QoL. 
8.5.2.2 Individualised Questionnaire? 
Considering the diverse effects of the different muscle conditions, the advantages of 
individualised questionnaires in eliciting QoL evaluations at a personalised level are 
very appealing. However, fully individualised questionnaires that elicit specific 
concerns are difficult to implement in either research or clinical settings, as they tend 
to require administration by a trained interviewer, which makes them both time- and 
resource- intensive. Completely individualised measures may not even capture all the 
important issues (Pearlman and Uhlmann, 1991) if these issues do not come to mind 
or if patients are uncomfortable volunteering them. 
Individualised measures also tend to be conceptually more complicated than 
standardised questionnaires. They require respondents to have a reasonably high level 
of cognitive ability in order to complete the measures accurately. This excludes 
patients with lower levels of cognitive ability and/or educational level. 
In light of these difficulties the INQoL uses the importance rating method adopted in 
many individualised questionnaires to achieve a more accurate representation of each 
individual's experience of NMD. It does not ask patients to generate their own 
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domains. This fixed domain structure requires less cognitive effort from the patient 
and should also make it easier to monitor any changes in particular areas of QoL on 
repeated administrations of the scale. 
8.5.3 Scaling INQoL items 
In the pilot study (section 8.6) GRS and Likert scales were tested along with differing 
numbers of response options (See Appendix D for example of GRS scales). This 
ensured that the scale represented both extremes of the spectrum and provided enough 
gradations to elicit a representative range of responses and thereby enhance 
responsiveness. 
The provision of a representative scaling system and the incorporation of items that 
would encourage an even distribution of responses also aimed to enhance 
questionnaire reliability. 
8.5.4 Scoring the INQoL 
Responses to the questionnaire can be scored and presented as a profile. Scores 
reflecting symptom impact and the influence of NMD upon life domains are weighted 
using the patient's importance ratings. 
In order to ensure good inter-rater reliability a scoring scheme was devised to provide 
clear and unambiguous instructions for scoring. A Microsoft Access scoring database 
has also been designed and is programmed to score questionnaires automatically 
according to an established formula. 
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8.5.4.1 Scoring the INQoL using an Access database package 
The Access database system designed to automatically score the INQoL involves 
entering responses into a form displayed on the computer screen. The programme then 
scores the questionnaire and presents the profile of scores in a numerical format. 
Scores are presented as the percentage of maximum severity or impact, in order to 
facilitate statistical analyses. There are four scores that represent symptom impact, 
five that represent impact upon life domains and satisfaction with life domains and a 
composite QoL score representing the impact of NMD upon patients satisfaction with 
the five life domains. Treatment effects are represented by two scores. One of these 
represents the trade-off between the positive and negative effects of treatment and the 
other represents patients' expected treatment effect trade-off. 
The Access programme has an algorithm incorporated to impute values for any 
missing items (Appendix F). A variety of imputation methods (Curran et al, 1998) 
ensure minimal loss of data from missing items. This system is designed to impute 
sensible values for those items left out by patients. For example, if the `leisure 
activities' item is missed out (question 5a), the average value of the other items in this 
section is imputed. If fewer than half the items that make up each subscore are left out 
no score is calculated for that particular subdomain. 
8.5.4.2 Scoring the INQoL by hand 
The questionnaire can be scored by hand with the use of a scoring sheet (Appendix G) 
and if necessary, imputation methods for missing data. The scoring sheet describes 
the necessary calculations and provides boxes in which to mark down the subdomain 
scores and graphs in which to represent the profile of scores. This scoring method is, 
of necessity, somewhat complicated and use of the Access package is recommended. 
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However, scoring each form by hand is feasible, taking approximately 5 minutes per 
questionnaire. 
8.6 Piloting the INQoL 
The questionnaire was piloted in a total of 25 patients to ensure its acceptability. This 
involved pre-testing for appropriateness of layout, timeframe, response scaling, 
wording and content validity. During the pilot study the INQoL was revised twice 
after which it was re-piloted in different patients. 8 of the 25 patients completed the 
INQoL following final revisions. 
8.6.1 Phase 1 
8.6.1.1 Methods 
The original version of the questionnaire (Appendix D) was piloted in 11 patients 
attending the outpatients clinic or for a separate research appointment. The time taken 
to complete the questionnaire was recorded and patients were interviewed once they 
had completed the scale. They were asked whether the questionnaire was easy to 
follow, and whether they liked the adopted wording, layout and scaling methods. 
Patients were also asked what they felt the questionnaire was about and whether it 
captured all the issues of importance with regard to the effects of their condition. 
8.6.1.2 Results 
The questionnaire took patients between 10-20 minutes to complete. A number of 
difficulties were encountered. 
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Patients expressed difficulty in quantifying the impact of their condition upon a 
graphic rating (GRS) scale, scaled from 0-10 and anchored at the extreme ends of the 
scale by verbal descriptors. 
The timeframe `over the last two weeks' was also problematic for a number of 
respondents and some found the organisation of questions confusing. They found it 
difficult to rate the impact of individual symptoms (e. g. pain, weakness)upon specific 
life domains and tended to answer these questions in terms of the overall impact of 
their condition. 
8.6.2 Questionnaire revision and phase 2 of the pilot study 
8.6.2.1 Methods 
In order to address the difficulties encountered in the first phase of piloting a number 
of revisions were made to the scale. 
The GRS was initially adopted as it is easier to score than a visual analogue scale yet 
avoids problems associated with patients' differing interpretations of Likert scale 
category labels. However, given problems with the GRS, 5- and 7-point Likert scales 
were pre-tested, following recommendations for optimal numbers of categories 
(Streiner and Norman, 1995). The scales were labelled with numbers as well as verbal 
descriptors in order to minimise problems with differing interpretations of the 
descriptive category labels. These verbal descriptors were chosen to reflect differing 
degrees of impact or importance and patients were asked to comment on their 
appropriateness. 
The timeframe of the questions was also changed from `over the last two weeks' to `at 
the moment'. It was felt that this would overcome difficulties in recall of experiences 
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over a longer space of time but would avoid problems associated with asking patients 
how they feel `today'. This is because the day on which patients attend to fill in a 
questionnaire is unlikely to be a typical day (i. e. hospital visit) and responses may also 
be more influenced by mood. 
Confusion over question organisation was addressed by separating symptom questions 
from life domain questions and treatment questions. Therefore, rather than asking 
about the impact of individual symptoms upon each life domain, patients were asked 
about the severity of their symptoms, the difficulties caused by these and the 
importance of the difficulties caused by each symptom. Questions about the overall 
impact of NMD upon life domains, including independence and body image were 
incorporated into a separate section in the questionnaire. A separate section asking 
about perceived treatment effects and treatment expectations was also incorporated in 
order to circumvent difficulties with querying patients' expectations of treatment on 
individual symptoms. This also meant that patients not receiving treatment would be 
able to skip treatment questions more easily. 
Using the same methodology the questionnaire was piloted in a further 6 patients 
8.6.2.2 Results 
The Likert scale proved to be much more acceptable to patients in this phase of 
piloting and the 7-point scale was favoured over the 5-point scale as respondents felt 
they could represent their position more accurately. 
Phrasing the questions with the reference period, `at the moment' was also more 
acceptable as patients interpreted this to refer to a recent and ongoing time period. 
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8.6.3 Phase 3 
Following final revisions to response scales, the questionnaire was piloted in another 8 
patients. 
8.6.3.1 Results 
Following final revisions, the questionnaire still took between 10 and 20 minutes to 
complete. Patients found the questionnaire to be also acceptable and to 
comprehensively cover relevant and important issues. 
Patients judged the questionnaire to be about `how you as a person are affected by 
your muscle condition', `the way I feel' and `how patients feel about their illness'. 
8.7 Discussion 
Drug treatments and other physical interventions used in NMD tend to be aimed, first 
and foremost at the amelioration of symptoms, such as pain, fatigue and weakness. 
However, the consequences of symptoms in areas of life such as personal 
relationships and employment are of great importance to patients. These effects can 
be addressed indirectly through the amelioration of symptoms or through some other 
action or intervention (e. g. change in job/ increased social support). 
As existing measures do not look at how people evaluate and reach conclusions about 
the consequences of their condition (Hyland, 1992) it is difficult to interpret apparent 
changes in QoL. The INQoL was therefore designed to separate out the different 
stages of disease impact. Patients' perception of the severity of their symptoms and 
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the impact of these symptoms were separated from the effects of their condition upon 
particular areas of life. 
Breaking down scores into symptom impact and the impact of NMD upon life 
domains means that the INQoL could help in tailoring interventions to individuals. It 
should also increase understanding about the effects of interventions and patients' 
evaluation of these effects upon symptoms and important areas of life. 
Patients found the questionnaire to be easy to complete, comprehensive and 
representative of the effects of their muscle condition. 
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CHAPTER IX 
THE CLINIMETRIC PROPERTIES OF QOL QUESTIONNAIRES 
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Chapter 9: The Clinimetric Properties of QoL Questionnaires 
9.1 Evaluation of Health Status Measures 
It is important for new QoL questionnaires to be thoroughly tested in order to 
determine their interpretability, reliability, validity, sensitivity to change and ease of 
use. This gives an indication of the degree of confidence we can have in the results of 
QoL studies. This is important if findings are to be used to implement changes in 
service provision and treatment. 
The validation process is expensive and time-consuming and involves large numbers 
of participants (Reid, 1996; Fraser, 1993). It is therefore important to plan validation 
studies carefully and choose the most appropriate methods for determining the 
clinimetric attributes of QoL questionnaires. 
9.2 Important Attributes of QoL Measures 
9.2.1 Interpretability 
It is important for the results obtained from QoL instruments to make sense. For 
example, the significance of a particular change in score will only become clear once 
the questionnaire has been used repeatedly. This is because a seemingly remarkable 
change may in reality reflect a minimal effect, whereas a small change in score in 
another instrument may signify a substantial effect. For example, a change of five 
points on the Beck Depression Inventory (BDI) (Beck et al, 1961) may signify a 
substantial change in depression (e. g. from moderate to clinical depression) whereas a 
change of five points on a pain VAS may not signify a remarkable change in an 
individual's level of pain. 
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9.2.2 Reliability 
Reliability refers to the degree to which scores on a measure remain the same 
assuming that the attribute of interest has not changed. Therefore, if the attribute 
remains the same, a reliable instrument will yield the same score when administered 
on different occasions, in different conditions, or by different interviewers. 
The reliability of an instrument also influences its validity, as measurement error 
compromises the ability of the instrument to accurately reflect the entity of interest. 
Despite this, good reliability does not guarantee the validity of the instrument. For 
example, individuals may achieve similar results on a repeated test of grip strength but 
this would clearly not be a good measure of their verbal ability. 
Sources internal to the questionnaire influence its reliability. For example, if the 
wording is ambiguous or the if the scaling does not provide satisfactory response 
options it is less likely to elicit reliable responses. External factors, such as the person 
who administers the form or the setting in which the questionnaire is completed may 
also influence reliability. For example, even simple differences in instructions before 
a questionnaire is completed can result in differing responses from participants. These 
sources of variance can be difficult to identify and eliminate. However, various 
methods can be used to detect different types of reliability and help to identify sources 
of error. 
9.2.2.1 Different types of reliability 
9.2.1.1 Internal consistency 
Assessing the reliability of scales that measure one-dimensional attributes such as 
depression often includes a test of their internal consistency. This is important as all 
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the items within such questionnaires should measure aspects of the same phenomenon. 
Good internal consistency is demonstrated by a high correlation between scale items 
(Nunally, 1978). However, scale developers usually aim for a moderate rather than a 
high correlation, as each item should measure a different aspect of the phenomenon. 
One method commonly used to measure internal consistency is split-half reliability. 
This involves randomly dividing scale items into two sub-scales and correlating them. 
Higher correlation coefficients indicate greater internal consistency. Cronbach's 
alpha may also be used (Cronbach, 1951). This indicates whether internal consistency 
can be improved by excluding specific items from the scale. 
Item-total correlation can also be used to determine internal consistency. This 
involves correlating each individual item score with the overall score, minus the 
contribution from that item (as this would artificially inflate the correlation) (Streiner 
and Norman, 1995). This helps to ensure that each questionnaire item captures an 
aspect of the phenomenon. 
However, when it comes to assessing the reliability of multidimensional 
questionnaires it is not appropriate to test for internal consistency as dimensions 
within such scales should not relate closely to one another. For example, the 
dimensions within QoL questionnaires such as emotional and physical well-being may 
bear some relationship to each other but they should measure very distinct aspects of 
the construct. It is therefore inappropriate to test QoL measures for internal 
consistency. 
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9.2.2.1.2 Inter-rater reliability 
If the measure is interviewer- administered or if responses provided are open to 
interpretation whilst scoring, the reliability of the instrument between interviewers or 
raters should be assessed. A clear scoring system that may not be influenced by the 
interpretation of different individuals should demonstrate good inter-rater reliability. 
As the INQoL is a patient-completed measure with a predetermined scoring system 
there was no need to look at inter-rater reliability. 
9.2.2.1.3 Intrarater / Test-retest reliability 
It is important that questionnaire scores remain stable when no change has occurred in 
the attribute of interest. This is determined by comparing the scores from the initial 
assessment with a repeat assessment conducted after a short space of time within 
which the attribute of interest is unlikely to have changed. Enough time should be left 
between assessments to minimise the chance that respondents will recollect their 
previous responses. If the instrument reproduces the result obtained in the previous 
assessment, the questionnaire is said to have intrarater or test-retest reliability. 
The appearance of reliability may be compromised if there is any real change in the 
attribute of interest. This is particularly likely when measuring aspects of health in 
which change may occur over a relatively short period of time (e. g. fatigue). The test- 
retest reliability of multidimensional questionnaires may also be lower as they possess 
more dimensions in which a change could occur between test and retest. 
9.2.2.2 Quantifying reliability 
There are a number of ways to quantify reliability. The Pearson product-moment 
correlation has been used most widely. This measures the extent to which the 
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relationship between two variables can be explained by a regression line. However, 
this method is believed to be rather liberal in its estimation of reliability (Streiner and 
Norman, 1995). . Like other measures of correlation, it measures the relationship 
between two scores, rather than their agreement. This means that scores obtained on 
the second administration of the scale could be consistently different from the initial 
score, and yet yield a high correlation coefficient due to a strong linear relationship. 
One further complication with this method arises if more than two sets of data have to 
be compared (e. g. if there are more than two interviewers). In this situation, several 
tests of correlation have to be calculated between the data sets and there is no way to 
combine their results into one score. 
The intraclass correlation coefficient (ICC) circumvents this problem and allows a 
single coefficient to be calculated that represents the average correlation between the 
sets of scores (Streiner and Norman, 1995). Derived from analysis of variance 
(ANOVA), it is used to measure the relationship between any two measures in the 
same subject and unlike Pearson's correlation the ICC will yield a value of one only if 
all the observations in each subject are identical. 
Cohen's kappa (Cohen, 1960) is used to measure agreement between assessments on 
binary scales, for example those that measure the presence or absence of an attribute. 
Kappa corrects for the agreement that would be expected to arise by chance by 
subtracting the proportion of agreement expected by chance from the observed 
amount of agreement. Agreement is then expressed as a proportion of the highest 
possible amount of agreement (i. e. a proportion of 1.00 minus the proportion of 
agreement expected by chance). Weighted kappa (Cohen, 1968) follows the same 
principles but it is adapted for use with categorical rather than binary data. This 
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method reflects the degree of agreement, with a difference of one category indicating 
less disagreement than a difference of two or more categories, an important 
consideration in assessing the reliability of a scale. This method is mathematically 
equivalent to the ICC, but is used when ratings are made on a categorical rather than 
an interval scale (Fleiss and Cohen, 1973). 
Bland and Altman (Bland and Altman, 1986; Altman, 1991) present another method 
for measuring agreement that is useful in assessing test-retest reliability. This involves 
plotting the difference between the two observations against the mean of the pairs of 
observations and the standard deviation of the differences between these scores. This 
graph should also indicate the line of equality on which all points would lie if the two 
assessments elicited the same score. Finally, the limits of agreement are calculated, 
the upper and lower limits of which lie two standard deviations away from the mean 
of the difference between the scores. Greater agreement is reflected by a smaller 
discrepancy between the upper and the lower limits of agreement. 
This method provides an informative summary of the data, and is enhanced by 
diagrams illustrating the mean difference in the scores (in scatterplots). It also shares 
an advantage with the ICC in that it measures agreement between scores rather than 
the strength of their relationship. However, it has an additional advantage of not 
depending upon the variation in the scores between subjects. Correlation coefficients 
are higher the greater the variation in scores between subjects which results in a 
misleading picture of reliability (Bland and Altman, 1986). 
9.2.3 Validity 
The validity of an instrument refers to the degree to which it measures what it is 
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intended to measure. It is easy to validate simple measures of observable physical 
entities such as height or weight. This is because an objective criterion of some 
known quantity such as length in centimetres can be taken and compared with the new 
measure (Bland and Altman, 2002). 
It is more difficult to establish the validity of scales that attempt to measure more 
abstract concepts. There is no way to categorically confirm whether a score 
representing an artificial construct such as depression accurately captures the entity of 
interest. Quality of life is one such concept and QoL measures require thorough 
validation to determine whether their scores make sense and can be used to draw 
inferences. 
9.2.3.1 Face Validity 
Face validity refers to the extent to which an instrument appears to be measuring what 
it is intended to measure. This judgement is usually cast by experts but can also be 
established by pilot testing the measure in a small sample of the population of interest. 
This is particularly relevant in establishing the validity of QoL measures as patients 
are the indisputable experts when it comes to assessing the influence of illness on their 
- own lives. Pilot testing questionnaires with patients is therefore useful in confirming 
their clinical relevance. 
Face validity is unlikely to be an appropriate indicator of the usefulness of scales 
designed to assess socially undesirable attitudes or matters perceived by respondents 
to be of a personal nature (e. g. spending habits, sexual practices). In these cases 
instruments with high face validity may not glean representative results, as responses 
are less likely to be truthful. However, in the case of health status and QoL, face 
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validity is a useful measure of scale validity. ' 
9.2.3.2 Content Validity 
Content validity is a measure of whether the questionnaire comprehensively covers 
the attribute of interest (Nunnally, 1978). It is determined by looking at how well the 
instrument assesses all the domains of interest in terms of relevance and 
comprehensive coverage. Selecting items during instrument development is therefore 
crucial in the achievement of content validity. As with face validity, it is more likely 
to be achieved if QoL questionnaire items are developed from patients' experiences 
rather than from `expert' opinion. 
9.2.3.3 Criterion validity 
The assessment of criterion validity involves comparing the results obtained using the 
new measure with those obtained using an established gold standard or criterion. For 
example, the validity of an evaluator's assessment of grip strength could be assessed 
against the gold standard of a calibrated grip strength dynamometer. ' 
The two types of criterion validity are concurrent and predictive validity. Concurrent 
validity refers to degree of correspondence between two measures administered at the 
same time, such as Beck's Depression Inventory (Beck et al, 1961) and a clinical 
evaluation of depression. Predictive validity refers to the correlation between the 
measure and a value emerging at a later time point. An example of this would be 
preliminary tests of mathematical ability and GCSE maths exam results. Criterion 
validity also refers to the ability of a shorter version of an instrument (the test) to 
predict the results of the full-length index (the gold standard). 
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Well-established QoL measures (e. g. the SF36, Ware & Sherbourne, 1992; the SIP; 
Bergner et al, 1981) have been used in the past as standards with which to appraise 
other newly developed QoL questionnaires. However, their use may not always be 
appropriate given the lack of an agreed definition of QoL. Such measures are also 
likely to assess QoL from a different perspective than that of the new measure. 
9.2.3.4 Construct Validity 
Criterion validity is easy to establish if the attribute of interest is directly observable. 
However, when it comes to measuring more subjective aspects of health it becomes 
necessary to test the `construct' that underlies the assessment. 
Determining the construct validity of an instrument involves testing a series of 
hypotheses in order to see whether the new scale relates to other variables in the 
expected way (Bland and Altman, 2002). For example, does a measure of depression 
result in different scores for individuals who have recently experienced bereavement 
compared to those who have not? Does a measure of post-traumatic stress provide 
different scores in soldiers before and after real life combat? 
The more frequently an instrument is used and the more situations in which it 
performs as expected, the greater the confidence can be instilled in its validity. 
However, it is important to revalidate measures when using them in a new setting or 
with a new population as the wording or questionnaire format may, when used in a 
different language or culture, emphasise issues that differ from the original aim of the 
scale. 
There are two types of construct validity; convergent and discriminant validity. 
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Convergent validity refers to the relationship of an instrument to other measures of the 
same construct (e. g. the depression subscale of the Hospital Anxiety and Depression 
Scale and Beck's Depression Inventory) or to other related constructs (e. g. stress 
levels and blood pressure). A higher correlation between measures indicates better 
convergent construct validity. If a scale has discriminant validity it should not 
demonstrate strong relationships with instruments that claim to measure unrelated 
constructs (e. g. intelligence and pain). 
9.2.4 Sensitivity/responsiveness 
Responsiveness refers to the ability of an instrument to detect change in patients who 
have either improved or deteriorated but not in those who have remained the same 
(Hays and Hadhorn, 1992). It is therefore an important attribute of instruments used to 
measure outcome in clinical trials. 
Ceiling and floor effects in questionnaires can be detrimental to their responsiveness. 
Measures that demonstrate a ceiling effect elicit a disproportionate number of scores 
at the upper end of the scale whereas floor effects refer to a disproportionate number 
of scores at the low end of the scale (Bindman et al, 1990). Scales that demonstrate 
these effects do not adequately represent the entity of interest, which means that they 
are unlikely to provide a representative measure of change. For example, in a QoL 
scale in which high scores indicate better QoL, a ceiling effect would leave little room 
to represent improvement in patients obtaining high scores. On the other hand, floor 
effects would result in a failure to detect deterioration in those with the worst scores. 
9.2.4.1 Determining responsiveness 
There are a number of methods that can be used to help determine the responsiveness 
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of a scale. The most simple methods involve comparing reports of change provided 
by patients or clinicians with measures of change in clinical status, intervening health 
events, and interventions of known or expected efficacy (Liang et al, 1985). 
If responsiveness is measured over the course of an intervention it must be 
administered to two groups, one receiving treatment and the other a non-treatment 
control group. Scores can be compared using an unpaired t-test (Liang et al, 1985) or 
by conducting a repeated measures ANOVA and responsive measures should detect 
any change that occurs in the treatment group. 
Responsiveness can also be evaluated by using the effect size statistic (Kazis et al, 
1989). This is calculated by dividing the mean change in score by the standard 
deviation of the baseline score with variation in baseline score used as a reference 
against which to judge change. Effect size is most commonly used to measure change 
in clinical trials where the variation in scores obtained after baseline may have been 
influenced by the intervention. Its widespread use in clinical research and resultant 
familiarity means that it is better understood than other measures of responsiveness 
and therefore more readily adopted. 
Despite this, it has been argued that as the effect size statistic does not include 
information about response variance it cannot be used to test the statistical 
significance of the response means (Liang et al, 1990). The standardised response 
mean (SRM) (Liang et al, 1990) was proposed to represent this variance. The only 
way the SRM differs from effect size is that the mean change in scores is divided by 
the standard deviation of these changes rather than by the standard deviation of the 
baseline scores. The responsiveness statistic (Guyatt et al, 1987) is similar to both 
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these methods but divides the mean change in score by the standard deviation of the 
scores of patients who do not change. The reasoning behind this is that the variation 
in those who remain stable provides a good estimate of background noise. 
Receiver operator characteristic (ROC) curves are used as a gold standard to evaluate 
responsiveness. The area under the ROC curve estimates the probability that a score 
from one population chosen at random, will exceed a score from the other population 
(Pereira-Maxwell, 1998). Therefore, instruments that classify patients correctly as 
improved versus non-improved will have a larger area under the ROC curve. 
Unfortunately the relative value of these methods is still not well understood and 
requires further investigation (Bolton and Wilkinson, 1998). The effect size statistic is 
therefore likely to remain the responsiveness statistic of choice given its familiarity to 
researchers and ease of use. 
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CHAPTER X 
CLINIMETRIC EVALUATION OF THE INQOL: METHODS 
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Chapter 10 
Clinimetric Evaluation of the INQoL: Methods 
10.1 Introduction 
In order to determine the clinimetric properties of the scale a number of studies were 
conducted. 
" Construct validity was established by conducting hypothesis testing. Hypotheses 
were made about the relationships between subscales of the new QoL scale and a 
range of symptoms, functional disability, work-related factors, emotional well-being 
and so on. 
" Reliability was assessed by test-retest reliability over a one-week period. 
"A preliminary measure of responsiveness was obtained by administering the new 
questionnaire again after a period of three to six months, along with the other 
assessments administered at the first time point. 
" In order to investigate the clinical utility of the INQoL a pilot study was conducted. 
The questionnaire was incorporated into patients' clinic appointment and an 
observational study was conducted to determine its influence on the consultation. 
" The interpretability of the questionnaire was established over the course of the 
validation studies 
10.2 Validity of the Questionnaire 
10.2.1 Face Validity 
Face validity tends to be based on expert opinion. However, as the aim was to 
develop a patient-centred measure it was considered more appropriate to determine 
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the face validity of the instrument based on respondents' feedback. This took place 
during the pilot study (section 8.6, p. 196) in which patients completed the INQoL and 
were interviewed about its acceptability and coverage of important issues. 
10.2.2 Content Validity 
The thorough exploration of patients' experiences in the qualitative interviews and 
postal survey helped to ensure the content validity of the scale. The pilot study 
(section 8.6) also verified content validity as patients were asked whether they felt the 
INQoL adequately covered the NMD-related QoL issues. 
10.2.3 Criterion validity 
As there is no accepted definition of QoL and no universally accepted criterion 
measure of QoL, criterion validity was felt to be an inappropriate measure of validity 
in this study. In its place, a series of hypotheses about NMD-related QoL were tested 
in order to determine the construct validity of the scale. 
10.2.4 Construct validity. 
In order to test the validity of the INQoL and its subscales, the hypothetical constructs 
underlying the scale were tested against a series of established measures. The following 
hypotheses were tested: 
1. Patients with more functional disability will report a greater impact of NMD upon 
their activities and independence and will give higher ratings of symptom impact 
2. Patients who perceive their NMD symptoms as more severe will report these 
symptoms to have a greater impact upon their lives. 
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3. Patients reporting difficulties with mobility and self-care tasks will report more 
difficulty in carrying out physical activities and greater dissatisfaction with their 
ability to carry out their activities. 
4. Patients reporting difficulties with mobility and self-care tasks will report lower levels 
of independence and greater dissatisfaction with their degree of independence. 
5. Patients who have less social support will: 
Ia. experience greater difficulties in social relationships. 
Ib. report a greater impact of NMD upon their quality of life. 
Patients reporting difficulties in social relationships will also: 
IIa. report more of an influence of NMD upon their relationships and greater 
dissatisfaction with these relationships. 
6. Patients exhibiting high levels of depression and anxiety will report a greater 
impact of NMD upon their emotions and will be more dissatisfied with their 
emotional well-being. 
7. Patients with a more negative body image will report more of an impact of NMD 
upon how they feel about their physical appearance. 
8. Patients with low levels of QoL as measured by generic QoL scales will have 
more negative QoL as measured by the INQoL. 
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10.3 Instruments (Appendix H) 
10.3.1 Generic QoL Questionnaires 
Commonly used generic QoL measures were among the instruments used to test the 
construct validity of the INQoL. 
These looked at the constructs hypothesised to be an important feature of HRQL in 
NMD, including the experience of symptoms and their psychological, social and 
functional well-being. The hypotheses related to predicted relationships between the 
subdomains of the validated questionnaires and those of the new scale. 
10.3.1.1 Standardised questionnaires used in the validation 
The Nottingham Health Profile (NHP) (Hunt et al, 1985; Hunt and McKenna, 1989) 
has 38 items that can be divided into 6 subscales; sleep, energy, emotional reactions, 
social isolation, physical mobility and pain. Responses are given on a binary, `yes/no' 
scale and each item has an individual weight which, when added to the other items 
within the subscale, produce a combined maximum score of 100. Higher scores indicate 
greater impact or lower QoL within that domain. The NHP has been used in myositis 
patients, showing an impact of muscle disease across most of its subdomains, particularly 
energy, physical mobility and social isolation (Chung et al, 2001). 
The SF-36 (Ware and Sherbourne, 1992; Brazier et al, 1992) was selected as it is the 
most widely used generic measure of QoL and it has also been used in studies of 
myositis (Alexanderson et al, 1999). The 36 items of this self-completed measure cover 
8 dimensions: physical functioning, social functioning, role limitations due to physical 
problems, role limitations due to emotional problems, mental health, energy/vitality, pain 
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and general health perception. Aggregated item scores are transformed into a score on a 
scale of 0 to 100. Higher scores indicate a better health state. 
The SF-36 has been found to have good reliability and validity (Ware and Sherboume, 
1992; Brazier, 1992) and responsiveness (Garratt et al, 1993; Garratt et al, 1996; 
Harwood and Ebrahim, 2000). 
The Functional Limitations Profile (Patrick and Peach, 1989) is the British adaptation 
of the Sickness Impact Profile (SIP) which has been used in numerous studies of QoL in 
muscular dystrophy (Ahistrom et al, 1994; Ahlstrom and Gunnarsson, 1996; Ahlstrom 
and Sjöden, 1996; Pehrsson et al, 1994). It has 136 individually weighted items, which 
the respondent answers by ticking statements that apply and are due to his/her health. 
Twelve subscale scores, two dimension scores (physical and psychosocial) and the 
overall FLP score are obtained by adding together scores of items endorsed by the 
respondent, dividing the total by the maximum score possible and multiplying this by 
100. This results in scores out of 100. Higher scores indicate greater limitation. 
10.3.1.2 Individualised Questionnaires used in the validation 
The Patient Generated Index (PGI) (Ruts et al, 1994) is an individualised QoL 
questionnaire based on Calman's definition of quality of life as "the extent to which 
our hopes and ambitions are matched by experience" (Calman, 1984). The final PGI 
score is designed to represent the extent to which reality falls short of expectation in 
the areas of life in which the patient would most value an improvement. 
The version used in this study (www. dundee. ac. uk/epidemiology/PGI) asked 
respondents to think of the most important areas of life affected by their NMD and list 
up to five of these areas. These areas are rated according to how the patient would like 
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to be in each particular area. The patient then distributes 14 points over the these 
domains, spending more on those they would most like to improve. This weights the 
contribution of the individual domains, which are then combined to achieve a total 
PGI score out of 100 with higher scores indicating better QoL. 
The PGI has not previously been used with NMD patients. However, both the INQoL 
and the PGI are based upon patients' satisfaction with life domains and use `the way I 
would like to be' as a reference point against which to assess these domains. It was 
therefore hypothesised that PGI scores would correlate with the QoL score of the new 
questionnaire. A moderate rather than strong relationship between the scale scores was 
predicted as on the PGI, patients generate their own individual domains whereas the 
INQoL provides broad life domains. The domains are also weighted differently, the PGI 
involving spending points rather than rating importance. 
10.3.2 Measurement of symptoms. 
10.3.2.1 Muscle Weakness and Myotonia 
Visual analogue scales (VASs) were adopted to measure the symptoms of muscle 
weakness and myotonia (muscle `locking') as there are no existing measures that assess 
perceptions of these symptoms. VASs are widely used to measure patients' perceived 
symptom severity. They are simple, brief and easy to administer. The scales used 
consisted of a 100mm long line anchored at either end by the extremes of the symptom. 
For muscle weakness the labels were `no weakness' and `extreme weakness' and for 
muscle locking, `no locking' and'extreme locking'. 
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10.3.2.2 Pain 
As VASs are commonly used to measure patients' experience of pain it was considered 
appropriate to use one here. The 100mm VAS was labelled at either end by the extremes 
of `no pain'(0) and `extreme pain'(100). The pain subscales of the SF36 and the NHP 
were also used to determine the validity of the pain question in the new questionnaire. 
10.3.2.3 Fatigue 
Chalder's fatigue scale (Chalder et al, 1993) was used to measure the degree of the 
patients' fatigue. This scale has eleven items that can be split into two subscales, physical 
fatigue (7 items) and mental fatigue (4 items). Items are scaled on a 4-point Likert scale 
ranging from `less than usual' to `much more than usual'. These are scored from 0-3 and 
result in scale totals out of 21 (physical fatigue) and 12 (mental fatigue), with higher 
scores indicating higher levels of fatigue. 
The scale is intended to detect cases of fatigue in epidemiological studies and to detect 
change, for example, in controlled clinical trials. Despite its brevity it has been shown 
to be reliable and valid. A similar scale on which this scale was based has been used to 
measure fatigue in NMD patients (Wessley and Powell, 1989). This earlier scale 
demonstrated elevated physical fatigue scores but relatively low levels of mental fatigue 
in NMD patients. 
The Energy/vitality items in SF-36 and NHP were also used to validate the fatigue 
dimension of the INQoL. 
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10.3.2.4 Measurement of Function 
It was not feasible to measure patients' muscle strength, as this would have necessitated 
the involvement of either a trained physiotherapist or clinician. Therefore, in place of 
manual muscle strength testing, two functional measures were incorporated. These were 
a timed walk and a timed `stands' test, simple tests that have been found to be very 
sensitive to change in the functional capacity of the lower limbs (Wade and Langton- 
Hewer, 1987). The `stands' test required the participants to stand up from a straight- 
backed chair ten times (with the use of arms permitted). The timed walk involved the 
patient walking as fast as they could over a distance of 10 metres with the use of 
technical aids (e. g. walking stick) permitted. The results from these tests were compared 
to INQoL symptom scores as well as the activity and independence domain scores. 
10.3.3 Quality of life domain measurement 
10.3.3.1 Activities 
The Physical Activities subscale of the SF-36 was used to validate the activities 
subscale along with the timed functional tests mentioned above. 
10.3.3.2 Independence 
The Barthel index (Barthel, 1956) and timed functional tests were used to validate the 
Independence dimension of the scale. The Barthel index was adopted as the most 
widely used and well-established measure of activities of daily living (ADL) (Patel et 
al, 2000; Wade, 1992). It has also been use to measure disability in children with 
Duchenne muscular dystrophy (Nair et al, 2001). It contains 10 items, which list 
statements that describe different levels of independence in a number of functional 
tasks (e. g. grooming, dressing, and bathing). Item scores are added up and result in a 
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score that ranges from 0, indicating the lowest level of independence to 20, which 
indicates the highest level of independence. 
10.3.3.3 Social Relationships 
It was predicted that the Social Relationships subscale of the FLP and the Social Role 
subscale of the SF-36 would be related to the Relationships subscale of the new 
questionnaire. 
As there are no measures designed specifically to measure the impact of disease upon 
social relationships, the Social Support Questionnaire: six item version (SSQ6) (Sarason 
et al, 1987) was also adopted. This scale measures the amount of social support 
available to each respondent and their satisfaction with this support. This is represented 
in two subscale scores. The scale representing the number of people available to offer 
support (SSQ6-N) results in a score ranging from 0-9, and the scale that represents 
satisfaction with overall support (SSQ6-S) results in a score between 0-6, higher scores 
indicating greater social support. The scores obtained using the SSQ6 are similar to 
those found using the full length SSQ (Sarason et al, 1983) yet it is less burdensome to 
complete and easier to score (Sarason et al, 1987). 
It was predicted that scores on the SSQ6 would correlate with scores on the 
Relationships subscale of the new questionnaire. It was also hypothesised that there 
would be a relationship between scores on the SSQ6 and the overall QoL score as social 
support has been found to mediate the impact of ill health on QoL (Newsom and Schulz, 
1996; Lewis, Manne et al, 2001; Bennett et al, 2001). 
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10.3.3.4 Emotional Well-being 
The Hospital Anxiety and Depression Scale (HAD Scale) (Zigmond and Snaith, 1983) 
was adopted to measure underlying psychological well-being. It is a brief, easy to 
administer instrument of patient anxiety and depression that is a reliable screening'tool 
and valid measure of symptom severity. The scale has 14 items that consist of two 
subscales of 7 items. Each item has a 4-point scale that indicates the degree of severity. 
This is scored 0-3 with a maximum score of 21 on both scales. 
Developed as a measure to screen for psychiatric symptoms in hospital patients, scores of 
7 or less are interpreted as non-cases, 8-10 are uncertain cases and a score of 11 or more 
indicate a definite case, although the authors recommend that ultimate diagnosis should 
be based on clinical judgement. 
NHP emotional reactions, SF-36 mental health and FLP emotion subscales were also 
predicted to be related to the emotions subscale of the INQoL. 
10.3.3.5 Body Image 
Most measures of body image have been developed for the assessment of body image in 
people with eating disorders (Ben-Tovim and Walker, 1991). However, the impact of 
physical conditions upon body image has received increasing attention, for example in 
breast cancer (Mock, 1993) and deforming physical conditions such as rheumatoid 
arthritis (Gutweniger et al, 1999). 
The Arthritis Body Experience Scale (ABES) (Williams and Barlow, 1998) was 
developed to measure the body image of patients with rheumatoid arthritis. It has nine 
item which are divided into two dimensions; Body Totality (5 items) and Body Self- 
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consciousness (4 items), both of which have high internal consistency (personal 
communication with B. Williams, 2000). This scale was considered relevant and 
appropriate to NMD patients. It was therefore adopted and only required small changes 
to three items. This involved substituting the word `arthritis' for `muscle disease'. 
Items are scaled from 1-10 and subscale scores are derived by adding the scores of each 
item, to achieve a score between 0 and 50 for Body Totality, and 0 and 40 for Body Self- 
consciousness. Higher scores indicate a more positive body image. 
Table 10.1: Summary table of the predicted relationships between the scales 
SUBSCALES OF THE QUESTIONNAIRE PREDICTED CORRELATION WITH: 
Weakness score Weakness VAS 
Pain score Pain VAS 
Pain subscales of the SF-36 and the NHP. 
Fatigue Score Energy subscale of the NHP 
Fatigue scale (Chalder et al, 1993) 
- Total score 
- Physical fatigue score 
Muscle 'locking' score Muscle 'locking' VAS 
Body image (physical appearance) score Adapted Arthritis Body Experience Scale (ABES): 
Body totality score 
Body self-consciousness score 
Activities score SF-36: Physical activities 
Timed functional tests 
Independence score Barthel Index 
Timed functional tests 
Social relationships score Social Support Questionnaire (SSQ6) 
SF-36: Social Functioning 
FLP: Social Interaction 
NHP: Social Isolation 
Emotional impact score HAD Scale 
FLP: Emotion 
NHP: Emotional reactions 
SF-36: Mental Health 
NMD-related QoL score PGI 
FLP total score 
SSQ6-S & SSQ6-N 
225 
10.4 Recruitment 
Patients from King's College Hospital clinics were sent a letter of invitation to take part 
in the study along with a patient information sheet and consent form. Those who wished 
to take part completed the consent form and returned it in a prepaid envelope. These 
patients were contacted by telephone to arrange their study appointment. 
Patients were also recruited through patient support groups; the Myositis Support Group 
(MSG) and the Muscular Dystrophy Campaign. These patients were invited either by 
letter or during the annual general meeting of the MSG. Those recruited at the meeting 
were given booklets of questionnaires to complete at home and return by post. Those 
who accepted the invitation either attended King's College Hospital for a study 
appointment or elected to have the questionnaires sent to them by post for completion at 
home. 
10.5 Study Appointments 
The appointments took between half an hour and one hour and a half. Patients were 
allocated to a specific group and asked to complete the subset of questionnaires and 
assessments designated to that group (either list A or list B. See table 10.2). This was 
done to reduce the burden of completing a large number of questionnaires and thereby 
maximise the representativeness of the data gathered. 
Questionnaires were administered in a random order to reduce the influence that 
particular questionnaires might have on responses to subsequent questionnaires. 
Questionnaires were randomised by assigning a number to each questionnaire and 
arranging them in packs according to number sequences listed in random number 
tables. 
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Table 10.2: Questionnaires and Assessments used in the Validation study 
(Appendix G for copies of the forms) 
LIST A LIST B 
INQoL INQoL 
The MOS SF-36 (Ware and Sherbourne, 1992) The Functional Limitations Profile (FLP) 
(Brazier et al, 1992) (Patrick and Peach, 1989) 
The Patient Generated Index (PGI) (Ruta et al, The Nottingham Health Profile (NHP) 
1994) (Hunt et al, 1985) 
The Fatigue Questionnaire (Chalder et al, 1993) Social support questionnaire- 
Brief version (SSQ6) (Sarason et al, 1987) 
A subjective pain visual analogue scale (VAS) Hospital Anxiety and Depression Scale (HADS) 
(Zigmond and Snaith, 1983) 
A subjective weakness VAS 
A subjective myotonia P locking' VAS 
The Arthritis Body, Image Scale (ABES) 
(Williams and Barlow, 1998)- Adapted for 
Neuromuscular Disease (ABES-r) 
Barthel Index (Mahoney et al, 1958) 
Functional assessment 
- Timed walk (10metres) 
- Timed stands test (10 stands 
10.6 Reliability Study 
I 
As the scale was designed to be able to detect change over time it was important to 
determine its test-retest reliability. A one-week period was considered short enough to 
minimise the chance that change would occur in any of the dimensions and long 
enough to reduce the chance of patients recollecting their previous responses. Patients 
were also requested to complete a5 -point subjective change question on their second 
completion of the scale in order to determine whether they had experienced any 
change in their condition since the previous appointment. 
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A number of respondents elected to complete the questionnaire at home and post it 
back rather than return for a second appointment one-week later. This was due to the 
difficulties involved in travelling to attend the study appointment. 
10.7 Responsiveness study 
Patients taking part in the responsiveness study were asked to return to complete the 
same set of questionnaires (table 10.2, list A) after a period of 3-6 months. Symptom 
scales and timed functional tests were administered at both time points to demonstrate 
any physical or functional changes over this period of time. As the SF-36 was also 
administered at both time points in order to detect change in individual life domains. 
As the PGI is based on a similar theoretical premise to the INQoL, patients were also 
asked to provide a rating on a 5-point scale to indicate whether or not they had 
experienced a change in their condition since their first study appointment. This 
rating was used in order to determine whether a perceived change in their condition 
corresponded to changes on subscales of the INQoL. 
10.8 Statistics 
10.8.1 Reliability 
As the INQoL is multidimensional with only a few items within the individual 
subscales it was inappropriate to test its internal consistency. The assessment of 
reliability therefore concentrated on the INQoL's test-retest (intrarater) reliability. 
Correlation methods were considered inappropriate in assessing reliability as they tend 
to result in a spuriously high appearance of reliability given the high correlation 
coefficients that are bound result from scores on the same scale. It was deemed more 
appropriate to obtain a measure of agreement. For this reason, Bland and Altman's 
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(1986) method for calculating limits of agreement was adopted to assess the size of 
the differences between the first and second set of scores. This method also has the 
advantage of presenting a meaningful visual display of scatterplots that indicate 
agreement between individual's scores at test and retest. Confidence interval analysis 
determined upper and lower levels of agreement. 
10.8.2 Validity 
Hypothesis testing was conducted using Spearman's correlations. The use of a priori 
hypotheses ensured a robust validation process (Jaeschke and Guyatt, 1990). This meant 
that instead of testing all possible combinations, specific scores were correlated in order 
to minimise any false relationships likely to arise by chance. 
10.8.3 Responsiveness 
The responsiveness of the questionnaire was ascertained using effect sizes. An effect 
size of 0.8 or more is considered to reflect a large change, 0.5-0.8 reflects a moderate 
change and 0.2-0.5 reflects a small change. The effect sizes of all the scales used in 
the study were calculated in order to see if changes in score could be related across the 
various measures and particularly to changes in the new scale. 
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CHAPTER XI 
RESULTS AND DISCUSSION OF THE VALIDATION STUDY 
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Chapter 11: Results and discussion of the validation study 
11.1 Results 
11.1.1 Patients 
Altogether 95 people completed the questionnaire on at least one occasion during the 
study. The male: female ratio of the entire sample was 1: 2.2 and the mean age was 
55 (SD 17.08, min-max 19-97). Patients were made up of three subgroups; 35 patients 
with a CSP NMD, 50 patients with an ARR NMD and 10 with an ASP NMD. Table 
11.1 presents a summary of the number of patients who took part in each part of study. 
Table 11.1: Number of patients taking part in each study 
Validity 1 Validity 2 Test-retest Responsiveness 
Allocated Allocated 
measures from measures from 
subset A subset B 
Validity 1 54 26 35 t 25 
Validity 2 - 60 27 5 _ Test retest - - 40 13 
Responsive- - - - 25 
ness 
The cells indicate the numbers taking part in one part of the validation study who also completed another part (e. g. 
t 35 patients completing the questionnaires from list A also took part in the test-retest reliability study). 
Table 11.2 provides a description of the patients in each of the sub-samples who took 
part in the validation studies. In the test-retest studies most of the respondents who 
completed the scale for the first time during a visit to the hospital elected to complete 
the scale at home on retest due to long distance involved in travelling to attend the 
research visit. All those who completed the scale for the first time at home also 
completed it at home on retest, returning their forms by post. All but three of the 
respondents taking part in the responsiveness study completed the scale in clinic on 
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both occasions. These three patients were unable to return for their final appointment 
and therefore completed the forms at home. 
Table 11.2: Sample characteristics of patients participating in each study 
Patient subgroups 
CSP= congenital, slowly progressive neuromuscular disease 
ARR= acquired, relapsing remitting neuromuscular disease 
ASP= acquired, slowly progressive neuromuscular disease 
Study Patients % of Mean age Number of 
(N= patients) sample patients by 
female sub rou 
Validity 1 32* 57% 52 29 CSP 
(N=54) 22t SD= 13.86, 19 ARR 
min-max 22-86 6 ASP 
Validity 2 15* 81% 57 14 CSP 
(N=60) 45t SD=19 44 ARR 
min-max 18-97 7 ASP 
Test retest timel= 22*, 18t 55% 53 19 CSP 
(N=40) time 2= 5*, 35t SD= 16 14 ARR 
min-max 22-86 7 ASP 
Responsive- time 1= 25* 48% 51 19 CSP 
ness (N=25) time 2= 22*, 3t SD= 13.4 4 ARR 
min-max 28-77 2 ASP 
Total sample 47* 70% 55 35 CSP 
(N=95) 67t SD= 17.08 50 ARR 
min-max 18-97 10 ASP 
19 completed validity 
studies 1&2 
* Patients completing scales in clinic 
t Patients completing questionnaires at home and returning them by post 
The test-retest reliability and responsiveness studies are split into time 1 and time 2 indicating how many 
completed the scales in clinic and how many at home on first and repeated administrations. 
11.1.2 Response profile of the patient sample 
A description of the mean scores on individual subscales of the INQoL is displayed in 
table 11.3. The data provided is based on patients' first completion of the scale. 
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Table 11.3: Mean scores on the INQoL from the first completion of the 95 
patients taking part in the validation study. 
Higher scores indicate greater negative impact 
Questionnaire dimension Possible range 
of scores 
Mean (SD) Range (min-max) 
Weakness 0-100 54.7 (27.68) 0-100 
Muscle 'locking' 0-100 16.5 (26.66) 0-90 
Pain 0-100 28.2 (29.99) 0-100 
Fatigue 0-100 49.8 (32.81) 0-100 
Symptoms 0-100 38.1 (22.38) 0-100 
_ Activities 0-100 49.7 (29.18) 5-95 
Independence 0-100 38.6 (30.40) 0-100 
Relationships 0-100 22.9 (20.08) 0-95 
_ Emotions 0-100 40.7 27.32 0-100 
Bod image 0-100 43.8 (29.57) 0-100 
Perceived treatment effects -100 to +100 16.9 (39.88) -75 tolOO 
Expected treatment effects -100 to +100 39.88 (37.7) -100 to 100 _ NMD-related oL 0-100 44.2 (24.51) 0-95 
Negative scores for perceived or expected treatment effects indicate that patients' 
perceived or expected negative effects outweighed the positive effects. Positive 
scores for treatment effects indicate that perceived or expected positive effects 
outweighed the negative effects. 
Figures 11.1-11.12 show the number of respondents scoring within each ten-point 
interval on the scales of the questionnaire (0-100). The wide distribution of scores 
indicates that INQoL dimensions capture a wide range of disease impact. Roughly 
equal numbers of patients obtained scores ranging from the minimum (0) to the 
maximum (100) score possible for Weakness (fig 11.1) and Fatigue (figure 11.4). A 
large number of respondents did not report muscle `locking' (figure 11.2) and a third 
of patients did not report pain (figure 11.3). This accounts for the skewed distribution 
of scores on these dimensions. Of those patients who did report these symptoms, 
scores obtained were evenly distributed across the range of possible scores. 
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Figure 11.9: Distribution of Body Image scores 
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Scores on the Activities (figure 11.5), Emotions (figure 11.8) and Body Image (figure 
11.9) dimensions were evenly distributed across the range, but scores on 
Independence (figure 11.6) were slightly skewed towards the lower end of the scale. 
The Relationships dimension (figure 11.7) was also skewed towards the lower end of 
the scale, although scores were still distributed across the spectrum. NMD-related 
QoL scores (figure 11.10) were normally distributed, with the majority of patients 
obtaining mid-range scores. Treatment effect scores demonstrated a bell-shaped 
distribution (figures 11.11 and 11.12), indicating most respondents to report similar 
levels of positive and negative treatment effects. 
11.1.2.2 Score profiles across subgroup 
The scores obtained by the different subgroups, as displayed below in tables 11.4 to 
11.15, demonstrate the INQoL's ability to reflect differing profiles of disease impact. 
Patients in the ASP group demonstrated higher mean scores on many of the 
dimensions, demonstrating a greater negative impact of their NMD upon these areas 
of life. This suggests that these patients have poorer QoL than patients in the other 
subgroups as higher scores indicate worse QoL. 




Mean Median SD Min Max 
CSP (N=35) 57.71 68.42 27.06 0 100 
ARR =50 50 52.63 29.49 0 100 
ASP =10 67.37 65.79 14.21- T47.4 94.7 
For the weakness dimension (table 11.4) scores were distributed evenly across the 
spectrum for the CSP and ARR groups but ARR patients' scores were skewed towards 
the upper end of the scale, indicating greater levels of muscle weakness. The lowest 
score obtained by patients with an ASP NMD was 47.4. 
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Table 11.5: Muscle `locking' scores on the INQoL in 95 patients with NMD 
Patient 
subgroup 
Mean Median SD Min Max 
CSP (N=35) 28.29 21.06 29.23 0 68.42 
ARR =50 9.92 0 21.69 0 94.74 
ASP =10 0 0 0 0 0 
A large proportion of respondents did not report experiencing muscle `locking' (table 
11.5). None of the patients in the ASP group and only a very small number of the 
ARR group reported this symptom, which unsurprising as this symptom is not a 
recognised feature of these conditions. 
Table 11.6: Pain scores on the INQoL in 95 patients with NMD 
Patient 
subgroup 
Mean Median SD Min Max 
CSP (N=35) 19.08 0 28.26 0 73.68 
ARR =50 31.84 21.05 31.42 0 100 
ASP (N=10) 25 21.05 25.55 0 57.89 
The mean and median scores for pain (table 11.6) indicate that patients tend to 
experience this symptom less intensely than they experience muscle weakness or 
fatigue. 
Table 11.7: Fatigue scores on the INQoL in 95 patients with NMD 
Patient 
subgroup 
Mean Median SD Min Max 
CSP (N=35) 44.73 50 40.66 0 89.47 
ARR =50 50 52.63 29.49 0 100 
ASP (N=10) 51.32 47.37 21.65 31.58 78.95 
The fatigue scores (table 11.7) demonstrate more of a spread over the range of 
possible scores, although ARR patients did not score at either the extreme low or 
extreme high ends of the scale. 
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Table 11.8: Activities scores on the INQoL in 95 patients with NMD 
Patient 
subgroup 
Mean Median SD Min Max 
_ CSP (N=35) 46.64 33.33 28.47 21.30 97.22 
ARR =50 46.03 47.22 30.35 0 97.22 
ASP (N=10) 67.13 69.45 25.00 39.81 89.81 
Patients demonstrated activities scores ranging across the scale from low to high. 
However patients in the CSP and ASP groups did not score at lowest end of the scale 
indicating that all the patients with these muscle conditions were influenced in their 
activities in some way. The ASP group in particular had high scores for negative 
impact upon their activities. 




Mean Median SD Min Max 
CSP =35 35.42 30.56 36.45 0 86.11 
ARR =50 34.34 30.56 28.85 0 86.11 
ASP (N=10) 59.03 59.72 6.94 50 66.66 
The range of Independence scores in the CSP and the ARR subgroups of patients 
(table 11.9) suggest that the INQoL captures a wide range of independence levels. 
ASP patients demonstrated scores within a more limited range. 
Table 11.10: Social Relationships scores on the INQoL In 95 patients with NMD 
Patient 
subgroup 
Mean Median SD Min Max 
CSP (N=35) 25.81 28.71 15.51 0 47.22 
ARR =50 22.50 23.15 17.74 0 60.19 
ASP =10 35.42 30.56 24.46 12.96 67.59 
The Social Relationship subscale was more skewed towards the lower end of the 
scale, with patients perceiving there to be less of an impact upon their Social 
Relationships than upon other life domains incorporated in the scale. 
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Table 11.11: Emotions scores on the INQoL in 95 patients with NNID 
Patient 
subgroup 
Mean Median SD Min Max 
CSP (N=35) 48.26 43.06 34.02 8.33 91.67 
ARR =50 34.39 33.33 22.27 0 92.59 
ASP (N=10) 47.92 40.28 22.27 30.56 80.56 
The Emotions subscale demonstrates a wide variation in scores, although the ASP 
group scores were not as widely distributed. 
Table 11.12: Body Image scores on the INQoL in 95 patients with NNID 
Patient 
subgroup 
Mean Median SD Min Max 
CSP (N=35) 43.06 40.28 35.07 0 97.22 
ARR =50 43.76 41.67 30.50 0 97.22 
ASP =10 55.56 58.34 23.35 25.00 80.56 
The Body image subscale again demonstrated a wide distribution of scores (table 
11.12). Average scores fell around the mid-point of the scores possible. 




Mean Median SD Min Max 
CSP =35 41.60 33.61 27.23 11.67 87.22 
ARR =50 42.82 48.33 25.38 0 83.33 
ASP (N=10) 60.97 53.61 17.73 49.44 87.22 
Scores for NMD-related quality of life (table 11.13) were spread across the range of 
scores possible and average scores were close to 50 (or the mid-point on the scale). 
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11.1.3 Construct validity 
Table 11.2 shows the characteristics of the patients taking part in testing the validity of 
the INQoL. 
Hypothesis 1: Functional disability 
Patients with more functional disability will report NMD to have a greater impact 
upon their activities and their independence and will give higher ratings of 
symptom impact. 
Of the patients attending for an appointment, 32 completed the `timed walk' and 29 the 
`timed stands' task. As shown in table 11.14 there was a strong correlation between 
both the Activities and the Independence scores and scores on the functional tests. 
Table 11.14: Relationships between the dimensions of Activities and 
Independence and the timed functional tests 
Test Activities Independence 
Spearman's rho value Spearman's rho p value 
Timed 
10m walk 
0.45 0.006 0.67 0.000 
Timed 
stands 
0.76 0.000 0.82 0.000 
Tables 11.15 to 11.17 show the correlation coefficients found between individual 
symptom scores and functional tests. The muscle weakness scores demonstrated a 
strong correlation with the functional tests. There were no significant relationships 
between any of the other symptom scores and times on the functional tests. 
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Table 11.15: Relationship between the dimensions of Muscle Weakness and 
Fatigue and the timed functional tests 
Test Muscle Weakness Fatigue 
Spearman's rho value Spearman's rho p value 
Timed 
10m walk 
0.59 0.000 0.29 0.07 
Timed 
stands 
0.77 0.000 0.20 0.14 
Table 11.16: Relationship between the dimensions of Muscle `Locking' and pain 
and performance on the timed functional tests 
Test Muscle 'Locking' Pain 
Spearman's rho p value Spearman's P value 
rho 
Timed 0.11 0.395 0.32 0.038 
10m walk 
Timed -0.05 0.282 0.26 0.088 
stands 
As only 17 of the 32 patients reported muscle `locking' and just 20 reported pain, a 
subgroup analysis was performed for these two symptoms. The subgroup analysis 
yielded higher correlation coefficients between these symptoms and the functional 
tasks, but only the pain score and timed stands correlation reached significance (tables 
11.17 and 11.18). 
Table 11.17: Relationship between muscle 'locking' scores and timed functional 
tests in patients reporting muscle `locking' 
Muscle 'Locking' 
N Spearman's rho p value 
Timed 
10m walk 









Table 11.18: Relationship between pain scores and timed functional tests in 
patients reporting pain 
Pain 
N Spearman's rho p value 
Timed 
10m walk 
20 0.18 0.218 
Timed 
stands 
17 0.45 0.04 
Hypothesis 2: Symptoms 
Patients who rate their NNID symptoms as more severe will report these symptoms 
to have a greater impact upon their lives 
Table 11.19 shows the Spearman's rank correlation coefficients between the symptom 
subscales of the questionnaire and the validated reference measures. The hypothesis 
was supported with concordance between the VASs for pain, weakness and muscle 
`locking' and the corresponding subscales of the INQoL. 
The relationship between INQoL Fatigue scores and Chalder fatigue scores was 
weaker than the relationships demonstrated between the other symptoms and their 
reference measures. 
Table 11.19: Relationships between symptom subscores of the INQoL and 
validated measures of these symptoms 
New questionnaire dimension and validation scale Spearman's rho p value 
Muscle weakness score and weakness VAS 0.76 0.000 
Muscle `locking' score & Locking VAS' 0.69 0.000 
Pain score & Pain VAS 0.75 0.000 
Pain score & SF36 Pain -0.78 0.000 
Fatigue score & Chalder Fatigue score 0.49 0.000 
Fatigue score & Chalder physical fatigue score 0.51 0.000 
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Hypothesis 3: Activities 
Patients reporting difficulties with mobility and self-care tasks will report more 
difficulty in carrying out physical activities and greater dissatisfaction with their 
ability to carry out their activities. 
The hypothesis was fulfilled with a reasonably strong relationship (Spearman's Rho= - 
0.59; p= 0.000) between the Activities score of the INQoL and the Physical Functioning 
scale of the SF-36. 
Hypothesis 4: Independence 
Patients reporting difficulties with mobility and self-care tasks will report lower 
levels of independence and greater dissatisfaction with their degree of 
independence. 
This hypothesis was fulfilled by a strong relationship (r= 0.67; p= 0.000) between 
Independence scores and scores on the Barthel index. 
Hypothesis 5: Social Relationships 
Patients who have less social support will: 
Ia. experience greater difficulties in social relationships. 
Ib. report a greater impact of NMD upon their quality of life. 
Patients reporting difficulties in social relationships will also: 
IIa. report more of an influence of NMD upon their relationships and greater 
dissatisfaction with these relationships. 
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As displayed in table 11.20, the SSQ6 demonstrated a modest but significant 
correlation with the Social Relationships dimension of the INQoL. The social impact 
domains of the SF-36, FLP and the NHP demonstrated much stronger relationships 
with the social dimension of the INQoL. Scores on the SSQ6 also demonstrated a 
modest relationship with NMD-related QoL scores on the INQoL. 
Table 11.20: Relationships between INQoL Social Relationships score and 
validated measures of social support and social functioning 
New questionnaire dimension and validation scale Spearman's rho p value 
Relationships score & SSQ Number score -0.29 0.009 
Relationships score & SSQ Satisfaction score -0.34 0.003 
Relationships score & SF36 Social functioning -0.61 0.000 
Relationships score & FLP Social Interaction 0.66 0.000 
Relationships score & NHP Social Isolation 0.54 0.000 
QoL score & SSQ Number score -0.37 0.002 
QoL score & SSQ Satisfaction score -0.31 0.009 
Hypothesis 6: Emotions 
Patients exhibiting high levels of depression and anxiety will report a greater 
impact of NMI[) upon their emotions and will be more dissatisfied with their 
emotional well-being. 
The Emotions subscale score of the INQoL demonstrated a strong relationship with the 
Anxiety and Depression dimensions of the HAD scale and with the corresponding scales 
of the SF-36, the FLP and the NHP (Table 11.21). 
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Table 11.21: Relationships between Emotions score on the INQoL and validated 
measures of emotion 
New questionnaire dimension and validation scale Spearman's rho p value 
Emotions score & HADS Anxiety 0.63 0.000 
Emotions score & HADS Depression 0.66 0.000 
Emotions score & SF36 Mental health -0.55 0.000 
Emotions score & FLP Emotion 0.71 0.000 
Emotions score & NHP Emotional Reactions 0.66 0.000 
Hypothesis 7: Body Image 
Patients with a more negative body image will report more of an impact of NMD 
upon how they feel about their physical appearance. 
This was fulfilled by a strong relationship between the Body Image dimension scores 
with both dimensions of the ABESr (table 11.22). 
Table 11.22: Relationships between the Body Image dimension of the INQoL and 
validated measures of Body Image 
New questionnaire dimension and validation Spearman's rho p value 
scale 
Body image score & ABESr (Body Totality) -0.68 0.000 
Body image score & ABESr (Body Self- -0.57 0.000 
consciousness) 
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Hypothesis 8: Quality of Life 
Patients with low levels of QoL as measured by generic QoL scales will have 
more negative QoL as measured by the INQoL. 
As predicted, the QoL scores derived from the FLP and from the PGI demonstrated 
strong concordance with the NMD-related QoL score on the new questionnaire (Table 
11.23). 
Table 11.23: Relationship between QoL score on the INQoL and validated 
measures of QoL 
New questionnaire dimension and validation scale Spearman's rho p value 
NMD-Related QoL & FLP Total score 0.76 0.000 
NMD-Related QoL & PGI -0.57 0.000 
There was also a considerable overlap between the domains generated by patients for 
the PGI and those domains incorporated in the INQoL (table 11.24). Patients also 
generated other more specific life areas not specifically mentioned in the new 
questionnaire (e. g. holidays, safety, and confidence). 
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Table 11.24: Domains listed by the patients in the PGI that correspond to the 
domains in the new questionnaire 




Work 20 Activities 
Social life/socialising 18 Activities 
Social/leisure activities 10 Activities 
Sport includin : football, squash, outdoor sports) 17 Activities* 
Walkin 13 Activities* 
Holidays/Travel 11 Activities* 
Mobili 6 Activities* 
Specific leisure activities (e. g. dancing, walks) 5 Activities* 
Stairs 5 Activities* 
Physical activities 5 Activities* 
Independence 5 Independence 
Family 5 Relationships 
Cooking/housework 5 Activities 
Falls 5 N/A 
Relationships 5 Relationships 
Home 4 N/A 
Emotions (including depression & woEyj 4 Emotions 
Shopping 4 Activities* 
Bathing 4 Activities* 
Tiredness/Ener 3 Symptoms 
Strength 3 symptoms 
Physical char es/ A earance 3 Body Image 
Fitness 3 N/A 
Grandchildren 3 Relationships* 
Relationships with spouse/partner 3 Relationships 
_ Lifting 3 Activities* 
_ Standing, getting u from chair 3 Activities* 
_ Eating food/swallowing 2 Activities* 
Rash 2 Body image* 
Other people's social behaviour / General public 2 Relationships* 
Confidence 2 Emotions* 
Balance 2 N/A 
Other `life areas' listed 
Sleep, Looking after children, Safety, Grip, 
Choking, Driving, Rolling own cigarettes, Close 
friendships, Diet, Future, Public transport, Daily 
living, Sleeping, Treatment, Physical well-being, 
ability to use hands, religion, academic, building, 
safety, freedom, eating, feeling cold, clothing, 
trying to stay motivated, Personal qualities, Use of 
brain, Acceptance of problem 
1 Various domains 
V 
* Indicates `domain' covered but not specifically mentioned in the INQoL 
N/A Signifies domain not included in the INQoL 
251 
11.1.4 Reliability 
Of the 46 people asked to participate in the test-retest reliability study, 40 patients 
took part, completing the form on a second occasion, one week after the initial 
administration (see table 11.2 for a description of patient characteristics). 
The scatterplots depicted in figures 11.13 to 11.22 show the agreement between 
scores on the individual scales at initial completion of the scale and at retest. 95% 
confidence intervals were calculated for all the dimensions and these upper and lower 
limits of agreement are marked on the graph. 
Table 11.25: Agreement between the two administrations of the questionnaire in 
40 NMD patients 
INQoL Domain Mean 
change in 
INQoL score 










Muscle weakness 5.62 14.15 33.35 -22.68 
Muscle `locking' -0.0003 14.55 28.52 -28.52 
Pain 1.6 19.52 39.86 -36.66 
Fatigue -1.05 19.52 37.21 -39.31 
Activities 1.82 14.15 29.55 -25.91 
Independence 0.19 15.24 30.06 -29.68 
Relationships -1.68 13.63 25.03 -28.39 
Emotions 0.25 12.93 25.59 -25.09 
Body Image 4.12 18.80 40.97 -32.73 
NMD related QoL -0.34 12.87 24.89 -25.57 
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The test-retest reliability of the scale is demonstrated by the mean difference between 
the INQoL domain scores at initial test and retest, the standard deviation (SD) of the 
mean change in INQoL scores and upper and lower levels of agreement (table 11.25). 
All but two of the ten subscales demonstrated a mean change of less than 2 points for 
their mean score, demonstrating a good level of stability. Out of the ten subscales, 
seven demonstrated a mean score that, was slightly higher on retest, indicating a slight 
worsening of scores from initial test to retest. Nonetheless, seven of the ten subscales 
demonstrated limits of agreement that were less than 35 points from zero (point of no 
change). 
Figures 11.13 and 11.14 demonstrate that the scores obtained for Weakness and 
Muscle `Locking' on the first and second administration of the scale demonstrated 
acceptable levels of agreement. For Pain and Fatigue the distribution of the difference 
scores was wider with a SD of 19.52 on both scales (figures 11.15 & 11.16). 
Scores on the Activities (figure 11.17), Independence (figure 11.18), Social 
Relationships (figure 11.19) and Emotions (figure 11.20) subscales at initial test and 
retest also demonstrated good levels of agreement with upper and lower limits of 
agreement less than 30. points away from 0 (0= perfect agreement). Scores on the 
Body Image subscale (figure 11.21) demonstrated slightly lower levels of agreement 
with differences demonstrating a SD of 18.8. 
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Table 11.26 shows the mean changes in each of the scale dimensions over the 3-6 
month period in which the responsiveness of the questionnaire was tested. These 
changes were very small with negligible effect sizes in all but the Pain and Emotion 
dimensions. In these dimensions, small changes were reflected (worsening of Pain, 
improvement in Emotions). 
Table 11.26: Effect sizes demonstrated by INQoL subscales 
_Questionnaire 
Dimension Mean change Effect size 
Muscle weakness -0.16 -0.01 
Muscle 'locking' -4 -0.15 





Activities 0.09 -0.00 
Independence -0.44 -0.01 
Relationships -0.43 -0.02 
Emotions -6.89 -0.24 
_Body 
Image -0.43 -0.02 
Negative impact of NMD -1.49 -0.06 
NMD related QoL -1.09 -0.04 
t Bold print indicates effect size of note. Negative score indicates improvement and positive score 
indicates decline. 
Table 11.27 shows the mean changes and effect sizes for the other variables measured 
at both time points. Effect sizes of small magnitude were demonstrated in some of the 
other measures, namely the `locking' VAS, both scales of the ABES, fatigue scores, 
and the timed stands test. The effect sizes demonstrated in the other scales did not 
correspond to the effect sizes demonstrated by the INQoL. 
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Table 11.27: Effect sizes of the various reference measures 
Variable Mean change Effect size 
Barthel 0.2 I 0.07 
Weakness VAS 1.08 (D) 0.04 
Pain VAS 2.56 (D) 0.10 
'Locking' VAS 7.12 (D) -0.28 
Patient Generated Index 3.18 (D) 0.11 
ABES (Body totality) 2.64(1) 0.312 
ABES (Body self-consciousness) -2.12 (D) -0.216 
Fatigue score 1.84 (D) -0.34 
Physical fatigue 1.4 (D) -0.32 
Mental fatigue 1.08 (D) -0.44 
Timed walk 1.16 (D) -0.12 
Timed stands 4.87 D -0.18 
SF36 Physical functioning 0.60 I 0.02 
SF36 Role Physical -4 D -0.09 
SF36 Role Emotional 5.35(1) 0.13 
SF36 Social Functioning 4.93(1) 0.17 
SF36 Mental Health -0.92 D -0.06 
SF36 Energy/Vitality -3.4 (D) -0.15 
SF36 Pain 0.88 I 0.03 
SF36 General Health Perceptions -2.64 (D) -0.13 
t Bold print indicates effect size of note, l= Improvement, D= Decline 
Patients who completed the questionnaire were divided into three groups based on 
whether they reported an improvement, deterioration or no change'in their condition 
since their, first appointment. The characteristics of the patients within these three 
subgroups are reported in table 11.28. 
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Table 11.28: Characteristics of the sub-samples taking part in the responsiveness 
study 
Subsamples Male female ratio Mean age Patient 
subgroup 
Worse (N=7) 1.33: 1 56 (SD 10.95 min-max 32-63) 6 CSP 
1 ASP 
Better (N=4) 1: 3 49 ( SD 0.5 min-max 3 8-64) 1 CSP 
3 ARR 
Same (N=14) 1.33: 1 49 ( SD 14.7 min-max 28-77) 12 CSP 
l ARR 
1 ASP 
This enabled an analysis of effect sizes in patients who would be expected to 
demonstrate a change in score corresponding to a reported change in their condition 
compared to patients who reported no change (table 11.29). 
Effect sizes on a number of the subscales demonstrated changes in the expected 
direction. In the four patients who reported improvement there were small effect sizes 
indicating improvements in fatigue, activities, independence and NMD-related quality 
of life and a moderate effect size reflecting improvement in emotions. 
In the patients who stayed the same there were small effect sizes in three of the 
subscales. These indicated a small improvement in emotions but deterioration in pain 
and fatigue scores. 
For the seven patients reporting deterioration in their condition, the Pain scale 
demonstrated a moderate effect size in the expected direction (decline = increased 
pain). 
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Table 11.29: Effect sizes in dimensions of the INQoL by subgroups representing 








Effect size in patients 
reporting staying the 
same (14 patients) 


















-2.63(1), -0.09 2.35 (D) 0.08 -3.76 (I) -0.21 
Muscle 
'locking' 
-5.26 (I) -0.5 -4.13 (I) -0.15 -3.01 (I) -0.10 
Pain -2.63 (I) -0.09 6.77 (D) 0.21 10.53(D) 0.40 
Fatigue -7.85 (I) -0.20 6.28 (D) 0.19 1.51 (D) 0.05 
Symptoms -4.61 (I) -0.17 2.44 (D) 0.10 -1.46 (I) -0.09 
Activities -6.71 (I) -0.24 0.69 (D) 0.02 2.78 (D) 0.12 
Independence -3.48 (I) -0.21 -1.79 (I) -0.05 3.97 (D) 0.13 
Relationships -2.32 (I) -0.15 0.55 (D) 0.02 -1.32(1) -0.08 
Emotions -16.99 (I) -0.56 -6.81 (I) -0.26 -1.19 (I) -0.04 
Body Image 0.69 (D) 0.05 -3.17 (I) -0.11 4.42 (D) 0.13 
NMD-related 
oL 
-5.57 -0.22 -0.40 (1) -0.02 0.09 (D) 0.005 
t Bold print indicates effect size of note. Negative score indicates improvement and positive score 
indicates decline. 
Table 11.30 lists the effect sizes demonstrated by the other scales in the subgroup 
analysis. In the patients reporting an improvement in their condition, large effect 
sizes reflected changes in the expected direction on the Chalder Fatigue Scale, 
especially on the physical fatigue subscale, the timed walk, the Social Functioning 
subscale of the SF-36 and SF-36 Pain. Moderate effect sizes were demonstrated on 
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the Barthel, the `Locking' VAS, Chalder's Mental Fatigue scale, SF-36 Physical 
Functioning and SF-36 Change in Health. Small effect sizes were found on the Pain 
VAS, ABES Body Totality, timed stands and SF-36 Role Physical, EnergyNitality 
and General Health Perceptions. 
In those patients who judged their condition to have stayed the same, patients showed 
a small improvement on Chalder's Fatigue Scale and a small deterioration on both the 
Energy/vitality and General Health Perceptions scales of the SF-36. 
For patients reporting their condition to have deteriorated, small discrepant 
improvements were demonstrated on the Pain VAS, Chalder's Physical Fatigue 
subscale, and the PGI. A moderate effect size demonstrated a discrepant improvement 
on the `Locking' VAS. Scores on the SF-36 demonstrated the expected deterioration 
in score on all the subscales except for Role Emotional, which reflected a small 
improvement. 
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Table 11.30: Effect sizes in validated health status measures by subgroups 
representing patients who reported either an improvement, a deterioration or no 
change in their condition 
Measure Effect size in patients Effect size in patients Effect size in patients 
reporting an reporting staying the reporting an 
improvement in their same (14 patients) deterioration in their 
condition 4 patients) condition 7 patients) 
Mean Effect size Mean Effect size Mean Effect size 
change change change 
Barthel 1.25(1) 0.5 -0.07 D -0.019 0.141 0.068 
Weakness -2.5 (I) -0.138 3.85(D) 0.126 -2.43(I) -0.010 VAS 
Pain VAS -6.75(1) -0.240 -1.85(1) -0.058 -5.85(I) -0.375 
`Locking' -8.25 (I) -0.508 -3.36(I) -0.130 -14(I) -0.896 VAS 
Fatigue score -4.75(1) -0.927 -1.641 -0.318 -0.57(l) -0.097 
Physical -4.5 (I) -1.071 -1.29(I) -0.284 0.14(D) 0.340 fatigue 
Mental fatigue -2.75(1) -0.601 -0.79 I -0.376 -0.71(I) -0.373 
Patient -2.9 (D) -0.092 3.195(I) 0.124 6.299(I) 0.270 Generated 
Index 
ABESr 1.75 (I) 0.294 -0.5(D) -0.073 1.86(I) 0.177 (Body total ty) 
ABESr -2.25 (D) -0.180 -2.08(D) -0.197 0.28(1) -0.035 (Body Self- 
consciousness) 
Timed walk -1.258(1) -1.17 0.708(D) 0.104 -0.3291 -0.021 
Timed stands -1.17(l) -0.442 0.814(D) 0.05 -3.001(1) -0.080 
SF36 Physical 12.5 (I) 0.66 2.5(1) 0,063 -10 (D) -0.388 functioning 
SF36 Role 25(1) 0.433 -7.14(D) -0.173 -14.28 -0.378 
_Physical SF36 Role 8.25 (I) 0.165 2.41(I) 0.054 9.57(1) 0.300 
emotional 
SF36 Social 32.25 (I) 
, 
0.867 1.09(I) 0.036 -3(D) -0.120 Functioning 
" 
SF36 Mental 0.25 (I) 0.009 -1.14(D) -0.08 -1.14(D) -0,075 Health 
SF36 12.5 (I) 0.333 -4.64(D) -0.205 -10(D) -0.800 Energy/vitality 
SF36 Pain 33.25(1) 1.123 0.05(1) 0.002 -15.94(D) -0.306 SF36 10(1) 0.419 -4.14(D) -0.226 -6.86(D) -0.298 General Health 
Perceptions 
SF36 Change 18.75 (I) 0.786 -1.79(D) -0.066 -5.86(D) -0.298 in health 
t Bold print indicates effect size of note, I= Improvement, D= Decline 
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11.2 Discussion 
The important properties of health status measures include reliability, validity, 
interpretability and responsiveness to clinically important change (Feinstein, 1987) 
(McDowell and Newell, 1996; Streiner and Norman 1995; Fitzpatrick et al, 1998; 
Hays and Hadhorn 1992). In order to ensure that these properties were fulfilled, a 
series of steps were taken to evaluate the new questionnaire. The results of this 
evaluation will be discussed in the following pages. 
11.2.1 Interpretability 
The wide distribution of scores on the various subscales demonstrates the ability of 
the measure to pick up a broad range of symptom and disease impact and therefore 
also its potential to detect change. The normal distribution of NMD-related QoL 
scores further suggests that the scale is likely to be responsive to change. 
Roughly equal numbers of respondents obtained scores across the range possible for 
Weakness and Fatigue, indicating the ability of the scale to represent patients at 
varying levels of symptom impact. As expected, a large number of respondents 
reported having no muscle `locking' and a considerable number did not have any pain. 
This accounts for the skewed distribution of domain scores on these dimensions. 
However, in the patients who did report an impact of these symptoms, scores were 
evenly distributed from the lowest to the highest scores possible. 
Scores on the Activities, Emotions and Body Image dimensions were evenly dispersed 
across the spectrum. Independence was slightly skewed towards the lower end of the 
scale. This is likely to be because a number of patients in the study experienced only 
mild NMD symptoms, and they were therefore able to maintain a good level of 
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independence. The Relationships dimension was particularly skewed towards the 
lower end of the scale, although responses still ranged from the lowest to the highest 
score possible. This floor effect suggests that the scale may allow little room for 
improvement. However, it may be that many NMD patients' relationships fare well 
despite the effects of their condition. This is supported by findings about the positive 
influence of social support on coping with illness (Sarason et al, 1985) and those 
showing illness to have a positive effect on relationships (Padilla et al, 1990). 
The pattern of differences in scores across the different disease subgroups indicates 
the ability of the questionnaire to reflect differing amounts of disease impact. For 
example, most of the subscale scores were higher for patients diagnosed with an ASP 
condition. The higher scores elicited in this group may be due to the small sample 
size, greater disability experienced in these patients, their older age and the later onset 
of their condition. Not only may they have had less time to adapt to their condition, 
they may also have less social support. 
The high levels of weakness reported by patients in the ASP group are likely due to 
the fact that inclusion body myositis patients commonly receive their diagnosis 
following problems with weakness. This symptom is particularly characteristic of 
these patients whereas patients with an acquired, relapsing, remitting condition may 
go through periods of remission where they experience little weakness. Similarly, 
patients with a congenital condition may have a diagnosed muscle condition but 
experience little noticeable weakness. 
It was to be expected that only a small proportion of respondents would report muscle 
`locking'. This is because the symptom of myotonia or muscle `locking' is 
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experienced by patients with myotonic dystrophy or myotonia congenita and is not a 
feature of the other muscle conditions. This explains why none of the ASP patients 
reported this symptom and the low mean and median score of patients in the ARR 
group. However, the high maximum score of muscle `locking' in the AAR group 
indicates that this particular question may need further refinement to ensure 
comprehension. The maximum score on this symptom scale for the CSP group was 
still relatively low, suggesting that patients may not feel that symptom is considerably 
bothersome compared, for example, to the symptom of muscle weakness. 
Pain is less of a feature in muscle conditions than muscle weakness, which explains 
the low pain scores on the INQoL. The median score of zero for congenital patients 
indicates that a considerable number of these patients do not experience pain. 
Despite these findings it is still important to include `locking' and pain in the 
questionnaire as they are important features of NMD for many patients that influence 
QoL and can be amenable to treatment. 
The ASP group in particular had high scores for negative impact upon their activities, 
which is likely also due to their older average age and the associated limitations. The 
congenital group had a lower median score for Activities which may be because a 
number of these patients were only mildly affected by their condition. These 
diagnoses are often made following the diagnosis of another family member, not 
always as a consequence of intrusive physical symptoms. 
Although there was wide variation in scores on the Emotions subscale, the scores 
obtained by the ASP group did not demonstrate such wide variability, which again is 
likely due to the small sample size. 
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Once the INQoL has been used more extensively the significance of particular profile 
scores will become clearer. 
11.2.2 Validity 
The results of the validation study demonstrate the INQoL's acceptability to patients 
and ease of completion. The profile of scores also provides useful information about 
patients' symptoms and NMD impact upon important areas of life. 
11.2.3 Face and Content Validity 
The use of qualitative data detailing NMD patients' experiences of muscle disease as 
the basis for the INQoL, maximised the face and content validity of the scale. These 
properties were confirmed during pilot testing of the instrument (section 8.6, p. 196). 
11.2.4 Construct Validity 
The lack of consensus on a definition of QoL means that it is difficult to establish the 
validity of QoL scales. There are no existing gold standards of QoL, therefore validity 
was established by investigating relationships between the dimensions of the INQoL 
and a series of validated scales hypothesised to measure constructs associated with 
NMD-related QoL. 
The relationship demonstrated between the subscales of the INQoL and the 
established measures confirmed many of the hypotheses. Correlation coefficients 
ranged between 0.29 to 0.78 with many greater than 0.5, indicating that the reference 
measures are related to the subscales of the INQoL but measure 'a different entity. 
Correlations of this magnitude were to be expected considering the differences 
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between the INQoL and the established scales in their scaling methods, underlying 
constructs and development for use in different circumstances. 
11.2.4.1 Functional ability and QoL dimensions 
Patients with more functional disability are likely to experience greater difficulty in 
performing physical activities and more likely to. need help in performing many of 
these activities. Therefore, it was predicted that the greater the patient's functional 
disability, the higher their scores would be on the dimensions of Activities and 
Independence. This hypothesis was fulfilled with the timed stands test demonstrating 
a strong relationship with Activities (Rho= 0.76,0=0.000) and Independence (Rho= 
0.82, p= 0.000). The ten metre walk also demonstrated significant but slightly more 
modest correlation coefficients of 0.45 (p=0.006) and 0.67 (p=0.000) with Activities 
and Independence respectively. The stronger relationship between these dimensions 
and the timed stands test than they have with the ten metre walk supports their 
validity. This task takes longer, is more physically demanding and therefore more 
reflective of physical disability. 
11.2.4.2 Functional ability and INQoL Symptoms 
Of 
-the symptoms, weakness demonstrated a strong and significant relationship with 
both timed tasks with a Spearman's Rho of 0.50 (p=0.000) for the timed walk and 
0.77 (p=0.000) for the stands. Neither Fatigue nor Muscle `locking' demonstrated a 
significant relationship with these tasks. Pain had a significant but weak correlation 
with the timed stands test in the subgroup analysis of patients reporting pain. 
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These findings support the validity of the symptom scores given the considerable 
impact that weakness has upon physical tasks and the influence that pain is likely to 
have in slowing down task performance. 
The lack of relationship between the `locking' and fatigue scores and the timed tasks 
indicates that these symptoms have a less important role in short term physical 
activities. Muscle `locking' (or myotonia) may play a role in the performance of 
certain activities. However `locking' as reported by patients on the questionnaire did 
not seem to influence time taken on these tasks. Similarly, the fatigue reported by 
patients is unlikely to have had a considerable effect on short-term physical activity. 
The kind of fatigue associated with muscle conditions is more likely to influence 
physical activity over longer periods of time. 
It would have been interesting to include a test of upper limb function as well as the 
timed walk and stands task. Measures that can be used for this purpose and that could 
be adopted in further validation of the INQoL include dynamometry to determine grip 
strength and peg tests to measure arm disability (Wade, 1992). Peg tests involve 
timing patients' performance in placing a set number of pegs into holes. They can be 
sensitive, however they focus on manual dexterity rather than arm strength and they 
are not sensitive in measuring degrees of moderate to severe disability. 
11.2.4.3 Symptoms 
Symptom scores on the new scale and those on the established measures were strong. 
Spearman's Rho coefficients ranged between 0.69 and 0.78 for the weakness, 
`locking' and pain scores of the INQoL and respective VAS scales. The fatigue 
subscale demonstrated a slightly more modest relationship with Chalder questionnaire 
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scores (Rho= 0.49, p= 0.000). These strong relationships were to be expected given 
that physical symptoms are less likely to be influenced by the individual's situation or 
their subjective interpretation than ratings of disease impact on life dimensions. 
However, symptom impact as well as symptom severity is measured in the INQoL, 
placing the effect of symptoms within the context of the patient's life and their 
adaptation to symptom effects. The VASs measure symptom severity alone, which 
explains why the correlation between these measures was not even stronger. The Pain 
scale of the SF-36 includes 'a question about the interference of pain as well as its 
severity, which accounts for the strong relationship between this and the Pain scale of 
the INQoL (rho= -0.78, p=0.000). 
Weaker concordance between scores on the fatigue subscale and those on Chalder's 
fatigue scale is likely to be due to the emphasis of Chalder's scale on a change in 
fatigue over the last 6 weeks, rather than upon fatigue experienced `at the moment' as 
measured by the INQoL. 
11.2.4.4 Activities 
The Physical functioning subscale of the SF-36 measures limitation in performing 
daily activities such as lifting, walking, climbing stairs and self-care. The activities 
dimension of the INQoL measures the impact of NMD upon daily activities, leisure 
activities and work. It was therefore predicted that these two scales would correlate 
with each other. The hypothesis underlying this premise was that patients who 
experience greater difficulty in physical activities and self-care tasks would report 
more problems in carrying out activities and greater dissatisfaction with their ability to 
complete these activities. This was supported by the correlation between the scores on 
the Physical Functioning scale of the SF-36 and the Activities dimension of the 
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INQoL (Rho= -0.59, p=0.000). Unlike the INQoL, the SF-36 focuses on activities of 
daily living. It does not specifically ask about work activities, and leisure activities 
are only implied in items about vigorous and moderate activities. This may account 
for the more moderate correlation between these scales than might have been 
expected. 
11.2.4.5 Independence 
The Barthel scale assesses functional ability and degree of independence in carrying 
out activities of daily living, such as dressing, grooming and bathing. The 
independence dimension of the INQoL measures NMD impact upon patients' 
independence and satisfaction with their level of independence. The correlation 
between these scores (rho= 0.67, p= 0.000) therefore supports the hypothesis that 
those with difficulties in mobility and self-care tasks would report lower levels of 
independence and greater dissatisfaction with their level of independence. 
11.2.4.6 Social Relationships 
The Social Relationship subscale of the new questionnaire measures the impact of 
NMD upon relationships with partner/spouse, family, friends and other social 
contacts. It also looks at patient satisfaction with these social relationships and the 
importance patients attach to the effects of NMD upon them. The SSQ6 measures 
social support, in terms of the number of people available to provide support in 
various circumstances and their satisfaction with this support. The small but 
significant negative correlation between these scales testifies to their measurement of 
differing constructs. However, it also indicates that social support plays a role in 
maintaining positive relationships. 
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Social Functioning as measured by the SF-36, FLP Social Interaction and NHP Social 
Isolation yielded much stronger associations with the Social Relationships dimension 
of the INQoL. This is likely to be because they measure the impact of illness upon the 
dynamics of social relationships, whereas social support, is more important in 
mediating the relationship between life events and illness (Sarason et al, 1985). The 
moderate correlation coefficients demonstrated between the social support scores and 
NMD-related-QoL as measured by the INQoL supports the hypothesis that social 
support plays a role in maintaining QoL. 
11.2.4.7 Emotions 
The Emotions dimension of the INQoL measures the impact of NMD upon the 
emotional well-being of the respondent, specifically whether it causes the patient to 
feel depressed, anxious, low in confidence or frustrated by their condition. It also 
measures patients' satisfaction with their emotional well-being. The HAD scale 
screens for depression and anxiety and as expected, its subscales were strongly related 
to the Emotions dimension of the INQoL (HADS Anxiety; Rho= 0.63, p=0.000) 
(HADS Depression; Rho= 0.66, p=0.000). 
The Emotions subscale of the FLP includes nine items relating to depression, anxiety, 
irritability and emotional stability. The Emotional Reactions subscale of the NHP 
includes nine items, which cover feelings of anxiety, depression and loss of control. 
Correlation of INQoL Emotions subscale with these subscales further supports the 
validity of the dimension. The closely related construct, Mental Health as measured 
by the SF-36 was also significantly correlated to the Emotions subscale of the INQoL. 
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11.2.4.8 Body Image 
The ABES measures the impact of arthritis upon body image, more specifically how 
patients feel about their physical appearance, the way their body moves and how self- 
conscious they are about their body. The Body Image subscale of the 1NQoL measures 
the perceived impact of NMD upon physical appearance and upon patients' 
satisfaction with the way they look. 
The strong relationship between the subscale scores of the ABES and the 1NQoL 
subscale support the validity of the scale in measuring body image. INQoL Body 
Image and Body Totality on the ABES demonstrated a stronger correlation than the 
relationship between INQoL Body Image and Body Self-consciousness. This was to 
be expected as the Body Totality scale measures impact upon satisfaction with 
appearance rather than embarrassment due to physical effects of their condition, which 
is a rather more specific construct. 
11.2.4.9 Quality of Life 
The composite QoL score of the INQoL is generated by combining the scores 
representing patients' satisfaction with each of the five dimensions with the 
importance attached to NMD impact on these dimensions. 
The PGI measures the impact of disease upon the five most important life areas 
affected by the patient's condition, `all other health-related aspects of life' and `all 
non-health aspects of life. ' 
The significant relationship between these measures supports the validity of the 
INQoL composite score. The PGI purports to provide a score that represents 
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individualised health-related quality of life and, like the INQoL is based on the 
definition of QoL as the difference between an individual's current state and their 
expectations -or ideals (Calman, 1984). The considerable overlap between A he 
dimension of the INQoL and domains generated by patients on the PGI further 
supports the content validity of the scale (Table 11.24) and accounts for the 
relationship between the QoL scores on these two scales. However, as the PGI 
requires patients to generate dimensions of individual relevance it was inevitable that 
a number of the domains generated would differ from those on the INQoL. This and 
the incorporation of global ratings of other aspects of health and life in general 
accounts for the slightly weaker relationship between the PGI and QoL as measured 
by the INQoL than might have been expected. 
The FLP can be aggregated into a single index and covers a broad range of physical 
and psychological areas of life important to QoL in individual patients with physically 
disabling conditions. There was a strong relationship between the FLP and the QoL 
score on the INQoL, further supporting the validity of the new scale. 
To sum up, the association of INQoL dimensions with scores on related measures 
supported the hypothesised underlying constructs of the scale. This demonstrates the 
construct validity of the INQoL as a measure of QoL in patients with NMD. 
The INQoL's association with the FLP, a measure of disease impact in disabling 
conditions and the PGI, an individualised measure of health-related QoL, 
convincingly supports the validity of the INQoL. From this it may also be concluded 
that the FLP and PGI provide useful measures of QoL for NMD. However, there are 
limitations to the use of both the FLP and the PGI that are likely to impede their 
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uptake. For example, the FLP is long and takes an average of 20 minutes to complete. 
It also has a complicated scoring system that involves the aggregation of individual 
item weights. Furthermore, a large number of FLP items do not apply to a 
considerable number of patients. This is likely to dampen respondents' motivation to 
respond accurately and to complete the assessment. 
The PGI involves the generation of individually relevant items and is therefore likely 
to result in an accurate picture of individual patients' QoL. However, it is not suitable 
for use in many settings due to problems incurred in self-completion. The generation 
of individual domains and the complicated system of item weighting through point 
spending has resulted in low response rates (Macduff and Russell, 1998). The item 
generation phase may also mean that important issues are missed if they do not come 
to mind when completing the scale. It is therefore best if a trained interviewer 
administers the PGI. However, this is more time and resource consuming and means 
that the scale is not practical for use in most clinical and research settings. 
The SF-36 has also been used in muscle disease, more specifically in studies of myositis 
(e. g. Alexanderson, 1999). Many of the SF-36 dimensions demonstrated strong 
relationships with the INQoL scales (e. g. Pain and SF-36 Pain, Activities and SF-36 
Physical Functioning, Relationships and SF-36 Social Functioning) which suggests that 
these subscales may be useful in capturing aspects of QoL in NMD. However, as with 
the FLP, a number of SF-36 items are not relevant to many patients with NMD. For 
example, some of the items refer to functional activities that involve walking and 
climbing stairs, which are not applicable to wheelchair users. These are therefore 
inappropriate as well as limited in their ability to detect change in many patients. The 
generic nature of the scale also means that many items are not specifically relevant to the 
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impact of NMD, for example, the item `have you been a happy person' could be 
influenced by many different factors. Similarly, the relevance of questions such as `seen 
I get ill more easily than other people' (Qun 1la) provide little information about the 
impact of NMD on QoL. 
The INQoL therefore provides a more relevant and practical measure of QoL in NMD 
than these generic measures of QoL. It allows respondents to rate the impact of specific 
symptoms, the influence of NMD upon life areas, incorporates ratings of individual 
importance and can be completed without the assistance of an interviewer. 
11.2.5 Reliability 
The reliability of an instrument is the degree of consistency with which it measures 
the attribute of interest. This can be influenced by external sources, such as the 
individual respondents or the observers who score the measure. It can also be 
influenced by sources internal to the measure such as scaling or question wording. 
The INQoL is a multidimensional instrument, and it was therefore considered 
inappropriate to measure its internal consistency as items in the separate subscales 
were designed to measure different aspects of QoL. 
However, as it is important that the scale is able to detect real change, the test-retest 
reliability of the scale was investigated. This was done by measuring agreement 
between the scores obtained on two administrations of the scale separated by one 
week. This was considered short enough to minimise the chance of any change in the 
patients' condition but long enough to ensure that previous responses would not be 
recollected. 
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The Weakness and `Locking' scales demonstrated good levels of agreement between 
scores on these scales at time one and time two. Pain and Fatigue scores demonstrated 
slightly lower levels of agreement, but this may have been due to a real change in 
these symptoms between the two time points. Both pain and fatigue are likely to vary 
considerably over short periods of time and it may be that the questionnaire reflected 
changes in these symptoms between test and retest. 
Consistency was demonstrated between scores obtained on the first and second 
completion of the scale in the Activities, Independence, Social Relationships and 
Emotions subscales. Body Image scores were less consistent, but demonstrated an 
acceptable level of agreement. 
Seven of the ten subscales demonstrated a mean score, that was slightly lower on 
retest, suggesting that there may have been some kind of systematic bias between the 
administration points. More patients, completed the scale at home on their second 
completion of the scale. It could be that patients felt better when completing the scale 
at home, having not had the journey to the hospital or anxiety associated with 
attending a research appointment in a hospital setting. It could also be that respondents 
were more inclined to give negative responses when completing the measure in the 
presence of a researcher (investigator expectancy bias). 
Variability in scores from initial test to retest is likely to be due in part to the small 
sample size. If a larger sample size had been adopted the variance is likely to have 
been smaller as a greater number of difference scores would be likely to fall around 
the mean. Nonetheless, seven of the ten profile scores demonstrated limits of 
agreement that were less than 35 points from zero (point of no change). Greater 
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variability was demonstrated in the change in scores between times one and two in the 
Pain, Fatigue and Body Image subscales. 
The individualised nature of the questionnaire may also have influenced its reliability. 
Mid-range responses are more likely to be used with standardised scales (Lacasse et 
al, 1999) whereas importance ratings may elicit more polarised responses at the 
extreme ends of the scale. 
It is likely that the agreement between scores at test and retest would have been better 
if the conditions had remained the same at both time points. For those questionnaires 
completed at home it is uncertain whether the whole questionnaire was completed in 
one sitting and whether it was completed by the patient or by someone else. 
Furthermore, for respondents' completing the scale at home on retest there was little 
control over when the scale would be completed. This resulted in many respondents 
completing the scale more that one week after the initial test. 
There are a number of steps that could be taken to improve the appearance of test- 
retest reliability. For example, the use of a larger sample would reduce the variance in 
the difference between scores at time one and time two. Shortening the period 
between test and retest and having respondents complete the scale under the same 
conditions on both occasions would also improve the appearance of reliability. 
11.2.6 Responsiveness 
The ability to detect clinically important change is an essential property of clinical 
tools designed to monitor patients' progress over time or detect change in response to 
treatment (Guyatt et al, 1987; Fitzpatrick et al, 1992). Due to the time scale of the 
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project and difficulty in recruiting patients receiving treatment, a preliminary rather 
than complete assessment of responsiveness was undertaken. 
Most of the changes reflected by the scales used in the study were small. However, 
even in the parameters demonstrating a substantial change, the sample size was too 
small for the effect size statistics to be conclusive. 
When changes in the group as a whole were analysed, the Pain and Emotions scales 
demonstrated small effect sizes. These were not mirrored by changes in the reference 
measures. However, when patients were divided into groups representing their 
perception of whether they had improved, deteriorated or stayed the same, changes in 
the expected direction indicated the INQoL's potential to respond to change. For 
example, the small effect size on the Fatigue dimension in patients who had 
`improved' was mirrored by substantial improvements on the Chalder Fatigue scale. 
Faster times on the timed tasks in those who reported an improvement supported 
corresponding effect sizes in these patients for the Activities and Independence 
dimensions. 
In the patients reporting improvement in their condition, the small effect size on the 
Activities subscale was also reflected in the Physical Functioning subscale of the SF- 
36. The small improvement on the Independence subscale was also echoed by a 
moderate effect size on the Barthel index. However, improvement in Emotions as 
measured by the INQoL in this subgroup was not mirrored by an improvement on the 
Mental Health subscale of the SF-36. This might be because the scales measure 
somewhat different constructs. The INQoL measures the emotional impact of NMD 
whereas the SF-36 asks questions relating to general mental health (e. g. `have you 
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been a very nervous person', `have you been a happy person'). 
Similarly, the small effect size indicating an improvement in NMD-related QoL in 
patients reporting an improvement was not reflected by the PGI. This might suggest 
that the PGI does not adequately represent change, particularly considering the 
improvement in PGI scores in patients who reported a decline in their condition. 
The only notable change of score in patients reporting a decline in their condition was 
on the Pain subscale. This decline was not mirrored in the Pain VAS, although a 
small increase in Pain was registered on the SF-36. There were discrepant 
improvements in patients reporting a decline in their condition on numerous scales 
including the `Locking' VAS, the PGI and the timed functional tasks. This suggests 
that the condition of these patients may not have deteriorated. However, the increase 
in pain as reported on the INQoL may account for the reported decline in condition. 
This reported deterioration may also be due to their diagnosis. Six of the seven 
patients who reported a decline in their condition had a congenital, slowly progressive 
condition and one had an acquired, slowly progressive condition. It may be that these 
patients expected to have become a little worse since their initial visit, even though 
there may have been no notable change. 
Patients in the group that reported an improvement in their condition are more likely 
to have experienced a real change as three of these four patients had a relapsing 
remitting condition and may have gone into remission as the result of steroid 
treatment. 
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These results indicate the potential of the INQoL to be responsive to change. 
However, a study involving a larger sample of patients would be necessary in order to 
draw a more conclusive estimate of responsiveness. Ideally responsiveness should 
also be assessed in patients undergoing an intervention known to have a significant 
clinical effect. This is difficult in NMD as there are few treatments that have a proven 
beneficial effect. A rigorous test of responsiveness would therefore require a 
multicentre effort in order to recruit a large enough sample in receipt of such a 
treatment. 
The responsiveness demonstrated by the various measures may also have been better 
had patients been split into groups according to reported change in QoL rather than 
change in their condition. As discussed in chapter one, individuals tend to respond in 
different ways to the physical effects of illness and QoL levels may not always reflect 
physical or functional state. Therefore, changes demonstrated by patients subdivided 
into groups according to a reported change in QoL are likely to demonstrate greater 
correspondence to changes in QoL measures and other scales. 
11.3 Conclusion 
The INQoL has demonstrated good validity and reasonable levels of reproducibility 
and provides a promising measure of QoL in NMD. A preliminary study of 
responsiveness indicating the potential of the INQoL to be responsive to change 
indicates its usefulness as an outcome measure for clinical research. These properties 
also make the INQoL attractive as a clinical tool that could be used to document 
changes in QoL between consultations. 
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CHAPTER XII 
THE CLINICAL UTILITY OF THE INQOL 
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Chapter 12: The Clinical Utility of the INQoL 
12.1 Introduction 
Clinical instruments that look at quality of life can be useful in monitoring patients' 
condition between appointments and have the potential to highlight issues that may be 
overlooked in a brief clinic appointment (Fitzpatick et al, 1993). 
In order to see whether the questionnaire would be used during the consultation and 
whether it would highlight particular issues or influence doctor-patient' 
communication, a small observational study was conducted. This pilot of the INQoL 
as a clinical tool also enabled testing for feasibility in terms of time and ease of 
administration. 
12.2 Methods 
The practicality of using the INQoL as a clinical tool in routine clinical practice was 
assessed in the outpatient muscle clinics of two consultant neurologists in a small pilot 
study. Patients due to attend King's College Hospital for a consultation were 
contacted and invited to attend the clinic half an hour before their appointment in 
order to complete the questionnaire. The questionnaire was administered to 6 patients 
before their consultation. It was then scored and a graphical representation of the 
patients' profile of scores including overall QoL was passed onto the doctor at the 
beginning of the patients' consultation (see Appendix G). 
The consultation was tape recorded in order to capture all the issues discussed and to 
see whether the questionnaire influenced the consultation. 
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Patients were also briefly interviewed following their appointment. Specifically, they 
were asked whether they felt the questionnaire had influenced the consultation, in 
what way it had been influenced and how they felt the assessment fitted into their 
clinic visit. 
In order to determine ease of scoring and lucidity of the scoring scheme, the INQoL 
was also scored by a Consultant Neurologist and by a research assistant, both 
previously unfamiliar with the scoring system. 
12.3 Results 
12.3.1 Patients 
Six patients took part (5 M and 1 F). Four had a congenital NMD (e. g. muscular 
dystrophy) and two had inclusion-body myositis. 
12.3.2 Tape recorded consultations 
The INQoL profile was discussed in all six of the consultations, which varied 
considerably across the different patients depending on factors such as whether they 
were receiving treatment, whether they were working and their family situation. 
Issues of particular relevance to QoL that were captured in the questionnaire but were 
still either elicited by the consultant or brought up independently by the patient 
included practical problems such as difficulties in maintaining working activities. 
This was discussed in two of the consultations. Problems with transport (both public 
transport and driving) were discussed in three of the consultations. One patient 
mentioned fatigue as a significant factor in their decision to cut down on work. 
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The INQoL triggered discussion about psychosocial issues including confidence in 
going out and pursuing leisure activities, about independence and about social 
relationships. 
Wheelchairs and walking aids were discussed in two of the consultations and the 
INQoL was referred to in relation to the impact that this kind of intervention could 
have in terms of activities and independence. 
During the consultation one of the neurologists commented that symptom scores gave 
a good reflection of the individual clinical cases. Life domain scores and factors 
relating to symptoms and their impact on particular life domains were also discussed. 
It was remarked that the profile of scores would be of particular interest once the 
patient returned for a follow-up appointment and their INQoL profile compared with 
that of their last consultation. This would allow an evaluation of change in response 
to intervention and advice or as a result of any progression in the patient's muscle 
condition. 
12.3.3 Patients' comments following the consultation 
Patients believed that the questionnaire influenced the consultation positively in that it 
prompted them to mention concerns and issues not previously raised. They also liked 
that the questionnaire highlighted broader issues other than their physical well-being 
(e. g. emotional well-being and independence). One respondent mentioned that he 
would have liked to have been asked about more specific functional activities, such as 
staircases and obstacles. 
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The time taken to complete the measure before the consultation was believed to be 
acceptable. ' 
12.3.4 Scoring the INQoL 
The questionnaire took five minutes to score by hand. This was considered to be 
somewhat lengthy for the questionnaire to feasibly be incorporated into a busy clinic, 
unless there were someone available to score the questionnaire before the 
consultation. This would most likely require a member of staff employed specifically 
to administer and score the forms. 
As a result of this an Access database was developed to automatically score the 
questionnaire. With this database it takes approximately one minute to score each 
form. This should facilitate the incorporation of the scale into muscle clinics as the 
questionnaire could be easily scored and a printout of the patient's profile provided for 
use during the consultation and to be filed in patient notes for comparison with scores 
on follow-up consultations. 
12.4 Discussion 
The INQoL is the first QoL measure designed specifically to measure QoL in NMD. 
In the pilot study it was shown to represents individual patients' QoL and encourage 
discussion about the impact of symptoms upon broader areas of life and ways of 
addressing difficulties. 
Questions about more functional activities, as requested by one of the patients are best 
covered by disability scales such as the HAQ (Fries et al, 1980). 
In other specialities such as rheumatology (Guillemin, 2000) and oncology (Velikova 
et al, 1999) there has been increasing use of health status measures (including the 
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HAQ) in clinical practice. These measures are useful for indicating the impact of 
conditions like rheumatoid arthritis in which disease impact varies considerably and 
for which the treatment has varying degrees of effectiveness. Disability scales and 
QoL measures may also be useful in guiding clinical care and management in NMD 
given the progressive nature of these conditions, their disabling effects and the paucity 
of effective treatment. 
The clinical utility of questionnaires is hard to capture accurately and the actual 
practicality of QoL questionnaires in the UK neurology setting is uncertain. At the 
moment it is uncommon for outcome measures to be used in the clinic and therefore 
there are no resources and structures (e. g. staff, technology) available to support their 
use. 
The INQoL can be scored by hand which requires clinic staff to familiarise 
themselves with the scoring system. For the Access database scoring version the 
responses can be entered into a database and then the programme can score the 
questionnaire automatically. This requires the appropriate computer equipment and 
software and for there to be someone available to enter the data. Resources and 
facilities must therefore be in place before such questionnaires become commonplace 
in clinical consultations. Ultimately, there may be some kind of computerised 
interactive questionnaire that could be filled in directly by patients and scored 
automatically. This would result in a graphical representation of the QoL profile 
available to the doctor at the same visit that would facilitate comparisons across 
successive consultations. 
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12.4.1 Future work on clinical utility 
There is a need to test the utility of the INQoL in a larger study involving different 
outpatient departments to see whether it would fit into these differing systems and to 
assess the generalisability of the scale. This should be done over the period of at least 
a year to indicate whether QoL information benefits clinical care and whether changes 
in INQoL score provide useful information about the patient's condition and their 





Chapter 13: Discussions 
This project aimed to develop and validate a QoL questionnaire specific to NMD that 
would represent the impact of NMD in the context of individual patients' lives. 
Muscle diseases are much less common than chronic conditions such as arthritis, 
diabetes and asthma, for which there have been a proliferation of health status 
measures. However, the chronic and progressive nature of these disabling conditions 
makes quality of life a major goal in their treatment. The INQoL was therefore 
created to fill the need for a muscle disease-specific outcome measure that could be 
used in research and as a clinical tool. 
The clinimetric properties of the scale have been established through a rigorous 
validation process. This means that the measure can confidently be used alongside 
biological and functional measures to determine the effectiveness of treatment from 
the patients' perspective. 
The INQoL consists of 45 questions within 10 sections. Four of these focus on the 
impact of key muscle disease symptoms, five look at the impact of NMD on particular 
areas of life and one section asks about the effects of treatment. This results in a 
profile of ten scores, nine of which represent the sections of the INQoL and a 
composite score, based on scores from the five life domain. 
Two other scores can be derived from the treatment section. These represent patients' 
perceived treatment effects and expected treatment effects respectively. 
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13.1 Questionnaire development 
Semi-structured qualitative interviews allowed the investigation of all the areas of life 
that could potentially be influenced by NMD. This was followed by a postal survey 
that required patients to rate the degree to which particular areas of their lives are 
influenced by NMD. This verified the domains of life that were important to include 
in the questionnaire. Results from this survey enabled items to be selected on the 
basis of their importance to patients, thereby maximising the likelihood that the 
measure would accurately capture QoL. 
13.2 Implications of the study 
The INQoL represents individual patients' quality of life making it a useful measure 
of change in perceived symptom impact and also 
in specific areas of life. 
The INQoL has already demonstrated good construct validity but the clinimetric 
evaluation of the scale should continue as the questionnaire goes on to be used in 
different areas of research. This will further 
increase confidence in the significance of 
scores generated by the INQoL. 
The INQoL can also. be used as a clinical tool that could be used to highlight 
individual concerns and help monitor patients' progress and the effectiveness of 
intervention over time. 
Over time the way in which different interventions 
influence individual scores on the 
measure will become apparent. It 
is likely that physical, social and psychological 
interventions will each influence scores on the 
INQoL differently. For example, 
independence may improve following the acquisition of an electric wheelchair, and 
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psychological interventions (e. g. coping skills training, cognitive behavioural therapy) 
could improve emotional well-being, body image or social relationships. 
13.3 Limitations 
The INQoL demonstrated a good level of test-retest reliability. However, this may 
have been higher if not for some limitations in this part of the study. For example, the 
sample size was quite small, and a considerable number of respondents completed the 
scale at home on their second completion due to long distances involved in travelling 
to study appointments. If conditions had been more similar between test and retest, 
with a greater degree of control over the period between the two time points 
agreement between the scores is likely to have been better. 
It was also difficult to obtain a good idea of how responsive the scale is to change. 
Few patients receive treatment, and in those who do, there is often. uncertainty about 
how effective the treatment will be. In order to obtain a good idea of questionnaire 
responsiveness a large sample of patients should be studied over a prolonged period 
during which they are likely to demonstrate change. 
13.4 The way forward for the INQoL 
13.4.1 INQoL responsiveness 
Further work is needed to establish the responsiveness of the INQoL to clinically 
important change. Given the comparative rarity of NMD and the lack of effective 
treatment, the most appropriate forum for the investigation of scale responsiveness 
would be a large scale multicentre clinical trial, comparing reported change in QoL 
and traditional outcome measures (muscle strength, functional measures) with change 
on the INQoL. 
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As there were no large scale clinical trials taking place during the timescale of the 
project it was not possible to conduct a thorough investigation of responsiveness. 
However, there are plans to continue the validation of the INQoL in upcoming trials. 
These studies will also provide opportunities for cross-cultural validation of the 
INQoL (see sections 13.4.3 and 13.4.4). 
13.4.2 Module Questions 
Question two, which asks about `muscle locking' is one of the symptom questions that 
could be treated as an `add in' or `leave out' question, depending on the population of 
interest in a particular study. This question only has relevance for a small number of 
patients (specifically those patients with myotonia congenita or myotonic dystrophy). 
Its inclusion in the questionnaire is superfluous for many patients and may be 
confusing for those who do not experience this symptom. By turning this question 
into a module item, the responsiveness of the questionnaire might be enhanced. 
Similarly, the questionnaire could be adapted for use in other diseases by 
incorporating different symptom questions relevant to'the particular patient group of 
interest. 
13.4.3 Using INQoL in other chronic diseases 
The sound theoretical grounding and 
incorporation of importance ratings in the 
INQoL makes it likely that it could successfully be adapted for use in other chronic 
conditions. The symptom scales could be altered and the five major life domains 
maintained, as it is likely that these issues are 
influenced in numerous other chronic 
disabling conditions. There are already plans to extend the use of the INQoL to other 
neuromuscular conditions (myasthenia gravis and periodic paralysis). Extending its 
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use will involve revalidating the questionnaire to ensure the validity'of the dimensions 
and any individual symptom questions in these particular patient groups. 
13.4.4 Cross-cultural validation 
There are also plans to adapt the INQoL for use in other countries (specifically 
Holland, Italy, Germany and the USA). This would involve qualitative studies to 
investigate issues of importance to patients of other nationalities, which would 
indicate whether the content of the questionnaire should be adapted. Translation and 
back-translation of the questionnaire would ensure that adaptation into different 
languages leads to results that have similar meaning regardless of language (Guillemin 
et al, 1993; Bullinger et al, 1993). This would enable findings from different 
countries to be compared or collated for use in large-scale studies. 
13.4.5 INQoL Clinical Utility 
The pilot study of the INQoL in a clinical setting indicated its usefulness in 
highlighting individual problems and promoting discussion between doctor and 
patient about quality of life issues. Its clinical utility should 
be investigated further in 
a variety of hospitals to ensure its applicability within 
different systems. This will 
increase the weight that can be invested in the significance of INQoL scores in the 
clinical setting. 
As clinicians become more familiar with the scale and the meaning of INQoL scores, 
its useful application will increase. For example, 
INQoL scores could be used to 
support the provision of resources for 
health care strategies or encourage funding of 
research into the physical, social and psychological well 
being of NMD patients. 
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13.4.6 Other areas of research 
13.4.6.1 Proxy measures and carer QoL 
There are several other respondent groups in which QoL assessment could be of 
considerable value. 
For example, the measurement of caregiver QoL also deserves greater attention. It has 
been documented in other conditions including motor neurone disease (MND) that 
caregivers' QoL can be negatively influenced (Jenkinson et al, 2000; Bromberg and 
Forshew, 2002). 
Individualised measures such as the SEIQoL and the PGI may prove useful in 
capturing caregiver QoL. Furthermore, measures taken to ameliorate burden may 
improve QoL for both patient and carer. 
13.4.6.2 Children 
A QoL measure specifically for use in children with NMD is also lacking. However, 
the adaptation of the INQoL for children would not be appropriate as the QoL concept 
differs considerably between children and adults (Rosenbaum et al, 1990). Illness 
influences the child's development, and the issues of relevance to children differ 
considerably from those that are important to adults (Hanai, 1996). QoL assessment 
in children must be therefore be approached in a different way. A thorough 
investigation of the impact of NMD in children followed by observational studies of 
the resultant measure's acceptability and appropriateness would have to be conducted 
alongside validation studies. It is also advisable to develop different measures for 
different age groups and to adopt different administration methods according to age 
(e. g. interview vs. self completion) (Christie et al, 1993). Proxies including parents, 
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schoolteachers and physicians may also provide useful information to complement 
QoL reports elicited from children (Hoare and Russell, 1995; Finkelstein 1998). 
13.4.6.3 The use of technology in QoL assessment 
The routine assessment of QoL in research and clinical practice could be facilitated by 
the use of technology (Guillemin, 2000). Not only can questionnaires be scored using 
database packages, but questionnaire responses could also be scanned directly into a 
computer and automatically scored. 
Interactive technology including touch-screen programs and internet access to 
questionnaires may also facilitate the assessment of QoL in the future. Responses to 
QoL measures could also be registered over the telephone, using the key pad to 
respond to automated questionnaire items. 
The popularity and applicability of these methods remain to be tested. If they prove to 
be feasible they would facilitate data collection, allowing easy access to greater 
numbers of patients and for ongoing monitoring of QoL over time. 
13.5 The future of QoL assessment 
Dramatic developments in health care have led to increased emphasis on improving 
care for the chronically ill or disabled. 
The assessment of QoL in clinic and the implications of this assessment necessitates 
changes to the clinical consultation as well as the treatment and follow-up of patients. 
It may also challenge the role of the clinician. Where before the doctor's role has 
predominantly involved treating physical ailments, the assessment of QoL and the 
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ultimate goal of improving QoL necessitates addressing broader social and 
psychological issues. 
Some may believe this to be an intrusion into matters that are not the concern of the 
physician. It would therefore be necessary to conduct studies to determine patients' 
attitudes towards such changes as well as the practicality and economic feasibility of 
any change. 
Such a shift in healthcare provision would be likely to involve changing from a 
doctor-centred system to one involving more multidisciplinary teamwork, changes 
that are already apparent in many healthcare departments (e. g. stroke rehabilitation, 
diabetes care, addiction services). These teams might involve specialist nurses, 
occupational therapists, physiotherapists, psychologists and other health professionals 






Chapter 14: Conclusions 
" Quality of life is a complicated concept that can best be defined as the distance 
between an individual's current state and the state to which they aspire. 
" NMD patients are influenced in all major aspects life, from their activities and 
independence to their emotional well being. 
" NMD symptoms (e. g. weakness and fatigue) underlie many of the problems 
experienced in these life areas. 
" The INQoL was designed based upon patients' experiences of NMD and a 
theoretical model of QoL. It thereby provides an idea of symptom impact and the 
influence of NMD upon major areas of life. The INQoL should therefore help to 
target treatment towards specific needs and in monitoring specific symptoms and 
their influence upon specific areas of life. 
" The Individualised Neuromuscular Disease Quality of Life (INQoL) questionnaire 
is a valid and reliable measure of QoL in NMD. 
" Early indications of INQoL responsiveness should be confirmed in larger studies 
involving patients in receipt of treatment. 
" Early findings indicate the usefulness of the INQoL as a clinical tool that can be 
used to highlight individual problems and monitor patients' progress. Further work 
should be conducted to establish its utility in a variety of clinical settings. 
" Future studies should include cross-cultural validation of the INQoL and the 
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Appendix A: Coding scheme for qualitative interview study 
Physical Symptoms 
P- B (Bladder problems) 
P- D (Discomfort) 
P- F (Fatigue) 
P- P (Pain) 
P- S (Other symptoms) 






DA- E (Eating) 
DA- D (Driving) 
DA- F (Falling) 
DA- G (General) 
DA- H (Housework, include cooking) 
DA- ML (Mobility-lower body e. g. standing up, walking, climbing stairs) 
DA- MU (Mobility- upper body e. g. gripping, lifting)) 
DA- SC (Self Care e. g. washing, dressing, toileting) 
DA- T (Transport) 
Leisure Activities. 
LA- G (General) 
LA- Gar (Gardening) 
LA- H (Holidays) 
LA- Q (Quiet activities, e. g. reading, knitting) 
LA- S (Sport) 
Employment(Work) 
W- C (Change/adaptation in work) 
W- G (General) 
W- P (Future propsects) 
W- S (Stopping) 
W- WP (Working practices) 
Financial Matters (Money) 
M- W (Related to employment/work) 
M- G (General) 




E- A (Annoyance/irritation) 
E- Ang (Anger) 
E- Anx (Anxiety) 
E- C (Confusion) 
E- D '(Depression) 
E- F (Frustration) 
E- G (General) 
E- I (Feelings of isolation) 
E- LC (Loss of confidence) 
E- U (Upset/sadness) 
Self-perception 
SP- G (General) 
SP- P (Physical) 
Dependence/Independence 
I- D (Desire for more independence/ to maintain independence) 
I- L (Feelings of loss) 
Dep (Dependence on others) 
Future. 
Fut- G (General) 
Fut- Par (Parenting) 




S- E (Embarrassment) 
S- OP (Other peoples perceptions) 




SA-E (Eating out) 
SA-G (General social outings) 
SA-S (Shopping) 
SA-V (Visiting friends/family) 
Social Relationships 
SR- F (Friends) 
SR- G (General) 
SR- W (Work collegues) 
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Family 
F- A (Family Activities, e. g. outings, visits) 
F- E (Emotional upset of family members) 
F- P (Parenting) 




Relationship with Partner/Spouse. 
RP- E (Emotional upset of partner/spouse) 
RP- G (General) 
RP- S (Sex life) 
General Effect. 
GE 
GE- S' (Slowed down) 
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Appendix B: Postal Questionnaire (version 1) 
Quality of Life in Adult Neuromuscular Disease. 
Postal Questionnaire. 
This questionnaire has been designed to assess which areas of your life are 
affected by your muscle condition, to what extent you are affected and how 
important these effects are to you. 
By understanding these effects, doctors will have a greater understanding of the 
problems muscle disease causes, enabling them to work towards more effective 
care and treatment to meet the needs of each individual. 
INSTRUCTIONS FOR FILLING IN QUESTIONNAIRE. 
ere are twelve questions to be completed in this questionnaire. These will require you to 
lace a tick in the box that indicates your response. 
(EXAMPLE QUESTION. 
ou do not need to answer this question 
Is your ability to complete household tasks (e. g. washing up, cleaning, dusting) affected by 
tour muscle condition ? 
slightly I moderately I quite a lot 
IF IT IS NOT AFFECTED, PLEASE GO TO THE NEXT QUESTION. 
) If your ability to complete household tasks is affected, overall is this effect : 
Good F1 Bad Other (Please specify 
ýC) How important to you is the effect of your muscle condition on your ability to complete 
household tasks? 











SECTION A: - ACTIVITIES. 
This first group of questions has been designed to assess the impact of your muscle 
disease on your activities. You will be asked about: 
a) Your day to day activities (e. g. washing, dressing, eating, getting around) 
b) Your working life (e. g. employment status, working practices, the money you earn) 
c) Your social and leisure activities 
Question 1 
a) Are your daily activities affected by your muscle condition? 
not at all slightly moderately quite a lot verymuch 
IF THEY ARE NOT AFFECTED, PLEASE GO TO QUESTION 2 
b) If your daily activities are affected, overall is this effect: 
Good F] Bad Q Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon your daily 
activities? 
not at all 
important 
quite important moderately 
important 
very important extremely 
important 
Question 2 
a) Is your working life affected by your muscle condition? (For example, 
employment status, working practices, the money you earn) 
IF THIS QUESTION DOES NOT APPLY TO YOU (FOR EXAMPLE, IF YOU ARE RETIRED) TICK THIS BOX 
AND GO TO QUESTION 3. 
not at all slightly moderately quite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO QUESTION 3 
b) If your working life is affected, overall is this effect : 
Good F1 Bad Other (Please specify______________ ) 
c) How important is this effect to you? 
not at all 
important 
quite important moderately 
important 




a) Are your social and leisure activities affected by your muscle condition? 
not at all slightly moderately quite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO THE ADDITIONAL COMMENTS SECTION, JUST BEFORE 
SECTION B 
b) If your social and leisure activities are affected, overall is this effect: 
Good Bad Q Other (Please specify____--) 
Q 
c) How important to you is the effect of your muscle condition upon your social and 
leisure activities? 











Please use this space if you would like to note down any additional comments about 
how your muscle condition affects any of your day to day, work, or social and 
leisure activities . 
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SECTION B: - RELATIONSHIPS AND SOCIAL INTERACTION. 
This next group of questions has been designed to find out about the impact of your muscle 
condition upon your relationships with other people. You will be asked about: 
a) Your relationships with friends 
b) Your relationships with family members 
c) Your relationship with your partner/spouse 
d) Your contact with other people in general (e. g. with strangers, acquaintances and 
colleagues). 
Question 4 
a) Are your relationships with your friends affected by your muscle condition? 
not at all slightly moderately quite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO QUESTION 5 
b) If your relationships with your friends are affected, overall is this effect: 
Good Q Bad Q Other (Please specify______________ )Q 
c) How important to you is the effect of your muscle condition upon your 
relationships with your friends? 
not at all 
important 
quite important moderately 
important 
very important extremely 
important 
Question 5 
a) Are your family relationships affected by your muscle condition? 
not at all slightly moderately quite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO QUESTION 6 
b) If your family relationships are affected, overall is this effect: 
)Q Good Q Bad Q Other (Please specify______________ 
c) How important to you is the effect of your muscle condition upon your family 
relationships? 
not at all 
important 
quite important moderately 
important 




a) Is your relationship with your partner/spouse affected by your muscle condition? 
IF THIS QUESTION DOES NOT APPLY TO YOU TICK THIS BOX 
Q 
AND GO TO QUESTION 7. 
not at all slightly moderately quite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO QUESTION 7 
b) If your relationship with your partner/spouse is affected, overall is this effect: 
Good Q Bad Q Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon your 
relationship with your partner/spouse? 
not at all 
important 
quite important moderately 
important 
very important extremely 
important 
Question 7 
a) Is your day to day contact with other people (e. g. how you get along with 
strangers, acquaintances, colleagues) affected by your muscle condition? 
not at all slightl moderatel uite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO THE COMMENTS SECTION, JUST BEFORE SECTION C. 
b) If your day to day contact with other people is affected, overall is this effect: 
Good Q Bad Q Other (Please specify_______________ )Q 
c) How important to you is the effect of your muscle condition upon your day to day 
contact with other people? 
not at all 
important 
quite important moderately 
important 




Please use this space if you would like to note down any additional comments about how 
your muscle condition affects any of your relationships, or your contact with other people 
in general. 
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SECTION C: - PERSONAL FEELINGS. 
This next group of questions, starting on the following page has been designed to find out about 
the impact of your muscle condition upon your personal feelings about yourself and about the 
future. You will be asked about: 
a) Your independence 
b) Your emotions 
c) Your feelings about your physical appearance 
d) Your feelings about the future 
Question 8 
a) Is your independence affected by your muscle condition? 
not at all slightly moderately quite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO QUESTION 9 
b) If your independence is affected, overall is this effect: 
Good Q Bad Q Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon your 
independence? 
not at all 
important 
quite important moderately 
import tn 
very important extremely 
important 
Question 9 
a) Does your muscle condition affect how you feel emotionally? 
not at all sliP-htl moderatel uite a lot very much 
IF YOU ARE NOT AFFECTED, PLEASE GO TO QUESTION 10 
b) If you are affected emotionally, overall is this effect: 
Good F1 Bad Other (Please specify______________ ) 
c) How important to you is the effect of your muscle condition upon how you feel 
emotionally? 
not at all 
important 
quite important moderately 
important 




a) Does your muscle condition affect how you feel about the way you look? 
not at all slightly moderately quite a lot very much 
IF YOU ARE NOT AFFECTED, PLEASE GO TO QUESTION 11 
b) If how you feel about the way you look is affected, is this effect: 
Good Q Bad Q Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon how you feel 
about the way you look? 
not at all 
important 
quite important moderately 
important 
very important extremely 
important 
Question 11 
a) Is your idea of the future affected by your muscle condition? 
not at all sli g ti moderate] uite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO THE COMMENTS SECTION, JUST BEFORE SECTION D. 
b) If your idea of the future is affected, is this effect: 
Good Q Bad Q Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon your idea of the 
future? 
not at all 
important 
quite important moderately 
important 




Please use this space if you would like to note down any additional comments about how 
your muscle condition affects how you feel about yourself in terms of your independence, 
your emotions, the way you look, or your idea of the future. 
0 
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SECTION D: - TREATMENT. 
This question is designed to find out about how the treatment you receive for your 
muscle condition affects your life. 
Question 12A 






IF "YES", GO TO QUESTION 12B 
IF "No", GO TO QUESTION 12C 
Question 12B 
a) Does the treatment you receive for your muscle condition have any good effects? 
none at all some moderate uite a lot man 
IF IT DOES NOT HAVE ANY GOOD EFFECTS, PLEASE GO TO PART (C) OF THIS QUESTION 
b) How important to you are the good effects of the treatment for your muscle 
condition? 
not at all 
important 
quite important moderately 
im ortant 
very important extremely 
important 
a) Does the treatment you receive for your muscle condition have any bad effects? 
none at all some moderate quite a lot many 
IF IT DOES NOT HAVE ANY BAD EFFECTS, PLEASE GO TO THE "ADDITIONAL COMMENTS" SECTION 
(TOP OF NEXT PAGE) 
b) How important to you are the bad effects of the treatment for your muscle 
condition? 
not at all 
important 
quite important moderately 
important 




Please use this space if you would like to note down any additional comments about 
how the treatment for your muscle condition affects your life. 
Question 12C. 
PLEASE ONLY ANSWER THIS QUESTION IF YOU DO NOT RECEIVE TREATMENT FOR YOUR 
CONDITION. 
a) For what reason don't you receive treatment for your muscle condition? 
There is no treatment for my muscle condition 
Q 
The treatment I received in the past did not work 
Q 
Stopped treatment because of side effects 
Q 
Other (Please specify, )Q 
b) How does not receiving treatment for your muscle condition make you feel? 
PLEASE WRITE IN THE SPACE BELOW 
PLEASE TURN OVER 
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Section E: Additional Comments. 
Please use this space if you would like to note down any other ways in which you feel 
your muscle condition affects your life, or any additional comments you would like to 
make. 
PLEASE MAKE SURE YOU HAVE COMPLETED ALL PARTS OF THE 
QUESTIONNAIRE THAT APPLY TO YOU AND THEN FILL IN THE DETAILS BELOW. 
Today's Date: 
Date of birth: 
Sex: Male Q Female Q 
What sort of muscle condition do you have (if known) : 
How long have you had this muscle condition: 
Who do you see about your muscle condition? 
A specialist 
A GP (General practitioner) 




Thank you very much for your time. 
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Appendix C: Postal Questionnaire (final version) 
Quality of Life in Adult Neuromuscular Disease. 
Postal Questionnaire. 
This questionnaire has been designed to assess which areas of your life are 
affected by your muscle condition, to what extent you are affected and how 
important these effects are to you. 
By understanding these effects, doctors will have a greater understanding of the 
problems muscle disease causes, enabling them to work towards more effective 
care and treatment to meet the needs of each individual. 
RNSTRUCTIONS FOR FILLING IN QUESTIONNAIRE. 
ere are twelve questions to be completed in this questionnaire. These will require you to 
lace a tick in the box that indicates your response. 
[EXAMPLE QUESTION. 
You do not need to answer this question 
) Is your ability to complete household tasks (e. g. washing up, cleaning, dusting) affected by 
our muscle condition ? 
IF IT IS NOT AFFECTED, PLEASE GO TO THE NEXT QUESTION. 
P) If your ability to complete household tasks is affected, overall is this effect : 
Good Bad F7l Other (Please specify______) [7] 
ýC) How important to you is the effect of your muscle condition on your ability to complete 
household tasks? 











SECTION A: - ACTIVITIES. 
This first group of questions has been designed to assess the impact of your muscle 
disease on your activities. You will be asked about: 
a) Your day to day activities (e. g. washing, dressing, eating, getting around) 
b) Your working life (e. g. employment status, working practices, the- money you earn) 
c) Your social and leisure activities 
Question 1 
a) Are your daily activities affected by your muscle condition? 
not at all slip-htl moderatel uite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO QUESTION 2 
b) If your daily activities are affected, overall is this effect: 
)Q Good Q Bad El Other (Please specify______________ 
c) How important to you is the effect of your muscle condition upon your daily 
activities? 
not at all 
important 
quite important moderately 
im ortant 
very important extremely 
important 
Question 2 
a) Is your working life affected by your muscle condition? (For example, 
employment status, working practices, the money you earn) 
IF THIS QUESTION DOES NOT APPLY TO YOU (FOR EXAMPLE, IF YOU ARE RETIRED) TICK THIS BOXE] 
AND GO TO QUESTION 3. 
not at all slightly moderately quite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO QUESTION 3 
b) If your working life is affected, overall is this effect : 
Good Bad Other (Please specify 
c) How important is this effect to you? 
not at all 
important 
quite important moderately 
important 




a) Are your social and leisure activities affected by your muscle condition? 
not at all slightly moderately quite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO THE ADDITIONAL COMMENTS SECTION, JUST BEFORE 
SECTION B 
b) If your social and leisure activities are affected, overall is this effect: 
Good Bad F] Other (Please specify______-----) 
Q 
c) How important to you is the effect of your muscle condition upon your social and 
leisure activities? 











Please use this space if you would like to note down any additional comments about 
how your muscle condition affects any of your day to day, work, or social and 
leisure activities . 
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SECTION B: - RELATIONSHIPS AND SOCIAL INTERACTION. 
This next group of questions has been designed to find out about the impact of your muscle 
condition upon your relationships with other people. You will be asked about: 
a) Your relationships with friends 
b) Your relationships with family members 
c) Your relationship with your partner/spouse 
d) Your contact with other people in general (e. g. with strangers, acquaintances and 
colleagues). 
Question 4 
a) Are your relationships with your friends affected by your muscle condition? 
not at all sliQhtl moderatel uite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO QUESTION 5 
b) If your relationships with your friends are affected, overall is this effect: 
Good Q Bad Q Other (Please specify______________ )Q 
c) How important to you is the effect of your muscle condition upon your 
relationships with your friends? 
not at all 
important 
quite important moderately 
important 
very important extremely 
important 
Question 5 
a) Are your family relationships affected by your muscle condition? 
not at all sliehtl moderatel uite a lot very much 
IF THEY ARE NOT AFFECTED, PLEASE GO TO QUESTION 6 
b) If your family relationships are affected, overall is this effect: 
Good Q Bad F1 Other (Please specify ) 
c) How important to you is the effect of your muscle condition upon your family 
relationships? 
not at all 
important 
quite important moderately 
important 




a) Is your relationship with your partner/spouse affected by your muscle condition? 
IF THIS QUESTION DOES NOT APPLY TO YOU TICK THIS BOX AND GO TO QUESTION 7. 
not at all Slightly moderately quite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO QUESTION 7 
b) If your relationship with your partner/spouse is affected, overall is this effect: 
Good Q Bad Q Other (Please specify______________ )Q 
c) How important to you is the effect of your muscle condition upon your 
relationship with your partner/spouse? 
not at all 
important 
quite important moderately 
im ortant 
very important extremely 
important 
Question 7 
a) Is your day to day contact with other people (e. g. how you get along with 
strangers, acquaintances, colleagues) affected by your muscle condition? 
not at all slip-htl moderatel uite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO THE COMMENTS SECTION, JUST BEFORE SECTION C. 
b) If your day to day contact with other people is affected, overall is this effect: 
Good Bad Q Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon your day to day 
contact with other people? 
not at all 
important 
quite important moderately 
important 




Please use this space if you would like to note down any additional comments about how 
your muscle condition affects any of your relationships, or your contact with other people 
in general. 
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SECTION C: - PERSONAL FEELINGS. 
This next group of questions, starting on the following page has been designed to find out about 
the impact of your muscle condition upon your personal feelings about yourself and about the 
future. You will be asked about: 
a) Your independence 
b) Your emotions 
c) Your feelings about your physical appearance 
d) Your feelings about the future 
Question 8 
a) Is your independence affected by your muscle condition? 
not at all sliehtl moderatel uite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO QUESTION 9 
b) If your independence is affected, overall is this effect: 
Good F] Bad Other (Please specify )Q 
c) How important to you is the effect of your muscle condition upon your 
independence? 
not at all 
important 
quite important moderately 
im ortant 
very important extremely 
important 
Question 9 
a) Does your muscle condition affect how you feel emotionally? 
not at all slightly moderately uitl eal°t very much 
IF YOU ARE NOT AFFECTED, PLEASE GO TO QUESTION 10 
b) If you are affected emotionally, overall is this effect: 
Good M Bad F1 Other (Please specify ) 
c) How important to you is the effect of your muscle condition upon how you feel 
emotionally? 
not at all 
important 
quite important moderately 
important 




a) Does your muscle condition affect how you feel about the way you look? 
not at all slightly moderately quite a lot very much 
IF YOU ARE NOT AFFECTED, PLEASE GO TO QUESTION 11 
b) If how you feel about the way you look is affected, is this effect: 
)Q Good M Bad Other (Please specify_______________ 
c) How important to you is the effect of your muscle condition upon how you feel 
about the way you look? 
not at all 
important 
quite important moderately 
import ant 
very important extremely 
important 
Question 11 
a) Is your idea of the future affected by your muscle condition? 
not at all sliehtl moderatel uite a lot very much 
IF IT IS NOT AFFECTED, PLEASE GO TO THE COMMENTS SECTION, JUST BEFORE SECTION D. 
b) If your idea of the future is affected, is this effect: 
Good Q Bad Q Other (Please specify______________ )Q 
c) How important to you is the effect of your muscle condition upon your idea of the 
future? 
not at all 
important 
quite important moderately 
important 




Please use this space if you would like to note down any additional comments about how 
your muscle condition affects how you feel about yourself in terms of your independence, 
your emotions, the way you look, or your idea of the future. 
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SECTION D: - TREATMENT. 
This question is designed to find out about how the treatment you receive for your 
muscle condition affects your life. 
Question 12A 






IF "YES", GO TO QUESTION 12B 
IF "No", GO TO QUESTION 12C 
Question 12B 
a) Does the treatment you receive for your muscle condition have any good effects? 
none at all some moderate uite a lot man 
IF IT DOES NOT HAVE ANY GOOD EFFECTS, PLEASE GO TO PART (C) OF THIS QUESTION 
b) How important to you are the good effects of the treatment for your muscle 
condition? 
not at all 
important 
quite important moderately 
im ortant 
very important extremely 
important 
a) Does the treatment you receive for your muscle condition have any bad effects? 
none at all some moderate quite a lot many 
IF IT DOES NOT HAVE ANY BAD EFFECTS, PLEASE GO TO THE "ADDITIONAL COMMENTS" SECTION 
(TOP OF NEXT PAGE) 
b) How important to you are the bad effects of the treatment for your muscle 
condition? 
not at all 
important 
quite important moderately 
important 




Please use this space if you would like to note down any additional comments about 
how the treatment for your muscle condition affects your life. 
Question 12C. 
PLEASE ONLY ANSWER THIS QUESTION IF YOU DO NOT RECEIVE TREATMENT FOR YOUR 
CONDITION. 
a) For what reason don't you receive treatment for your muscle condition? 
There is no treatment for my muscle condition Q 
The treatment I received in the past did not work Q 
Stopped treatment because of side effects Q 
Other (Please specify_ )Q 
b) How does not receiving treatment for your muscle condition make you feel? 
PLEASE WRITE IN THE SPACE BELOW 
PLEASE TURN OVER 
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Section E: Additional Comments. 
Please use this space if you would like to note down any other ways in which you feel 
your muscle condition affects your life, or any additional comments you would like to 
make. 
PLEASE MAKE SURE YOU HAVE COMPLETED ALL PARTS OF THE 
QUESTIONNAIRE THAT APPLY TO YOU AND THEN FILL IN THE DETAILS BELOW. 
Today's Date: // 
Date of birth: 
Sex: Male Q Female Q 
What sort of muscle condition do you have (if known) : 
How long have you had this muscle condition: 
Who do you see about your muscle condition? 
A specialist 
A GP (General practitioner) 




Thank you very much for your time. 
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Appendix D: First Version of the INQoL before piloting 
HOW YOUR MUSCLE CONDITION AFFECTS YOU 
his questionnaire is designed to see how your muscle condition affects you. 
'ou will be asked about your symptoms, how bad you feel they are, and how 
'ou expect treatment, if you receive any, to affect your symptoms. 
'ou will then be asked how each symptom affects your activities, relationships 
end your emotions. 
"here will be a section on how you feel about your physical ability, your 
elationships and your emotions in relation to how you would like them to be. 
he last section will ask about any side effects you have had or expect to have 
lue to treatment. 
he information you provide will help doctors to understand your problems. 
his will mean they can work towards better care and treatment*for you. 
fo answer the questions either tick boxes or to circle a number from 0 to 10. 
=or the 0-10 scale questions '0' indicates no effect, and 10' indicates the 
ireatest effect. 
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QUESTION 1: - THE WEAKNESS OF YOUR MUSCLES 
This set of questions will ask you about any weakness you have due to your 
muscle condition and how much it affects the different areas of your life. 
By weakness we mean muscle weakness affecting not only your legs and arms 
but other muscles such as the those affecting your grip, swallowing, eyes and 
face, bladder and bowel control, etc. 
1A a) Have you had any weakness over the last two weeks as a result of 
your muscle condition? 
NO 
YES 
-º PLEASE GO TO QUESTION 2 (PAGE 4). 
Z 
b) How bad has this weakness been over the last two weeks? 
PLEASE CIRCLE ONE NUMBER 





1c) How do you expect treatment to affect your muscle weakness? 
Tick here if you do not receive treatment for your muscle condition at the moment 0 
PLEASE TICK ONE BOX 
It will have no effect on my muscle weakness 
It will slow down the progression of my weakness 
It will stop the progression of my weakness 
It will improve my strength 
It will completely bring back my strength 
I have not thought about it 
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I B. THE THINGS YOU DO 
Has your muscle weakness made the following activities difficult, over the 
last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all 
Daily activities 01 
(for example, washing, 
dressing & housework) 
Work activities 01 
Please tick if you are 
unemployed/retired at the 
moment Q 
Leisure activities 01 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all 
1C. YOUR RELATIONSHIPS WITH OTHER PEOPLE 
Has your muscle weakness made relationships with the following people 
difficult over the last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all 
Partner/ spouse 01 
Please tick if not applicable 
Other family 01 
Friends 01 
Other people 0 
(for example colleagues 
much 
01 
acquaintances & strangers) 
I D. HOW YOU FEEL 






























QUESTION 2: - THE STIFFNESS/ `LOCKING' OF YOUR MUSCLES. 
This set of questions will ask you about any muscle stiffness/ `locking' of your 
muscles you have due to your muscle condition. You will then be asked how 
much this affects the different areas of your life. 
2A a) Have you had any stiffness/ 'locking' of your muscles over the last 
two weeks as a result of your muscle condition? 
NO 
YES 
PLEASE CIRCLE ONE NUMBER 
-0 PLEASE GO TO QUESTION 3 (PAGE 
6). 
Z 








How do you think treatment will affect the stiffness/ `locking' of your 
muscles? 
Tick here if you do not receive treatment for your muscle condition at the moment 
Q 
PLEASE TICK ONE BO) 
It will have no effect upon the stiffness/ 'locking' of my muscles 
It will slow down any increase in the stiffness/ `locking' of my muscles 
It will stop the stiffness/ 'locking' from becoming worse 
It will partly relieve the stiffness/ 'locking' of my muscles 
It will completely relieve the stiffness/ 'locking' of my muscles 
r have not thought about it 
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2A. THE THINGS YOU DO 
Has the stiffness/ `locking' of your muscles made the following activities 
difficult, over the last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all Very much 
Daily activities 0123456789 10 
(for example, washing, 
dressing & housework) 
Work activities 0123456789 10 
Please tick if you are 
unemployed/retired at the 
moment Q 
Leisure activities 23456789, '10 
2B. YOUR RELATIONSHIPS WITH OTHER PEOPLE 
Has the stiffness/ `locking' of your muscles made relationships with the 
following people difficult over the last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all Very much 
Partner/spouse 01 2' 3 4` 5 '6.7 89 ""'10, 
Please tick if not applicable 
Other family 0-1.2. ,3 4',, 5.6 
7' .89' 10 
Friends 0123456789 10 
Other people 01234567,8 9 10 
(for example colleagues 
acquaintances & strangers) 
2D. HOW YOU FEEL 
Over the last 2 weeks has the stiffness/ `locking' of your muscles made 
you feel: 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 






Depressed 0123456789 10 
Frustrated 012345 6' 789 10 
Low in confidence/ 0123456789 10 
self-esteem 
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QUESTION 3. - YOUR PAIN 
This set of questions will ask you about any pain you have due to your muscle 
condition and how much this affects the different areas of your life. 




-10 PLEASE GO TO QUESTION 4 (PAGE 8). 
Z 
b) How bad has this pain been over the last two weeks, on a scale of 
one to ten? 




c) How do you think treatment will affect your pain? 
Tick here if you do not and will not soon receive treatment for your muscle condition 
pain 
0 
PLEASE TICK ONE B0) 
It will have no effect on my pain 
It will slow down any increase in my pain 
It will stop my pain from getting worse 
It will partly relieve my pain 
It will completely relieve my pain 
L have not thought about it 
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3B. THE THINGS YOU DO 
Has your pain made the following activities difficult, over the last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all 
56789 10 
Daily activities 0123456789 10 
(for example, washing, 
dressing & housework) 
Work activities 1, ' 2, ; "3' "r" 4,, '56 "" 789, '10 ý 
Please tick if you are 
unemployed/retired at the 
moment Q 
Leisure activities 12 
3C. YOUR RELATIONSHIPS WITH OTHER PEOPLE 
Has your pain made relationships with the following people difficult over the 
last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all 
Partner/ spouse 01 




(for example colleagues 









3D. HOW YOU FEEL 
Over the last 2 weeks has your pain made you feel: 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 






Anxious/worried 01234567 8' 9' 10 
Depressed 0 1,2' 345 6' 789 10 
Frustrated 012 3456 789 10 
Low in confidence/ 0123456789 10' 
self-esteem 
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QUESTION 4: - HOW TIRED YOU FEEL 
This set of questions will ask you about any tiredness/fatigue you have due to 
your muscle condition and how much this affects the different areas of your 
life. 
4A a) Have you felt tired/fatigued over the last two weeks as a result of 
your muscle condition? 
NO 
YES 
-º PLEASE GO TO QUESTION 5 (PAGE 10). 
Z 
b) How bad has your tiredness/fatigue been over the last two weeks, 
on a scale of one to ten? 
PLEASE CIRCLE ONE NUMBER 
No 
fatigue 
c) How do you think treatment will affect your tiredness/fatigue? 
Tick here if you do not and will not soon receive treatment for your muscle condition 
No effect upon my fatigue 
Slow down any increase in my fatigue 
Stop my fatigue from becoming worse 
Increase the energy I have 
Completely bring back my energy 




PLEASE TICK ONE BOJ 
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4B. THE THINGS YOU DO. 
Has your tiredness/fatigue made the following activities difficult, over the last 
two weeks? 
Daily activities 0123456789 10 
(for example, washing, 
dressing & housework) 
Work activities 0123456789 10 
Please tick if you are 
unemployed/retired at the 
moment Q 
Leisure activities 0123456789 10 
4C. YOUR RELATIONSHIPS WITH OTHER PEOPLE 
Has your tiredness/fatigue made your relationships with the following people 
difficult over the last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all Very much 
Partner/ spouse 01 2 34 567,8 '9. ý'10- 
Please tick if not applicable 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all Very much 
0 
Other family 012 ý. 10 
Friends 012345" '6 789 10 
Other people 
(for example colleagues 
acquaintances & strangers) 
4D. HOW YOU FEEL 
Over the last 2 weeks has your tirednessifatigue made you feel: 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 




Anxious/worried 0 1' 23`45 '6 789 10, 
Depressed 0123456789 , 
10 
Frustrated 012345678: 9 10, - 




QUESTION 5: - THE WAY YOU LOOK 
This set of questions will ask you whether your muscle condition affects the 
way your look. and how much this affects the different areas of your life. 
5A a) Does your muscle condition affect the way you look? 
NO 
YES 
-10 PLEASE GO TO QUESTION 6 (PAGE 12). 
Z 
b) How badly has your muscle condition affected the way you look over 
the last two weeks? 







C) How do you think treatment will affect the way you look? 
Tick here if you do not and will not soon receive treatment for your muscle condition 
Q 
PLEASE TICK ONE BO) 
It will have no effect upon the way I look 
It will slow down the effects of my muscle condition upon the way I look 
It will stop any further effects of my muscle condition upon the way I 
look 
It will improve the way I look 
It will greatly improve the way I look 
I have not thought about it 
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5B. THE WAY YOU LOOK. 
Has the way you look made the following activities difficult, over the last two 
weeks? _ PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all Very much 
Daily activities 0123456789 10 
(for example, washing, 
dressing & housework) 
Work activities 0123456789 10 
Please tick if you are 
unemployed/retired at the 
moment Q 
Leisure activities 0123- 4' 56 7' 89 10 
5C. YOUR RELATIONSHIPS WITH OTHER PEOPLE 
Has the way you look made relationships with the following people difficult 
over the last two weeks? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at all Very much 
Partner/ spouse 0 ý1ý;. 234 56 789 ý10 
Please tick if not applicable 
0 
Other family 0123456789 10 
Friends 012 '3 456789 10 
Other people 0123456789 10 
(for example colleagues 
acquaintances & strangers) 
5D. HOW YOU FEEL 
Over the last 2 weeks has the way you look made you feel: 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 







Frustrated 012,3 45`6789 10 
Low in confidence/ 0123456789 10 
self-esteem 
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QUESTION 6: YOUR EXPECTATIONS 
6A a) My ability to do all the things I want to do is: 
PLEASE CIRCLE ONE NUMBER 
0123456,7 89 10 
Exactly 
as I want 
it to be 
b) How important is this to you: 




012345678 9' 10 
Not 
important 
6B a) My relationships with other people are: 
PLEASE CIRCLE ONE NUMBER 
012345 
Exactly 
as I want 
them to be 
b) How important is this to you? 




6C a) The way I feel emotionally is 












as I want 
it to be 
b) How important is this to you? 










6D a) My level of independence is 
PLEASE CIRCLE ONE NUMBER 
Exactly 
as I want 
it to be 
b) How important is this to you? 














-º PLEASE GO TO THE NEXT PAGE 
(PAGE 14). 
-1 




PLEASE LIST ANY PROBLEMS YOU HAVE HAD WITH YOUR TREATMENT 
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PLEASE LIST ANY PROBLEMS YOU EXPECT TO HAVE WITH TREATMENT 
Comments 
If you have any comments you would like to make about your condition and the way 
it affects you, please use the space below. 
THANK YOU VERY MUCH FOR YOUR HELP 
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Appendix E: Individualised Neuromuscular Quality of Life Questionnaire (INQoL) 
HOW YOUR MUSCLE CONDITION AFFECTS YOU 
This questionnaire is designed to see how your muscle condition affects 
you. 
You will be asked about your symptoms and how much they affect your 
life. There will be questions asking how you feel about your physical 
ability, independence, relationships, how you feel emotionally and the 
way you look. 
The last section will ask about any treatment you might receive. You will 
be asked about the effects this treatment has had and the effects you 
expect it to have. 
The information you provide will help doctors to understand your 
problems. This will mean they can work towards better care and 
treatment for you. 
Please read the questions carefully and answer all the questions that 
apply to you. Thank you. 
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QUESTION 1: - YOUR MUSCLE WEAKNESS 
1 Do you have any muscle weakness due to your muscle condition? 
By weakness we mean any weakness in your legs, arms and hands or in any other 
muscles. For example, your face, eyes, swallowing, breathing or bladder and bowel 
control may be affected. 
PLEASE TICK ONE BOX 
NO 
YES 
PLEASE GO TO QUESTION 2A (NEXT PAGE) 
Z 
a) How much weakness would you say you have in the muscles affected by 
your condition? 
PLEASE CIRCLE ONE NUMBER 
Very little Some A fair A A A lot An 
amount moderate considerable extreme 
amount amount amount 




b) Does your muscle weakness cause difficulties in your life at the moment? 
PLEASE CIRCLE ONE NUMBER 



















Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
imp rtant important important 
0 1 2 3 4 5 6". _ 
PLEASE CIRCLE ONE NUMBER 
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QUESTION 2: - THE `LOCKING' OF YOUR MUSCLES 
2 Do you have any `locking' (seizing up) of your muscles as a result of 
your muscle condition? 
PLEASE TICK ONE BOX 
NO 
YES 
PLEASE GO TO QUESTION 3A (NEXT PAGE) 
a) How much muscle `locking' would you say you have at the moment? 
PLEASE CIRCLE ONE NUMBER 
Very little Some A fair A A A lot An 
amount moderate considerable extreme 
amount amount amount 
2 3" 5' 6 -7 
b) Does the `locking' of your muscles cause difficulties in your life at the 
moment? 
PLEASE CIRCLE ONE NUMBER 
None at Some A fair A A Very An 
all amount moderate considerable many extreme 
amount amount amount 
0 ,j.. , 2' r. 3. .. _. 4 5' 6" 
How important to you are any difficulties caused by the `locking' of your 
muscles? 
PLEASE CIRCLE ONE 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
important important important 
0 1 2 ` '3 4 5 6; = 
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QUESTION 3: - YOUR PAIN 
3 Do you have any pain as a result of your muscle condition? 
PLEASE TICK ONE BOX 
NO 
YES 
-'0 PLEASE GO TO QUESTION 4A (NEXT PAGE) 
ýi 
a) How much pain would you say you have at the moment? 
PLEASE CIRCLE ONE NUMBER 
Very little Some A fair A A A lot An 
amount moderate considerable extreme 
amount amount amount 
1, 2. 3 4 5 6 ,7 
b) Does your pain cause difficulties in your life at the moment? 
PLEASE CIRCLE ONE NUMBER 
None at Some A fair A A Very An 
all amount moderate considerable many extreme 
amount amount amount 
0 1 2 3 4 5 6 
c) How important to you are any difficulties caused by your pain ? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- 


















QUESTION 4: - HOW TIRED YOU FEEL 
4 Do you feel tired/ fatigued as a result of your muscle condition? 
PLEASE TICK ONE BOX 
NO 
YES 
"0' PLEASE GO TO QUESTION 5 (NEXT PAGE) 
z 
a) How much tiredness/ fatigue would you say you have at the moment? 
PLEASE CIRCLE ONE NUMBER 
Very little Some A fair A A A lot An 
amount moderate considerable extreme 
amount amount amount 
1 2 3 4 5 6 7 
b) Does your tiredness/ fatigue cause difficulties in your life at the moment? 
PLEASE CIRCLE ONE NUMBER 
None at Some A fair A A Very An 
all amount moderate considerable many extreme 
amount amount amount 
0 1 2 3 4 5 6 
C) How important to you are any difficulties caused by your tiredness/ 
fatigue? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
important im ortant important 
0 1 2 3 4. ;.. _5 6 
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QUESTION 5: THE THINGS YOU DO 
5A At the moment, does your muscle condition affect your ability to do the 
following activities? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at Slightly A fair Moder- Consid- Very Extrem- 
all amount ately erably much ely 
1. Daily activities 0123 .456 (for example, washing, 
dressing & housework) 
H. Leisure activities 0123456 
III. Work activities 01 2° 3456 
If you have no paid employment (for example, you are unemployed or retired or you work in the home), 
please tick here Ü 
If you are not working due to your condition, please tick here Q 
B I. In the face of my condition, my ability to do all the things I want to do is: 
PLEASE CIRCLE ONE NUMBER 
Exactly as Good, but OK, but Neither Quite bad, Bad, but it The worst 
would like not quite not how I good nor but it could could be it could 
it to be how I would like bad be much worse possibly 
would like it to be worse be 
it to be 
0 1"1 , 111 2 3 ''4 '5 6 
II. How important to you is the effect of your muscle condition on your ability to 
do all the things you want to do? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important Important 
imp rtant important important 
0 1 2' 3- 4 5 6 
OR If your ability is 'exactly as you would like', please tick here 
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QUESTION 6: YOUR INDEPENDENCE 
6A At the moment, how much help do you need from other people in carrying 
out your activities? (for example, daily activities & going out) 
None at Some A fair AA Very An 
all amount moder- consid- much extreme 
ate erable amount 
amount amount 
0123456 
B I. In the face of my condition, my level of independence is: 
PLEASE CIRCLE ONE NUMBER 
Exactly as Good, but OK, but Neither Quite bad, Bad, but it The worst 
I would like not quite not how I good nor but it could could be it could 
it to be how I would like bad be much worse possibly 
would like it to be worse be 
it to be 
0ý 1 2 ' 3 1 4 5 '-6--. 
II. How important to you is the effect of your muscle condition on your 
level of independence? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- Moderate Consider- Very Extremely 
important important ably -ly ably important important 
important ortant important 
01 1. 1, k: 2. 3 4 5 . ý, 6. 
OR If your independence is'exactly as you would like', please tick here 
Q 
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QUESTION 7: YOUR RELATIONSHIPS 
7A At the moment, does your muscle condition cause any difficulties in 
your relationships with the following people? 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
None at Some A fair A 
all amount moder- 
ate 
amount 
I. Partner/ spouse 0123 
If you are not married or in a relationship at the moment 
or if you are widowed please tick here Q 
11. Other family '0 123 
members 
III. Friends 
IV. Other people 




A Very An 





B I. In the face of my condition, my close family relationships are: 
PLEASE CIRCLE ONE NUMBER 
6 
Exactly as Good, but OK, but Neither Quite bad, Bad, but The worst 
I would not quite not how I good nor but they they could they could 
like them how I would like bad could be be worse possibly 
to be would like them to be much be 
them to be worse 
0 1 2, ` 3 4, 5, -, 6 
II. How important to you is the effect of your muscle condition on your 
close family relationships? 
rLEASE GARGLE ONE NUMBE R 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
important important important 
0- 1 2: '"3 , 4 5 6` 
OR If your close family relationship are 'exactly as you would like', please tick here 
Q 
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III. In the face. of my condition, my close friendships are: 
PLEASE CIRCLE ONE NUMBER 
Exactly as Good, but OK, but Neither Quite bad, , 
Bad, but The worst 
I would not quite not how I good nor but they they could they could 
like them how I would like bad could be be worse possibly 
to be would like them to be much be 
them to be worse 
:0 2'" 3 4 5. ..,,. 6, 
IV. How important to you is the effect of your muscle condition on your close 
friendships? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
imp rtant important important 
=0 _ 1 , 2s , ;3,. 4 5` . . .6 
OR If your close friendships are 'exactly as you would like', please tick here 0 
V. In the face of my condition, my relationships with other people (for example, 
acquaintances, strangers and colleagues) are: 
PLEASE CIRCLE ONE NUMBER 
Exactly as Good, but OK, but Neither Quite bad, Bad, but The worst' 
I would not quite not how I good nor but they they could they could 
like them how I would like bad could be be worse possibly 
to be would like them to be much be 
them to be worse 
0 1 2 3 4 5 6 
VI. How important to you is the effect of your muscle condition on your 
relationships with these other people? 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
important important important 
0,... _, 2 3 4 5 6 
QUESTION 8: HOW YOU FEEL 
8A At the moment, does your muscle condition make you feel: 
PLEASE CIRCLE ONE NUMBER FOR EACH ITEM 
Not at Slightly A fair Moder- Consid- Very Extrem- 
all bit atel erably much ely 
1. Anxious/worried ý0123456 
II. Depressed 0123 4` 56 
III. Frustrated 0123 





B I. In the face of my condition, the way I feel emotionally is: 
Exactly as Good, but OK, but Neither Quite bad, Bad, but I The worst 
I would not quite not how I good nor but I could could be I could 
like to be how I would like bad be much worse possibly 
would like to be worse be 
to be 
0 1 2 3 4 5 ', 6 
II, How important to you is the effect of your muscle condition upon the way 
you feel emotionally? 
t'LEASE CIRCLE ONE NUMBE R 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
imp ortant important important 
0 .1 .2 , , 3, 4 , 15 
. 6., 
OR If the way you feel emotionally is 'exactly as you would like', please tick here 
Q 
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QUESTION 9: - THE WAY YOU LOOK 
9A At the moment, does your muscle condition affect the way you look? 
Your muscle condition might affect the way your body, face or skin looks or perhaps 
the way you move or whether to need to use a stick or wheelchair. 
PLEASE CIRCLE ONE NUMBER 
Not at Slightly A fair AA Very An 
all amount moder- consid- much extreme 
ate erable amount 
amount amount 
0123456 
B I. In the face of my condition, the way I look is: 
PLEASE CIRCLE ONE NUMBER 
Exactly as 
I would 















4 5 6 
lie How important to you is the effect of your muscle condition upon the way 
you look? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
imp ortant important important 
OR If the way you look is 'exactly as you would like', please tick here 
OK, but 
not how I 
would like 
to be 









QUESTION 10: TREATMENT 
10A Do you receive, or are you about to start receiving treatment for your 
muscle condition? (For example, tablets, injections or physiotherapy) 
PLEASE TICK ONE BOX 
NO 
YES 
PLEASE GO TO PAGE 14 (LAST PAGE) 
ýl 
I. Do you feel the treatment you receive for your muscle condition has had 
beneficial effects? 
PLEASE CIRCLE ONE NUMBER 
None at Some A fair A moder- A consid- Very An 
all amount ate erable many extreme 
amount amount amount 
0 1" 2' ,, '3 .. -' 4' 56 
If you are not yet receiving treatment, please tick here 
If you are unsure, please tick here Q 
ii. 
None at Some A fair AA Very An 
all amount moder- consid- many extreme 
ate erable amount 
amount amount 
0' 1.2 3456 
If you are unsure, or if you have not thought about it please tick here 
III. How important to you are the beneficial effects of treatment? 
0 
Do you feel the treatment you receive for your muscle condition will have 
beneficial effects in the future? 
PLEASE CIRCLE ONE NUMBER 
PLEASE CIRCL E ONE NUMBER 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
important important important 
0 1 2 3 4 5 6 
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10B I. Do you feel the treatment you receive for your muscle condition has 
had harmful side effects? 
PLEASE CIRCLE ONE NUMBER 
None at Some A fair A moder- A consid- Very An 
all amount ate erable many extreme 
amount amount amount 
0123456 
If you are not yet receiving treatment, please tick here Q 
If you are unsure, please tick here Q 
H. Do you think the treatment you receive for your muscle condition 
will have side effects in the future? 
PLEASE CIRCLE ONE NUMBER 
None at Some A fair AA Very An 
all amount moder- consid- many extreme 
ate erable amount 
amount amount 
t^2 4 5: 6 
If you are unsure, or if you have not thought about it please tick here Q 
III. How important to you are the side effects of treatment? 
PLEASE CIRCLE ONE NUMBER 
Not at all Quite Reason- Moderate- Consider- Very Extremely 
important important ably ly ably important important 
important important important 
0 '2 3' 4 :5 6 
PLEASE TURN OVER 
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Comments 
If you have any comments you would like to make about your pondition and the 
way it affects you, please use the space below. 
Your name (please print): 
Today's date: II 
THANK YOU VERY MUCH FOR YOUR HELP 
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Appendix F: Missing data. Instructions for scoring 
Quns 1-4 
1A-4A If missing and rest of symptom qun missing (i. e. part B) -> score zero 
113-413 a If missing, score '1' 
b If missing, impute previous value (part a) 
c If missing, score '0' 
Qun 5 
5A If an item item missing, sum completed items, and multiply by 6 if two items 
completed and 12 if only one item has been completed (to get score out of 72) 
(N. B. Work activities' item: if not working due to condition score '6' and count as a completed 
item). 
EXAMPLE: If 'Leisure activities' is missing, add values of 'Daily activities' & Work 
Activities'. Multiply this by 6. 
BI If missing, impute average of completed 'activities' items (from 5A) 
1311 If missing, score as'0' 
Qun 6 
6A If missing, score as'0' 
BI If missing, impute value from 6A 
1311 If missing, score as '0' 
Qun 7 
7A If item missing, sum the completed items and multiply by 4 if three completed items, 
6 if two completed items and 12 if one completed item. 
BI If missing, impute average of 7a items - I) Relationship with spouse/partner & 
ii) Relationship with other family members. 
BII If missing, score as'0' 
Bill If missing, impute value from 'Friends' (7AIII) item 
BIV If missing, score as '0' 
BV If missing, impute value from 'Other people' (7AIV) item 
BVI If missing, score as'0' 
Qun 8 
8A If item missing, sum the completed items and multiply by 4 if three completed items, 
6 if two completed items and 12 if one completed item. 
BI If missing, impute average of items completed in 8A 
BII If missing, score as'O' 
Qun 9 
9A If missing, score as'0' 
BI If missing, impute value from 9a 
1311 If missing, score as'0' 
Qun 10 
10A I If missing, score as '0' 
II If missing, score as '0' 
III If missing, score as'0' 
10B I If missing, score as'0' 
II If missing, score as '0' 
III If missing, score as'0' 
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Appendix G: INQoL Scoring Scheme and Profile Sheet 
1. Weakness score = (a+b+c) 119 X 100 
2. Muscle `locking' score = (a+b+c) / 19 X 100 
3. Pain score = (a+b+c) / 19 X 100 
4. Fatigue score = (a+b+c) / 19 X 100 
5. Activities score = [4 X (AI+AII+AIIl)] + [3 X (Bl+Bll)] / 108 X 100 
If not working due to condition item - AIII=6 
If retired/unemployed/work in home (not as a result of condition) 
-> [6 X (AI+AII)] + [3 X (BI+Bl1)] /108 x 100 
6. Independence score = [12 X A] + [3 X (BI+Bll)] 1108 x 100 
7. Social relationships = [3X(AI+All+Alll+AIV)+Bl+II+III+IV+V+VI] 1108 x 100 
If partner/spouse item(AI) not applicable : 
4 [4 X (AII+AIII+AIV)] + [BI+II+III+IV+V+Vl] / 108 x 100 
8. Emotions score = [3 X (AI+AII+AIII)] + [3 X (BI+BII)] / 108 x 100 
9. Body Image score = [12 X (A)] + [3 X (BI+BII)] / 108 X 100 
10. QoL score 
Add scores of items in section B for questions 5-9, divide total score by 180 and multiply by 100 
(to achieve percentage score) 
11. Perceived Treatment effects = [(AI+AIIi) - (BI+BIII)] / 12 x 100 
Expected treatment effects = [(AII+Alll) - (BII+BIlI)] / 12 x 100 
INQoL Profile 










Body Ima e 
'Treätrrment`effects ý` ýScöres ` 
; -1 Ö0 to.. +100 
Perceived treatment effects 
Expected treatment effects 
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inaiviauansed Neuromuscular Quality of Life Profile Date 
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muscle weakness muscle 'locking' fatigue 
_..... _ ... . 
Activities Independence Relationships Emotions Body image 
Perceived treatment effects (-100 to +100) 
Expected treatment effects (-100 to +100) 
Negative impact upon quality of life 









I) I lunt, McKenna & Mc1 wen 1980 
Listed below are some problems people might have in their daily lives. 
Read the list carefully and put a tick in the box under Yes for any problem 
that applies to you at the moment. Tick the box under No for any 
problem that does not apply to you. 
Please answer every question. If you are not sure whether to answer yes 
or no, tick whichever answer you think is most true at the moment. 
Yes No 
I'm tired all the time QQ 
I have pain at night QQ 
Things are getting me down QQ 
Yes No 
I have unbearable pain QO 
I take tablets to help me sleep QQ 
I've forgotten what it's like to enjoy myself OO 
I'm feeling on edge 
I find it painful to change position 





Please turn over 
C Hunt, McKama & McEwan 1980 
Yes No 
I can only walk about indoors QQ 
I find it hard to bend QQ 
Everything is an effort QQ 
I'm waking up in the early hours of the morning 
I'm unable to walk at all 





Remember, if you are not sure whether to answer yes or no to a problem, 
tick whichever answer you think more true at the moment. 
The days seem to drag 
I have trouble getting up and down stairs or steps 
I find it hard to reach for things 
I'm in pain when I walk 
I lose my temper easily these days 









Please turn over 
0 Hunt, McKama & McEwan 1980 2 
Yes No 
I lie awake for most of the night Q 
I feel as if I'm losing control QQ 
I'm in pain when I'm standing QQ 
Yes No 
I find it hard to dress myself QQ 
I soon run out of energy QQ 
I find it hard to stand for long QQ 
(e. g. at the kitchen sink, waiting for a bus) 
Yes No 
I'm in constant pain QQ 
It takes me a long time to get to sleep QQ 
I feel I am a burden to people QQ 
Worry is keeping me awake at night 
I feel that life is not worth living 





Please turn over 
3 
Yes No 
I'm finding it hard to get on with people QQ 
I need help to walk about outside QQ 
(e. g. a walking aid or someone to support me) 
Yes No 
I'm in pain when going up and down stairs or steps QQ 
I wake up feeling depressed QQ 
I'm in pain when I'm sitting QQ 
Now please go back to page 1 and make sure that you have answered "Yes" 
or "No" to every question, on all four pages of the questionnaire. 
Thank you for your help 
O Hunt, McKenna & McEwan 1980 
9907ms001-UK English d 
SF-36 HEALTH SURVEY 
i 
INSTRUCTIONS: This survey asks for your views about your health. This information will help keep track of 
how you feel and how well you are able to do your usual activities. 
Answer every question by marking the answer as indicated. If you are unsure about how to answer a 
question, please give the best answer you can. 











2. Compared to one year ago, how would you rate your health in general now? 
(circle one) 
Much better now than one year ago ........................................................................... 1 
Somewhat better now than one year ago ................................................................... 2 
About the same as one year ago ................................................................................ 3 
Somewhat worse now than one year ago ................................................................... 4 
Much worse now than one year ago ...................... 5 ..................................................... 
Copyright O 1992 Medical Outcomes Trust. 
1 
All rights reserved. 
(SF-36 Standard U. K. Version 1.0) 
3. The following questions are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? 











a. Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports 
1 2 3 
b. Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf 
1 2 3 
c. Lifting or carrying groceries 1 2 3 
d. Climbing several flights of stairs 1 2 3 
e. Climbing one flight of stairs 1 2 3 
f. Bending, kneeling, or stooping 1 2 3 
g. Walking more than a mile 1 2 3 
h. Walking half a mile 1 2 3 
i. Walking one hundred yards 1 2 3 
j. Bathing or dressing yourself 1 2 3 
4. During the past 4 weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of your physical health? 
circle one number on each line) 
YES NO 
a. Cut down on the amount of time you spent on work or other 
activities 
1 2 
b. Accomplished less than you would like 1 2 
c. Were limited in the kind of work or other activities 1 2 
d. Had difficulty performing the work or other activities (for 
example, it took extra effort) 
1 2 
2 
Copyright ®1992 Medical Outcomes Trust. 
All rights reserved. 
(SF-36 Standard U. K. Version 1.0) 
5. During the past 4 weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of any emotional problems (such as feeling depressed or anxious)? 
circle one number on each line) 
YES NO 
a. Cut down on the amount of time you spent on work or other activities 1 2 
b. Accomplished less than you would like 1 2 
c. Didn't do work or other activities as carefully as usual 1 2 
6. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with 
your normal social activities with family, friends, neighbours, or groups? 
(circle one) 






























Copyright ®1992 Medical Outcomes Trust. 
All rights reserved. 
(SF-36 Standard U. K Version 1.0) 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both work 
outside the home and housework)? 
(circle one) 
Not at all ....................................................................................................................... 
1 










9. These questions are about how you feel and how things have been with you during the past 4 weeks. 
For each question, please give the one answer that comes closest to the way you have been feeling. 
How much of the time during the past 4 weeks - 
circle one number on each line) 
.. A Good 
A Little 
All Most Bit of Some of the None 
of the of the the Time of the Time of the 
Time Time Time rime 
a. Did you feel full of life? 1 2 3 4 5 6 
b. Have you been a very nervous 1 2 3 4 5 6 
person? 
c. Have you felt so down in the 1 2 3 4 5 6 
dumps that nothing could cheer 
you up? 
d. Have you felt calm and peaceful? 1 2 3 4 5 6 
e. Did you have a lot of energy? 1 2 3 4 5 6 
f. Have you felt downhearted and 1 2 3 4 5 6 
low? 
g. Did you feel worn out? 1 2 3 4 5 6 
h. Have you been a happy person? 1 2 3 4 5 6 
i. Did you feel tired? 1 2 3 4 5 6 
a Copyright e 1992 Medical Outcomes Trust. 
AR rights reserved. 
(SF-36 Standard U. K. Version 1.0) 
10. During the past 4 weeks, how much of the time has your physical health or emotional Problems 
interfered with your social activities (like visiting with friends, relatives, etc. )? , 
(circle one) 
All of the time ............................................................................................................... 
1 
Most of the time ........................................................................................................... 
2 
Some of the time ......................................................................................................... 
3 
A little of the time ......................................................................................................... 
4 
None of the time .......................................................................................................... 
5 
11. How TRUE or FALSE is each of the following statements for you? 











a. I seem to get ill more easily than other 
people 
1 2 3 4 5 
b. I am as healthy as anybody I know 1 2 3 4 5 
c. I expect my health to get worse 1 2 3 4 5 
d. My health is excellent 1 2 3 4 5 
5 
Copyright ®1992 Medical Outcomes Trust. 
AN rights reserved. 
(SF-36 Standard U. K Version 1.0) 
FUNCTIONAL LIMITATIONS PROFILE (FLP) ® crown copyright 
We are interested in the activities that you do in carrying on your life and any changes 
that describe you today that are related to your health. 
This questionnaire lists statements that describe things people often do when they are 
not well. Even if you think you are well, some of these statements may stand out, 
because they describe you and are related to your health. As you read each statement 
in the questionnaire, think of yourself today. When you read a statement that 
describes you and is related to your health, place a tick in the box to the right of the 
statement. 
For example: 
I am not driving my car 
If you have not been driving for some time because of your health and are still not 
driving today, you should tick this statement. On the other hand, if you never drive or 
are not driving today because you car is being repaired, you should not tick it. Tick a 
statement only if you are sure it describes you and is due to health. 
AMBULATION ITEMS 
The following statements describe walking and use of stairs. Remember, think of 
yourself today. 
Only tick an item if it describes you and is due to your health. 
1. I walk shorter distances or often stop for a rest. 
2. I do not walk up or down hills. 
3. I only use stairs with a physical aid; for example, a handrail, stick or 
crutches. 
4. I only go up and down stairs with assistance from someone else. 
5. I get about in a wheelchair. 
6. I do not walk at all. r-I 
7. I walk by myself but with some difficulty; for example, I limp, wobble, 
stumble or I have a stiff leg. 
8.1 only walk with help from someone else. 
9. I go up and down stairs more slowly; for example, one step at a time or I 
often have to stop. 
10. I do not use stairs at all. 
11. I get about only by using a walking frame, crutches, stick, walls, or hold 
on to furniture. 
12.1 walk more slowly. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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BODY CARE AND MOVEMENT ITEMS 
The following statements describe how you move about, bath, go to the toilet, dress 
yourself today. 
Only tick an item if it describes you and is due to your health. 
13.1 make difficult movements with help; for example getting in or out of the 
bath or car. 
14. I do not get in and out of bed or chairs without the help of a person or 
mechanic aid. 
15.1 only stand for short periods of time. 
16.1 do not keep my balance. 
17.1 move my hands or fingers with some difficulty or limitation. 
18.1 only stand up with someone's help. 
19.1 kneel, stoop or bend down only by holding onto something. 
20.1 am in a restricted position all the time. 
21.1 am very clumsy. 
22. I get in and out of bed or chairs by grasping something for 
support or by using a stick or walking frame. 
23.1 stay lying down most of the time. 










25. I hold onto something to move myself around in bed. 
26. I do not bathe myself completely; for example, I need help with 
bathing. 
27. I do not bathe myself at all, but am bathed by someone else. 
28. I use a bedpan with help. 
29. I have trouble putting on my shoes, socks, or stockings. 
30. I do not have control of my bladder. 
31. I do not fasten my clothing; for example, I require assistance with 
buttons, zips or shoelaces. 
Q 
32. I spend most of the time partly dressed or in pyjamas. 
33. I do not have control of my bowels. 
34. I dress myself, but do so very slowly. 
35.1 only get dressed with someone's help. Q 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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MOBILITY ITEMS 
These next statements describe how you get about the house and outside. 
Only tick an item if it describes you and is due to your health. 
36. I only get about in one building. 
37. I stay in one room. 
38. I stay in bed more. 
39. I stay in bed most of the time. 
40. I do not use public transport now. 
41. I stay at home most of the time. 
42. I only go out if there is a lavatory nearby. 
43. I do not go into town. 
44. I only stay away from home for short periods. 
45. I do not get about in the dark or in places that are not lit unless I 
have someone to help. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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HOUSEHOLD MANAGEMENT ITEMS 
The following statements describe your daily work, around the home. When you 
answer, think of yourself today. 
Only tick an item if it describes you and is due to your health . 
46. I only do housework or work around the house for short periods 
of time or I rest often. 
47.1 do less of the daily household chores than I would usually do. 
48. I do not do any of the daily household chores that I would 
usually do. 
49. I do not do any of the maintenance or repair work that I would 




50. I do not do any of the shopping that I would usually do. 
51. I do not do any of the cleaning that I would usually do. 
Q 
52. I have difficulty using my hands; for example, turning taps, using 
kitchen gadgets, sewing or doing repairs. 
53. I do not do any of the clothes washing that I would usually do. 
54. I do not do heavy work around the house. 
55. I have given up taking care of personal or household business 
affairs: for example. oavina bills. banking or doinq household accounts. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS IN THIS SECTION Q 
RECREATION AND PASTIME ITEMS 
The following statements describe the activities you usually do in your spare time, for 
relaxation, entertainment or just to pass the time. Again, think of yourself today. 
Only tick an item if it describes you and Is due to your health. 
56.1 spend shorter periods of time on my hobbies and recreation. 
57. I go out less often to enjoy myself. 
58. I am cutting down on some of my usual inactive pastimes; for example, I 
watch TV less, play cards less, or read less. 
59. I am not doing any of my usual inactive pastimes; for example, I do not 
watch TV, play cards, or read. 
60. I am doing more inactive pastimes instead of my other usual activities. 
61.1 take part in fewer community activities. 
62. I am cutting down on some of my usual physical recreation or more 
active pastimes. 
63.1 am not doing any of my usual physical recreation or more active 
I pastimes. 
Q 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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SOCIAL INTERACTION ITEMS 
These statements describe your contact with family and friends today. 
Only tick an item if it describes you and is due to your health. 
64.1 go out less often to visit people. 
65.1 do not go out at all to visit people. 
66. I show less interest in other people's problems; for example, I don't 
listen when they tell me about their problems; I don't offer to help. 
0 
0 
67. I am often irritable with those around me; for example, I snap at people 
or criticise easily. 
68.1 show less affection. 0 
69. I take part in fewer social activities than I used to; for example, I 
go to fewer parties or social events. 
70.1 am cutting down the length of visits with friends. 
71.1 avoid having visitors. 
10 
0 
72. My sexual activity is decreased. 
I 73. I often express concern over what might be happening to my 
health. 
74.1 talk less with other people. 10 
75. I make many demands on other people; for example, I insist that they do 
things for me or tell them how to do things. 
0 
76.1 stay alone much of the time. 1 1: 1 
77. I am disagreeable with my family; for example, I act spitefully or 
stubbornly. Q 
78. I frequently get angry with my family; for example, I hit them, scream or 1-17 
throw things at them. 
79.1 isolate myself as much as I can from the rest of my family. 
80.1 pay less attention to the children. 
u 
--EF 
81. I refuse contact with my family; for example, I turn away from 
them. 
82.1 do not look after my children or family as well as I usually do. 
83.1 do not joke with members of my family as much as I usually do. I Li 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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EMOTION ITEMS 
The next statements describe your feelings and behaviour. Again, think of yourself 
today. 
Only tick an item if it describes you and is due to your health. 
84. I say how bad or useless I am; for example, that I am a burden on 
others. 
85. I laugh or cry suddenly. 
86. I often moan and groan because of pain or discomfort. 
87. I have attempted suicide. Q 
88. I behave nervously or restlessly. 
89. I keep rubbing or holding areas of my body that hurt or are 
uncomfortable. 
90. I am irritable and impatient with myself; for example, I run myself down, 
I swear at myself, I blame myself for things that happen. 
Q 
91. I talk hopelessly about the future. 
92.1 get sudden frights. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS IN THIS SECTION Q 
ALERTNESS ITEMS 
93.1 am confused and start to do more than one thing at a time. 
94.1 have more minor accidents; for example, I drop things, I trip and fall, or 
I bump into things. 
95. I react slowly to things that are said or done. 
96. I do not finish things I start. 
97. I have difficulty reasoning and solving problems; for example, making 
plans, making decisions, or learning new things. 
98. I sometimes get confused; for example, I do not know where I am, who 
is around, or what day it is. 
99. I forget a lot; for example, things that happened recently, where I put 
things, or to keep appointments. 
77 
100. I do not keep my attention on any activity for long. Q 
101. I make more mistakes than usual. 
102.1 have difficulty doing things which involve thought and concentration. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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SLEEP AND REST ITEMS 
These statements describe your sleep and rest activities today. 
Only tick an item if it describes you and is due to your health. 
103.1 spend much of the day lying down to rest. 
104.1 sit for much of the day. 
105.1 sleep or doze most of the time, day and night. 
106.1 lie down to rest more often during the day. 
107.1 sit around half asleep. 
108. I sleep less at night; for example, I wake up easily, I don't 
fall asleep for a long time, or I keep waking up. 








TICK HERE WHEN YOU HAVE READ ALL STATEMENTS IN THIS SECTION Q 
EATING ITEMS 
The following statements describe your eating and drinking habits. 
Only tick an item if it describes you and is due to your health. 
110. I eat much less than usual. 
111. I feed myself but only with specially prepared food or special utensils. 
- 112. I eat special or di ff erent food; for example, I follow a soft food, bland, 
low salt, low fat, or low sugar diet. 
113.1 eat no food at all, but I take liquids. 
114. I just pick or nibble at my food. 
115.1 drink less fluids 
116. I feed myself with help from someone else. 
- 117. I do not feed myself at all but have to be fed. 
118.1 eat no food at all except by tubes or intravenous infusion. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE Q 
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COMMUNICATION ITEMS 
These statements are about how much you talk to other people and write. 
Please think about yourself today. 
Only tick an item if it describes you and is due to your health. 
119. I have trouble writing or typing. 
120. I communicate mostly by nodding my head, pointing, or using 
sign language, or other gestures. 
121. My speech is understood only by a few people who know me well. Q 
122. I often lose control of my voice when I talk; for example, my voice gets 
louder or softer or changes unexpectedly. 
123. I don't write except to sign my name. 
124. I carry on a conversation only when very close to other 
people or looking directly at them. 
Q 
125. I speak with difficulty; for example, I get stuck for words, I stutter, I 
stammer, I slur my words. 
126. I am understood with difficulty. 
127.1 do not speak clearly when I am under stress. 
TICK HERE WHEN YOU HAVE READ ALL STATEMENTS ON THIS PAGE 0 
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WORK ITEMS 
The next group of statements has to do with any work you usually do 
other than managing your home. By this we mean anything that you regard as work 
that you do-on a regular basis. 
Do you usually do work other than managing your home? YES Q NO Q 
IF YES, COMPLETE THE WORK SECTION. 
IF NO: 
Are you retired? YES Q NO E] 
If you are retired, was your retirement due to your health? YES Q NO Q 
If you are not retired, but are not working, is this due to 
your health? YES Q NO Q 
IF YES TO EITHER OF THE PREVIOUS 2 STATEMENTS, PLEASE TICK ITEM 128 
AND SKIP THE REST OF THE ITEMS IN THIS SECTION. 
IF NO, PLEASE SKIP THIS SECTION. 
Only tick an item if it describes you and is due to your health. 
128. I do not work at all (INCLUDES RETIRED BECAUSE OF HEALTH) 
129. I do part of my job at home. 
130. I am not getting as much work done as usual. 
131. I often get irritable with my workmates; for example, I snap 
at them or criticise them easily. 
132. I work shorter hours. 
133.1 only do light work. 
134. I only work for short periods of time or often stop to rest. 
135. I work at my usual job but with some changes; for example, I use 
different tools or special aids or I swap jobs with someone else. 
136.1 do not do my job as carefully and accurately as usual. 
















ýN= Co y w' N C'0 0... C Co C.. ý0Np0 (1) 0C 
EE 
A0 C 
$"ý äý'S ý} ö a ö3Z'3ýöc}: ° 
oaý0t°O c`º-'rnoEEöýc 
yý 
























8 l0 tA 





2! >+ Co 
N«+ OYOO 7/L) O-6, 
ß 
M he 
0 . -e ýCY. 0 
>3 `3 ýO 3 ca 
3 º- 3E 
U_ >0 :g>3tý. ºý- wÜNý 32 
yýr- o 3Zcöc r. - 
3ý.. - 
0 t2 QO Cl. (1) 7 j,.. L Co mC 08 
ö °ö °o öý 0 ý°. 3cö , yo. cv c r, Co ac ý.. 
ý''`° k".. O= .50.. 3 výN a0 is m cm 0 NÖ0N` oý =ý ö Zy d 
ay cýý L 
Ü>Cýmtimd°>V ý 






























- öý Cl) r- E- v Eo 
öv cvCL 
g 
CL öt ac i« 3.. n(1) 
Muscle Weakness Visual Analogue Scale 
How bad is your muscle weakness? Please mark an X on the line 







Muscle `Locking' Visual Analogue Scale 
How bad is your muscle `locking' (how much do your muscles seize up)? 
Please mark an X on the line below, at the point that best describes your 
muscle `locking' at the moment. 
No I1 EXTREME 
LOCKING LOCKING 
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Pain Visual Analogue Scale 
How bad is your pain? Please mark an X on the line below, at the point 




FATIGUE QUESTIONNAIRE (Chalder et a], 1993) 
We would like to know whether or not you have been having any problems with feeling 
tired, weak or lacking in energy in the last few weeks. Please answer ALL the questions 
simply by underlining or circling the answer which you think most nearly applies to you. 
We would like to know how you feel either at the moment or recently, rather than a long 
time ago. If you have been feeling tired for a long time, we want you to compare yourself to 
how you felt when last well. 
Do you have Less No more More Much more 
problems with than usual than usual than usual than usual 
tiredness? 
Do you need Less 
to rest more? than usual 
Do you feel Less 
sleepy or drowsy? than usual 
Do you have 
problems starting 
things? 
Do you lack 
energy? 
Do you have less 
strength in your 
muscles? 
No more More Much more 
than usual than usual than usual 
No more More Much more 
than usual than usual than usual 
Less than No more 
usual than usual 
More Much more 
than usual than usual 
Better than No more 
usual than usual 
Better than No more 
usual than usual 
Do you feel weak? Less Same 
than usual as usual 
Do you have Less Same 
difficulty than usual as usual 
concentrating? 
Do you make slips Less No more 
of the tongue when than usual than usual 
speaking? 
More than Much more 
usual than usual 
More than Much more 
usual than usual 
More Much more 
than usual than usual 
More Much more 
than usual than usual 
More Much more 
than usual than usual 
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Do you find it Less No more More Much more 
more difficult to than usual than usual than usual than usual 
find the correct word? 
How is your Better No worse Worse Much worse 
memory? than usual than usual than usual than usual 
The next questions ask about muscle pain. 
Do your muscles Less No more Worse Much worse 
hurt at rest? than usual than usual than usual than usual 
Do your muscles Less No more Worse Much worse 
hurt after exercise? than usual than usual than usual than usual 
If you are tired at the moment, please indicate approximately how long this has lasted. 
Less than Less than Between 36 months 
1 week 3 months &6 months or more 
Overall, what percentage of the time do you feel tired? 
25% of the 50% of the 75% of the All the 
time time time time 




0= incontinent (or need to be given enemata) 
1= occasional accident (once a week) 
2= continent 
Bladder 
0= incontinent, or catheterised and unable to manage alone 
1= occasional accident (maximum once per 24 hours) 
2= continent 
Grooming 
0= Need help with personal care 
I= Independent face/hair/teeth/shaving (implements provided) 
Toilet use. 
0= Dependent 
1= Needs some help, but can do something alone 
2= Independent (on and off, dressing, wiping) 
Feeding 
0= Unable 
1= Needs help cutting, spreading butter etc. 
2= Independent 
Transfer (bed to chair and back) 
0= Unable, no sitting balance 
1= Major help (one or two people, physical), can sit 




1= Wheelchair independent, including corners 
2= Walks with help of one person (verbal or physical) 
3= Independent (but may use any aid; for example stick) 
Dressing 
0= Dependent 
1= Needs help but can do about half unaided 
2= Independent (including buttons, zips, laces, etc. ) 
Stairs 
0= Unable 




1= Independent (or in a shower) 
Total (0-20) 
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Social Support Questionnaire (Six Item Short Form. SSQ6 
The following questions ask about people in your environment who provide 
you with help or support. Each question has two parts. 
For the first part, list all the people you know, excluding yourself, whom you 
can count on for help or support in the manner described. Give the 
person's initials and their relationship to you (see example). 
Do not list more than one person next to each of the letters beneath the 
question. 
For the second part, circle how satisfied you are with the overall support 
you have. If you have no support for a question, tick the words "No one", 
but still rate your level of satisfaction. 
Do not list more than nine persons per question 
Please answer all questions as best you can. All your responses will be 
kept confidential. 
EXAMPLE 
Who do you know whom you can trust with information that could get you into 
trouble? 
No one Q 1) T. N. (brother) 4) T. N (father) 7) 
2) L. M. (friend) 5) L. N. (employer) 8) 
3) R. S. (friend) 6) 9) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
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1. Whom can you really count on to distract you from your worries when you 
feel under stress? 
No one Q 1) 4) 7) 
2) 5) 8) 
3) 6) 9) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
2. Whom can you really count on to help you feel more relaxed when you are 
under pressure or tense? 
No one Q 1) 4) 7) 
2) 5) 8) 
3) 6) 9) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
3. Who accepts you totally, including both your worst and your best points? 




6) 9) 3) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
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4. Whom can you really count on to care about you, regardless of what is 
happening to you? 
No one Q 1) 4) 7) 
2) 5) 8) 
3) 6) 9) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
5. Whom can you really count on to help you feel better when you are feeling 
generally down-in-the-dumps? 
No one Q 1) 4) 7) 
2) 5) 8) 
3) 6) 9) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
6. Whom can you count on to console you when you are very upset? 




6) 9) 3) 
How satisfied? 
6- very 5- fairly 4- a little 3- a little 2- fairly 1- very 
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied 
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HAD SCALE 
Reproduced for display only 
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Hospital Anxiety and 












item below and underline the reply which comes closest to how you have been feeling 
3ýh6- 
NFER-NELSON 
I. Polmloo town Doc/slows 
Name: Date: 
Clinicians are aware that emotions play an important part in most illnesses. If your 
clinician knows about these feelings he or she will be able to help you more. 
C4 1 This questionnaire is designed to help . your clinician 
to know how you feel. Read each 
Don't take too long over your replies, your immediate reaction to each item will 
probably be more accurate than a long, thought-out response. 
;, o in the past week. Ignore the numbers printed at the edge of the questionnaire. 
Q., 
0 
I oJ i; 
J 
.1 feel tense or `wound up' Most of the time 
A lot of the time 
From time to time, occasionally 
Not at all 
I still enjoy the things I used to enjoy 
Definitely as much 
Not quite so much 
Only a little 
Hardly at all 
t get a sort of frightened feeling as if 
something awful is about to happen 
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all 
t can laugh and see the funny side of things 
As much as I always could 
Not quite so much now 
Definitely not so much now 
Not at all 
Worrying thoughts go through my mind 
A great deal of the time 
A lot of the time 
Not too often 
Very little 




Most of the time 









I feel as if I am slowed down 
Nearly all the time 
Very often 
Sometimes 
Not at all 
I get a sort of frightened feeling like 
'butterflies' in the stomach 




I have lost interest in my appearance 
Definitely 
I don't take as much care as I should 
I may not take quite as much care 
I take just as much care as ever 
I feel restless as if I have to be on 
the move 
Very much indeed 
Quite a lot 
Not very much 
Not at all 
I look forward with enjoyment to things 
As much as I ever did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all 
I get sudden feelings of panic 
Very often indeed 
Quite often 
Not very often 
Not at all 






Now check that you have answered all the questions 
/ 
This form is printed in green. Any other colour is an unauthorized photocopy. 
IIADS Copyright ! )R. 1'. Snaith and AS. Ziemond. 1083_ I)9? _ I991. 
TOTAL 
Record torn, items originally published in Acnt p yihiun-AV Se a', dinct; 1e « 67,361 70. copyright h, Munksgaard International 
Publishers Ltd. Copenhagen, 1983. 
This edition first published in 1994 by The NFLR-NII. SON Publishing Company LId. Darville I louse, 2 Oxford Road Last. 
Windsor, lk rkshire SL4 I DF, UK. All rights reserved. 
The Arthritis Body Experience Scale (ABES) (Williams & Barlow, 1998) 
Adapted for Neuromuscular Disease 
These statements relate to the IMPACT of your MUSCLE DISEASE on your 
BODY. Please circle the appropriate number to indicate your agreement or 
disagreement with each statement on a scale of 1 (strongly disagree) to 10 
(strongly agree). 
1. I am happy with my body 
strongly disagree strongly agree 
123456789 10 
2. I am self-conscious about my body 
strongly disagree strongly agree 
123456789 10 
3. I am self-conscious about the parts of my body affected by 
muscle disease that are visible to others 
strongly disagree strongly agree 
123456789 10 
4. I wear particular clothing to hide certain parts of my body 
affected by my muscle disease 
strongly disagree strongly agree 
123456789 10 
5. I am happy with my posture 
strongly disagree strongly agree 
123456789 10 
6.1 am embarrassed about the parts of my body affected by 
413 
my muscle disease 
strongly disagree strongly agree 
123456789 10 
7. I am happy with the way I walk 
strongly disagree strongly agree 
123456789 10 
8. My body is physically attractive 
strongly disagree strongly agree 
123456789 10 
9. I am concerned with the physical fitness of my body 
strongly disagree strongly agree 
123456789 10 
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